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Zusammenfassung 
Im Rahmen dieser Arbeit wurden zwei Ansätze genutzt, um neue Einblicke bezüglich der 
Identität und molekularen Regulation inhibitorischer Interneurone im Gehirn zu erlangen. 
Zum einen wurde eine generelle molekulare Charakterisierung GABAerger Interneuron-
Subpopulationen durchgeführt, zum anderen wurden neue Regulatoren der Bulbus Olfaktorius 
Interneuron-Differenzierung identifiziert und funktionell analysiert. 
 
GABAerge Neurone, die häufigsten inhibitorischen Nervenzellen im Gehirn, sind essentiell 
für die korrekte Informationsverarbeitung im zentralen Nervensystem. Während die große 
Mehrheit dieser Zellen lokal projizierende Interneurone sind, findet man in einigen Arealen 
wie dem Striatum auch GABAerge Projektionsneurone. Bisher wurden GABAerge Neurone 
anhand einiger biochemischer, morphologischer und elektrophysiologischer Eigenschaften 
charakterisiert. Da aber keine strikte Korrelation zwischen diesen Faktoren existiert, gelang es 
bisher nicht, Subpopulationen GABAerger Zellen systematisch zu unterteilen.  
Im ersten Teil dieser Arbeit wurden die generellen molekularen Eigenschaften GABAerger 
Neurone analysiert und Unterschiede zwischen verschiedenen Hirnarealen definiert. Dazu 
wurden fluoreszent markierte GABAerge Neurone aus transgenen GAD67-GFP Mäusen mit 
Hilfe der FACS Technologie aus dem gesamten Hirn sowie den definierten Arealen Bulbus 
Olfaktorius, Cortex, Striatum und Cerebellum isoliert. Anschließend wurden Proteom- sowie 
Genexpressions-Analysen durchgeführt, die mit Hilfe von in situ Hybridisierungen und 
qPCRs validiert wurden. Neue intrazelluläre und Zelloberflächen-Marker sowie Gene, die 
vermutlich wichtig für die Entwicklung und Funktionalität GABAerger Neurone sind, wurden 
identifiziert. Korrelations- und Clusteranalysen zeigten insbesondere Unterschiede zwischen 
Zellen des Vorder- und Hinterhirns auf. Während GABAerge Neurone des Vorderhirns 
hauptsächlich durch drei Familien von Transkriptionsfaktoren, der Distal-less-Familie, der 
POU-Familie und der ETS/FOX-Familie, charakterisiert waren, definierten spezifische 
Transkriptionsfaktoren der ZIC- und LHX-Familien inhibitorische Hinterhirn-Neurone. 
 
Interneurone des Bulbus Olfaktorius werden zeitlebens durch adulte neuronale Stammzellen 
in der Subventrikulär-Zone generiert. Die molekularen Mechanismen der terminalen 
Differenzierung dieser Zellen sind bisher allerdings nur ansatzweise verstanden. 
Definierte Differenzierungsstadien dieser Interneurone sowie ihrer Vorläuferzellen wurden 
mit Hilfe magnetischer Zellisolierung nach Mikrodissektion von periglomerulärem 
beziehungsweise subventrikulärem Gewebe isoliert. Durch Genexpressions-Analysen wurde 
eine Reihe von Kandidaten identifiziert, die vermutlich an der Differenzierung olfaktorischer 
Interneurone beteiligt sind. Zwei dieser Gene, NeuroD1 und NeuroD2, wurden auf ihre 
funktionelle Relevanz in vivo hin untersucht. Mit Hilfe der in vivo Elektroporation wurde die 
Überexpression dieser Transkriptionsfaktoren in Stamm-, Vorläufer- sowie ausdifferenzierten 
Zellen induziert. Dabei konnte gezeigt werden, dass die starke Expression von NeuroD2 eine 
verzögerte Differenzierung GABAerger Interneurone des Bulbus Olfaktorius bewirkt. Im 
Gegensatz dazu war die Überexpression von NeuroD1 ausreichend, um eine vorzeitige und 
ektopische Differenzierung von Vorläuferzellen entlang ihrer tangentialen Migrationsroute 
sowie im Striatum auszulösen. Diese Überexpression führte weiterhin hochspezifisch zur 
Ausbildung eines Dopaminergen Neurotransmitter-Phänotyps, woraus eine zentrale Rolle von 
NeuroD1 für die Spezifizierung bifunktionaler GABA/Dopamin-positiver Interneurone 
hervorgeht. 
 
Im Rahmen dieser Studie wurde eine umfassende molekulare Basis für das Verständnis 
räumlich und zeitlich definierter GABAerger Neurone bereitgestellt. Weiterhin wurden Gene 
identifiziert, die zentrale Funktionen während der Differenzierung inhibitorischer Interneuron-
Subpopulationen übernehmen. 
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Abstract 
In this project two approaches have been used to gain insights into the identity and molecular 
regulation of interneurons in the brain. First, a general molecular characterization of 
GABAergic neuron subtypes has been performed and second, novel fate determinants 
specifically for olfactory bulb interneurons have been identified and investigated in detail. 
 
GABAergic neurons, the largest population of inhibitory neurons in the brain, play crucial 
roles in information processing. While most of these neurons are interneurons, some, for 
example in the striatum, represent projection neurons. So far, biochemical, morphological, 
and electrophysiological properties served as exclusive criteria for the classification of 
GABAergic neurons. Although these parameters allow for a partial description of 
subpopulations, a systematic dichotomy is not available.  
Therefore, the general molecular characteristics of GABAergic neurons were analyzed and 
differences among distinct brain regions were defined. Transgenic GAD67-GFP mice in 
concert with flow cytometric cell sorting were used to isolate GABAergic neurons from 
defined regions of the postnatal mouse brain, namely olfactory bulb, cortex, striatum and 
cerebellum. Subsequently, gene expression profiling as well as cell surface proteome analysis 
were carried out and identified genes were validated by in situ hybridization and qPCR. 
Potential new marker genes for GABAergic neurons and candidate factors necessary for their 
differentiation and general functionality were determined. Clustering of gene expression data 
revealed major differences between hind- and forebrain GABAergic neurons indicating a 
correlation between their development and localization. For example, while GABAergic 
neurons of the forebrain are characterized mainly by three groups of transcription factors, 
namely the Distal-less-family, the POU-family and the ETS/FOX-family; specific members 
of the ZIC- and LHX-family define hindbrain inhibitory neurons. 
 
Olfactory bulb interneurons are generated throughout live by adult neuronal stem cells 
localized in the subventricular zone. While considerable information is available concerning 
the generation and migration of these cells, the molecular mechanisms regulating their 
terminal differentiation are barely understood. 
Therefore, mature interneurons from the periglomerular layer and their specific precursors 
were isolated by microdissection and magnetic cell sorting. Gene expression analysis was 
performed by microarray analysis. Several candidate factors to be involved in the 
differentiation of olfactory bulb interneurons were identified. The bHLH transcription factors 
NeuroD1 and NeuroD2 were analyzed for their functional relevance in vivo. Using in vivo 
electroporation, overexpression of these transcription factors was induced in postnatal 
forebrain stem cell populations as well as their progeny, namely neuronal precursors and 
mature neurons of the olfactory system. It was shown that high expression of NeuroD2 
delayed the differentiation of Type A neuronal precursor cells into granule- and 
periglomerular neurons. In contrast, overexpression of NeuroD1 induced the premature and 
ectopic differentiation of precursor cells. Furthermore, NeuroD1 induced specifically a 
dopaminergic phenotype, indicating that it represents a novel key fate determinant for the 
specification of periglomerular interneurons, possibly with a GABA/dopamine bifunctional 
neurotransmitter phenotype. 
 
In conclusion, this study represents a comprehensive molecular basis for the understanding of 
spatially as well as temporally defined GABAergic neuron subpopulations and led to the 
identification of novel fate determinants for the differentiation of inhibitory interneuron 
subpopulations. 
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Abbreviations 
 
bp       Base pair(s) 
BrdU       5-Bromo-2-deoxyuridine 
BSA       Bovine serum albumin 
cDNA        Copy DNA 
CNS       Central nervous system 
dATP       Deoxyadenosine triphosphate 
dCTP       Deoxycytosine triphosphate 
dGTP       Deoxyguanosine triphosphate 
DMEM      Dulbecco’s modified Eagle’s medium 
DNA       Deoxyribonucleic acid 
dNTP       Deoxyribonucleotid triphosphate 
dTTP       Deoxythymidine triphosphate 
E       Embryonic day 
ECM       Extracellular matrix 
EPL       External plexiform layer 
FACS       Fluorescence-activated cell sorting 
FCS       Fetal calf serum 
GABA       γ-aminobutyric acid 
GCL       Granule cell layer 
GO       Gene Ontology 
h       Hour(s) 
HBSS       Hank’s Balanced Salt Solution 
IPL       Internal plexiform layer 
LV       Lateral ventricle 
MACS       Magnetic cell separation 
MCL       Mitral cell layer 
min       Minute(s) 
mRNA      Messenger RNA 
NSC       Neural stem cell(s) 
OB       Olfactory bulb 
P       Postnatal day 
PBS       Phosphate-buffered saline 
PCR       Polymerase chain reaction 
PGL       Periglomerular layer 
qPCR       Quantitative real-time PCR 
RMS       Rostral migratory stream 
RNA       Ribonucleic acid 
RT       Room temperature 
SAM       Serial analysis of microarrays 
sec       Second(s) 
SGZ       Subgranular zone 
SVZ       Subventricular zone 
U       Unit(s) 
VZ       Ventricular zone 
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1 Introduction 
1.1 GABAergic neurons: function and diversity 
Gamma-aminobutyric acid (GABA) represents the main inhibitory neurotransmitter in the 
adult mammalian brain (Owens and Kriegstein, 2002b). It was identified over half a century 
ago (Awapara et al., 1950). In vertebrates, GABA is synthesized from glutamate (Roberts and 
Frankel, 1950), which is the main excitatory neurotransmitter in the central nervous system. 
Two glutamic acid decarboxylase (GAD) enzymes, GAD65 and GAD67, catalyze this step 
(Erlander et al., 1991; Erlander and Tobin, 1991). Whereas GAD67 is more generally 
distributed among GABAergic neurons, GAD65 predominates in the visual and the 
neuroendocrine systems (Feldblum et al., 1993). Subsequent to its synthesis, GABA is 
transported into synaptic vesicles by the vesicular neurotransmitter transporter VGAT (Fon 
and Edwards, 2001). Upon activation of the cell, GABA is released into the synaptic cleft 
where it can bind to pre- or postsynaptically localized GABAA, GABAB or GABAC receptors 
(Fig. 1.1). While GABAA and GABAB receptors are found throughout the brain, GABAC 
receptors are predominantly expressed in the vertebrate retina (Bormann and Feigenspan, 
1995). GABAA and GABAC receptors are ionotropic, meaning that upon binding of GABA a 
chloride specific ion pore is opened, which results in a direct hyperpolarization of the target 
cell (Bormann, 2000). In contrast, GABAB receptors are metabotropic, mediating their 
downstream effect by activating a heterotrimeric G-protein coupled signaling cascade and 
therefore induce a slower but more persistent inhibition by modulation of either presynaptic 
calcium or postsynaptic potassium currents (Bormann, 1988). Subsequently, a reuptake of 
GABA by GABA transporters (GATs), localized in the plasma membrane of surrounding 
glial and neuronal cells, terminates the signaling (Cherubini and Conti, 2001). After 
transamination of GABA, catalyzed by the enzyme GABA-T, it is metabolized in the 
tricarboxylic acid cycle (Madsen et al., 2008; Palmada and Centelles, 1998). 
 
As nearly all organisms from bacteria to humans synthesize GABA, multiple functions of this 
amino acid have evolved (Elliott and Hobbiger, 1959; Morse et al., 1980; Owens and 
Kriegstein, 2002a), including the regulation of key developmental steps, like cell proliferation 
and circuit refinement (Owens and Kriegstein, 2002b). 
However, the most important role of GABA is its function as a neurotransmitter. 
Interestingly, while GABA acts exclusively as an inhibitory neurotransmitter in the adult 
brain, it can function also as an excitatory neurotransmitter during development. In 
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developing neurons, the intracellular chloride concentration is much higher than in mature 
neurons (Ben-Ari et al., 1989). Therefore, activation of GABAA receptors induces an efflux of 
chloride resulting in membrane depolarization that can directly evoke an action potential 
discharge in some cases (Chen et al., 1996). During cortical development, GABAA, GABAB 
and GABAC mediated signaling induces the modulation of proliferation, migration as well as 
differentiation (Owens and Kriegstein, 2002b). In addition, nonsynaptic GABA signaling 
from neuroblasts towards GFAP expressing neuronal stem cells during adult neurogenesis in 
the subventricular zone inhibits proliferation of these stem cells (Liu et al., 2005). 
 
 
Figure 1.1: GABA signaling and metabolism 
Schematic diagram of GABA metabolism and synaptic signaling. GABA is synthesized from glutamate 
via decarboxylation catalyzed by the enzymes GAD65 or GAD67and transported into synaptic vesicles 
by the vesicular neurotransmitter transporter VGAT. Upon activation of the cell, GABA is released into 
the synaptic cleft where it can bind to pre- or postsynaptically localized GABAA, GABAB or GABAC 
receptors. GABAA and GABAC receptors are ionotropic, whereas GABAB receptors are metabotropic. 
GATs (GABA transporters), localized in the plasma membrane of surrounding glial and neuronal cells, 
are responsible for the reuptake of GABA. After transamination of GABA, catalyzed by the enzyme 
GABA-T, it is metabolized in the tricarboxylic acid cycle. Modified from Owens and Kriegstein (Owens 
and Kriegstein, 2002b). 
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GABAergic neurons (Tab. 1.1) are defined as group of neurons using GABA as their primary 
neurotransmitter. Functioning mainly as inhibitory neurons, they play a crucial role in 
information processing by regulating the activity of other neurons. Their essential role for 
correct brain function becomes apparent as the loss or malfunction of these neurons results in 
the development of neurological diseases like Huntington’s disease or Schizophrenia (Bossy-
Wetzel et al., 2004a; Hashimoto et al., 2003). GABAergic neurons show a high degree of 
anatomical, electrophysiological and synaptic diversity (Blatow et al., 2005; Markram et al., 
2004). Historically defined, GABAergic neuron subtypes were classified and named 
according to their morphology and localization (Tab. 1.1). Whereas GABAergic cells 
represent local projecting interneurons in most brain regions, there are also GABAergic 
projection neurons in the striatum, which build up long range axonal innervations of the 
globus pallidus externa and substantia nigra (Flames and Marin, 2005; Lobo et al., 2006). 
Research over the past decades lead to further classification of these cells with respect to the 
expression of marker genes as well as their electrophysical properties. The calcium binding 
proteins Calbindin (CB), Parvalbumin (PV) and Calretinin (CR) as well as the neuropeptides 
Vasoactive intestinal peptide (VIP), Somatostatin (SST), Cholecystokinin (CCK) and 
NeuropeptideY (NPY) are differentially expressed among GABAergic neuron subtypes 
(Markram et al., 2004). Furthermore, a remarkable variety of receptors, especially AMPA-, 
NMDA-, Metabotropic glutamate-, GABAA, 5-HT3- and nicotinic receptors, complexes their 
diversity (Blatow et al., 2005). The interaction of these proteins as well as so far unidentified 
factors allow for a broad pattern of electrophysiological properties. Non-accommodating, 
accommodating, stuttering, bursting and irregular spiking are the five major 
electrophysiological classes among neocortical interneurons (Markram et al., 2004). Although 
all these parameter allow for a valuable, detailed and partly functional description of different 
GABAergic neurons, there is no clear correlation among these characteristics and a systematic 
dichotomy of defined subclasses is still lacking. 
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Table 1.1: Major GABAergic neuron subtypes 
    
    
Olfactory bulb Cortex Striatum Cerebellum 
    
    
Periglomerular neuron Chandelier neuron Striatopallidal medium  Purkinje neuron 
  spiny neuron  
Granule neuron Large basket neuron  Stellate neuron 
  Striatonigral medium   
 Nest basket neuron spiny neuron Basket neuron 
    
 Small basket neuron  Golgi neuron 
    
 Double bouquet neuron   
    
 Bipolar neuron   
    
 Bitufted neuron   
    
 Martinotti neuron   
    
 Cajal Retzius neuron   
    
 Neurogliaform neuron   
    
    
 
 
1.1.1 GABAergic neurons of the olfactory bulb 
Two main subtypes of GABAergic neurons are found in the olfactory bulb. Both 
subpopulations, namely periglomerular layer interneurons and granule neurons, are named 
according to their localization in the periglomerular- or granule layer of the olfactory bulb 
(see also Fig. 1.4). The periglomerular layer contains glomeruli, which are build up of 
globular tangles of axons and represent the region where axons from olfactory receptor 
neurons, localized in the olfactory epithelium, and dendrites from mitral and tufted neurons, 
projecting to the olfactory cortex, are connected (Ache and Young, 2005). Each glomerulus 
contains the axons of olfactory receptor neurons that express the same odorant receptor 
(Treloar et al., 2002). Therefore, it has been hypothesized that each odor is spatially mapped 
in the glomerular layer (Lledo et al., 2005). 
In contrast to previous data, which claimed that only a subpopulation of periglomerular layer 
interneurons are GABAergic, recent studies have shown that all of these cells indeed use 
GABA as neurotransmitter (Panzanelli et al., 2007). However, about 16% of periglomerular 
layer interneurons show a bifunctional GABAergic/dopaminergic neurotransmitter phenotype 
(Panzanelli et al., 2007; Parrish-Aungst et al., 2007). Further non overlapping subpopulations 
of these cells express either the calcium binding proteins Calbindin (14%) or Calretinin 
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(44%). Periglomerular interneurons establish intra- as well as interglomerular connections and 
therefore play a key role during the first step of olfactory processing (Lledo et al., 2005). 
Complex neuronal interactions via chemical synapses as well as gap junctions between 
periglomerular interneurons and mitral-, tufted- and olfactory receptor neurons are found 
(Kosaka and Kosaka, 2005). In general, upon activation of an interneuron by one of these 
cells, it triggers feedback- as well as lateral inhibition to the surrounding neurons via a rare bi-
directionality, dendro-dendritic class of synapses (Kosaka and Kosaka, 2005). 
Granule cells of the olfactory bulb connect to mitral and tufted cells via bi-directional, 
dendro-dendritic synapses (Arevian et al., 2008). Upon release of the excitatory 
neurotransmitter glutamate by mitral or tufted cells, the granule cell is activated and releases 
GABA, thereby inhibiting the initial as well as neighboring mitral and tufted cells (Ache and 
Young, 2005; Schoppa and Urban, 2003). 
In conclusion, both systems trigger feedback- as well as lateral inhibition to mitral- and tufted 
neurons. The general function of lateral inhibition is to enhance contrast, facilitate 
discrimination of similar stimuli, and mediate competitive interactions between active neurons 
(Hirsch and Gilbert, 1991). This probably increases the discrimination of similar odors and 
advantage strong versus intermediate and weak signals (Urban, 2002). 
One special feature of granule as well as periglomerular layer interneurons is the generation 
and replacement of these cells throughout live by adult neurogenesis (Lledo and Saghatelyan, 
2005), which is described in detail in chapter 1.2. 
 
1.1.2 GABAergic neurons of the cortex 
The cortex forms up to 80% of the mammalian brain and is essential for higher brain 
functions like memory, attention, perceptual awareness, thought, language and consciousness. 
This area harbors a huge amount of diverse GABAergic interneuron subtypes. More than 10 
morphological defined classes are localized in this area. However, the overall amount of 
GABAergic interneurons is outnumbered by pyramidal cells in cortical regions by 
approximately 10-fold (Peters et al., 1985). Despite their huge variety, cortical interneurons 
also have common features that distinguish them from pyramidal neurons. The majority of 
mature interneurons has aspiny dendrites and can receive excitatory as well as inhibitory 
synapses onto their somata. Furthermore, the axons of inhibitory neurons usually arborize 
within a cortical column and can project laterally across columns, but do not typically project 
down into the white matter to contact distant brain regions (Markram et al., 2004). 
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The major subclasses, which are listed in table 1.1, can be grouped according to their axonal 
aborization as interneurons seem to be particularly specialized to target different domains of 
neurons, different layers of a column and different columns (Markram et al., 2004). Thereby, 
they can be functionally divided into axon-targeting (Chandelier neuron), soma- and proximal 
dendrite-targeting (Nest basket-, Large basket- and Small basket neuron), dendrite-targeting 
(Double bouquet-, Bipolar-, Neurogliaform- and Bitufted neuron), and dendrite and tuft-
targeting (Cajal Retzius- and Martinotti neuron) interneurons (DeFelipe, 1997). Expression of 
the calcium binding proteins Calbindin, Parvalbumin and Calretinin as well as the 
neuropeptides Vasoactive intestinal peptide, Somatostatin, Cholecystokinin and 
NeuropeptideY further divides these anatomically defined classes into subpopulations. Most 
anatomical classes express several of these markers, but there are also excluded combinations. 
For example, Large basked cells never express Vasoactive intestinal peptide, whereas Double 
bouquet cells do not express Parvalbumin, Somatostatin or NeuropeptideY (Markram et al., 
2004). The observation of at least 15 distinct electrophysiological patterns further complexes 
the situation for an appropriate sorting of these cells into groups, especially, as no strict 
correlation among these characteristics exists (Markram et al., 2004; Monyer and Markram, 
2004). 
As the cortex processes many different higher brain functions, the huge diversity of inhibitory 
interneurons in this area may be necessary to provide sufficient sensitivity, complexity and 
dynamic range to match excitation regardless of the intensity and complexity of the stimulus. 
The synaptic diversity might be further crucial to secure the dynamic range and to 
choreograph moments of imbalance between excitation and inhibition in the context of any 
background (Silberberg et al., 2004). Subtypes with diverse electrophysiological properties 
could be driven by the need of interneurons to monitor and respond to many sources of 
excitatory input, like those from the same layer, the adjacent layer, neighboring columns, 
other neocortical regions, the opposite hemisphere as well as subcortical input (Markram et 
al., 2004). 
The developmental mechanisms underlying this wide range of interneuron diversity are still 
barely understood (Fig. 1.2). One factor is the existence of several origins for these neurons 
(Parnavelas et al., 2002; Parnavelas et al., 2000). Although initial studies focused on the 
lateral ganglionic eminence as source for cortical interneurons (Anderson et al., 1997), recent 
data claims that the medial ganglionic eminence is the primary source of these cells (Wonders 
and Anderson, 2005). Several observations also support the hypothesis that a minor 
population of cortical GABAergic neurons originates from the lateral ganglionic eminence 
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and, like cortical projection neurons, from the cortex itself (Wonders and Anderson, 2005). 
There is a number of correlations among the origin and later subtype of these interneurons. 
Whereas Parvalbumin expressing interneurons exclusively and Somatostatin expressing 
interneurons mainly originate from the medial ganglionic eminence, Calretinin positive cells 
are largely derived from the lateral ganglionic eminence (Wonders and Anderson, 2006). 
Furthermore, it was shown that the combinatory expression of DLX1, DLX2, DLX5, DLX6, 
NKX2.1, LHX6 and ER81 in combination with general position inputs can define the fate of 
cortical interneuron subtypes during embryonic development (Wonders and Anderson, 2006).  
 
 
Figure 1.2: Origins of cortical interneuron subpopulations 
Parvalbumin expressing cortical interneurons exclusively and Somatostatin expressing interneurons 
mainly originate from the medial ganglionic eminence (blue). Calretinin positive cells are largely 
derived from the lateral ganglionic eminence (green and red). In addition, also olfactory bulb 
interneurons are generated by stem cells localized in the dorsal part of the lateral ganglionic eminence 
(red) during development. The arrows indicate the migration path of newly generated interneuron 
precursors. Modified from Wonders and Anderson (Wonders and Anderson, 2005). Abbreviations: 
OB = olfactory bulb; CTX = cortex 
 
 
1.1.3 GABAergic neurons of the striatum 
The striatum, the largest component of the basal ganglia, is a key regulator for planning and 
modulation of movement. In contrast to other brain areas, where GABAergic neurons 
represent mainly local projecting interneurons, those of the striatum are GABAergic 
projection neurons innervating distant areas of the brain. However, there is also a minor 
fraction (< 2%) of GABAergic interneurons in the striatum, expressing either Parvalbumin, 
Somatostatin or Calretinin (Marin et al., 2000). Two morphologically indistinguishable and 
mosaically distributed subpopulations of GABAergic projection neurons are found in this area 
and defined by their target region (Lobo et al., 2006). The Striatopallidal medium spiny 
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neuron innervates the globus pallidus externa, whereas the Striatonigral medium spiny neuron 
innervates the substantia nigra (Gerfen, 1992). 
Current models of striatal function suggest that these two pathways provide balanced but 
antagonistic influences on the basal ganglia output. The Striatonigral (direct) pathway 
promotes movement, whereas the Striatopallidal (indirect) pathway inhibits movement 
(Graybiel, 2000). The functional imbalance of these pathways leads to a variety of movement 
disorders, like Huntington’s disease, Parkinson’s disease, Tourette syndrome and dystonia 
(DeLong, 1990). The specific loss of striatal GABAergic projection neurons probably 
represents the initial reason for the development of Huntington’s disease (Beal and Ferrante, 
2004). Therefore, the in vitro differentiation and subsequent transplantation of GABAergic 
neurons from multipotent neural stem cells is one promising approach for cell replacement 
therapies of this disease (Bosch et al., 2004). 
There is considerable agreement that the lateral ganglionic eminence is the origin of striatal 
projection neurons (Deacon et al., 1994), whereas less is known about the origin of striatal 
interneurons. The actual model proposes that both cell types originate from the lateral 
ganglionic eminence, with radially migrating cells generally become projection neurons, 
whereas tangentially migrating cells mainly form interneurons of the striatum and cerebral 
cortex (Marin et al., 2000). 
 
1.1.4 GABAergic neurons of the cerebellum 
The cerebellum is part of the hindbrain and plays a crucial role in integration of sensory 
perception and motor control. However, recent studies have demonstrated that the cerebellum 
influences also cognitive functions such as planning, verbal fluency, abstract reasoning, 
prosody and use of correct grammar in humans (Fine et al., 2002). The by far most frequent 
neurons in the cerebellum are glutamatergic granule cells, the overall most abundant cell type 
of the mammalian central nervous system constituting up to 80% of all brain cells (Fine et al., 
2002). However, this area harbors several subtypes of GABAergic neurons in distinct layers. 
Purkinje cells, like GABAergic projection neurons of the striatum, build long range axons to 
innervate the deep cerebellar- and vestibular nuclei in the brainstem (Huang et al., 2007). 
These cells receive excitatory input from cerebellar glutamatergic granule neurons via parallel 
fibers and from the inferior olivary nucleus via climbing fibers (Huang et al., 2007). A single 
Purkinje cell can receive input from 100,000 to 200,000 parallel fibers. Stellate- and basket 
cells are GABAergic interneurons localized in the molecular layer of the cerebellum. The 
stellate cell axons selectively innervate Purkinje cell dendrites, whereas basket cells project 
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exuberant axon terminals to the axon initial segments to form pinceau synapses (Sotelo, 
1990). Finally, golgi cells that are localized in the granule cell layer locally project to 
surrounding granule cells (Eccles et al., 1966; Schulman and Bloom, 1981). 
The function of GABAergic neurons in the cerebellum is mainly to regulate synaptic 
integration, probability and timing of action potential generation, and plasticity in principal 
neurons in order to refine sensory perception and motor control (Huang et al., 2007). 
Despite their variety, different types of cerebellar GABAergic neurons all derive from a 
subset of ventricular zone cells, which migrate in the white matter and proliferate up to the 
postnatal life span (Leto et al., 2006). 
 
1.2 Adult neurogenesis 
In contrast to the historical view that the brain is a static organ and existing neurons can not 
be replaced by new cells after birth (Ramon, 1952), post-developmental neurogenesis has 
been shown across species from crustaceans, birds and mammals up to humans (Lledo et al., 
2006). Interestingly, the degree of postnatal neurogenesis decreases with increasing brain 
complexity. Adult neurogenesis in lower vertebrates, such as lizards, provides an additional 
supply of neurons capable of regenerating entire brain parts, whereas in mammals adult 
neurogenesis is restricted to only a few regions, where it provides neuronal replacement 
(Lledo et al., 2006). This may be due to the problems of more difficult integration for 
newborn neurons in highly complex systems (Kempermann et al., 2004). It is widely accepted 
that two areas in the mammalian brain, namely the subgranular zone (SGZ) of the 
hippocampal dentate gyrus and the subventricular zone (SVZ), show adult neurogenesis 
(Fig. 1.3). The existence of constitutive neurogenesis in other brain areas, such as the 
substantia nigra, is discussed controversially (Frielingsdorf et al., 2004; Zhao et al., 2003). 
Granule cells of the dentate gyrus are generated throughout live by neuronal stem cells of the 
SGZ (Ming and Song, 2005). These cells are excitatory glutamatergic microneurons, 
projecting to the CA3 area of the Hippocampus. In contrast, inhibitory GABAergic 
interneurons of the olfactory bulb are generated by adult neuronal stem cells localized in the 
SVZ (Lledo and Saghatelyan, 2005). This system of adult neurogenesis was found in many 
mammalian species, including mice, rats and apes (Curtis et al., 2007a). However, whereas 
the existence of adult neuronal stem cells in the human SVZ is widely accepted, there is an 
ongoing discussion based on controversial data about the existence of adult neurogenesis in 
the human olfactory bulb (Curtis et al., 2007b; Sanai et al., 2004). 
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The function of neurogenesis during adulthood is not fully understood. It was suggested that 
the cellular function of adult born neurons might differ from that of their older counterparts 
(Lledo et al., 2004). For example, young granule cells in the adult dentate gyrus show a 
greater propensity for synaptic plasticity compared to older granule cells (Snyder et al., 2001). 
Newborn granule and periglomerular cells in the olfactory bulb show markedly different 
active membrane properties and greater plasticity in response to sensory deprivation 
compared with the existing neurons around them (Carleton et al., 2003; Saghatelyan et al., 
2005). However, it is not known, if adult-born cells only replace each other or if they also 
replace much older neurons (Lledo et al., 2006). The ongoing neurogenesis in the olfactory 
bulb probably enlarges the possibility of this system for building up new neuronal circuits in 
order to allow an increased adaptation to changing environmental influences (Lledo et al., 
2006). This is in concordance to data showing that an increase in neurogenesis could be 
initiated by olfactory discrimination learning (Alonso et al., 2006) and that reduction of 
progenitor proliferation leads to impaired odor discrimination in rodents (Gheusi et al., 2000). 
However, oppositional data exists regarding the modulation of neurogenesis in the dentate 
gyrus upon spatial learning (Lledo et al., 2006). 
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Figure 1.3: Regions of postnatal neurogenesis 
In the mammalian brain mainly two areas, namely the subgranular zone of the hippocampal dentate 
gyrus and the subventricular zone, show adult neurogenesis. Glutamatergic granule cells of the 
dentate gyrus are generated throughout live by neuronal stem cells of the SGZ. Furthermore, adult 
neuronal stem cells localized in the SVZ (1) generate precursors that migrate along the rostral 
migratory stream (2) and differentiate into inhibitory GABAergic interneurons of the olfactory bulb (3). 
In addition, there is also restricted early postnatal neurogenesis and migration in the cerebellum and 
the hypothalamus. Germinal zones (green) and adjacent target zones (red) are indicated by color. 
Modified from Ghashghaei et al. (Ghashghaei et al., 2007). Abbreviations: IGL = internal granule cell 
layer; EGL = external granule cell layer; CB = cerebellum; Hipp = hippocampus; DG = dentate gyrus; 
SGZ = subgranular zone; V = ventricle; SVZ = subventricular zone; RMS = rostral migratory stream; 
OB = olfactory bulb; Hyp = hypothalamus; OE = olfactory epithelium 
 
 
1.2.1 Stem cells in the subventricular zone 
The neuronal stem cells that give rise to GABAergic interneurons of the olfactory bulb 
throughout live are localized in the subventricular zone between the lateral ventricle and the 
striatum. Before and during approximately two weeks after birth, radial glia cells in the 
ventricular zone, directly contacting the lateral ventricle, represent the stem cells in this 
system (Merkle and Alvarez-Buylla, 2006). In several species, like birds, lizards, turtles and 
fish, radial glia remain neurogenic throughout live, whereas in mammals their role as neuronal 
stem cells is adopted by GFAP expressing astrocyte-like cells later on (Merkle and Alvarez-
Buylla, 2006). During the first weeks, the remaining radial glia give rise to neurons, 
oligodendrocytes, ependymal cells and parenchymal astrocytes as well as the mentioned 
neurogenic astrocytes in the SVZ of the mammalian brain (Merkle et al., 2004). However, 
some data indicate an intermediate role for Prominin-1 (CD133) expressing ependymal cells 
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as early, slow dividing stem cells which generate SVZ neurogenic astrocytes instead of their 
generation directly by radial glia (Coskun et al., 2008). 
Despite their different morphology and localization, radial glia and neurogenic astrocytes 
share common features as both equally give rise to neuronal precursors and mature neuronal 
cell types in the olfactory bulb. Both stem cell populations divide asymmetrically, resulting in 
the generation of one stem cell and one Type C transiently amplifying neuronal progenitor 
cell (Gotz and Barde, 2005). Upon arrival of these intermediate precursors in the SVZ, they 
send out numerous processes and start to divide symmetrically (Noctor et al., 2004). These 
divisions amplify the number of precursors originating from a single stem cell division (Gotz 
and Huttner, 2005). The molecular mechanisms underlying these processes are barely 
understood. However, it was shown that GABA is released by the precursor cells and inhibits 
the stem cell proliferation via nonsynaptic, SNARE-independent GABAA receptor signaling 
(Liu et al., 2005). This feedback loop thereby negatively regulates the amount of newly 
generated precursors, avoiding an overproduction of these cells (Liu et al., 2005), whereas 
synaptically released dopamine enhances the Type C cell proliferation via activation of 
D2 receptors (Hoglinger et al., 2004). Upon amplification, the Type C cells can differentiate 
into astrocytes, oligodendrocytes or Type A neuronal progenitors, which start their migration 
towards the olfactory bulb via the rostral migratory stream (Marshall et al., 2005). 
Recent studies have shown that the neuronal stem- and progenitor cells represent a 
heterogeneous population regarding both their origin and fate. Young et al. (Young et al., 
2007) determined the embryonic origins of adult forebrain SVZ stem cells. It was shown that 
all parts of the telencephalic neuroepithelium, including the medial ganglionic eminence, the 
lateral ganglionic eminence and the cerebral cortex, contribute multipotent, self-renewing 
stem cells to the adult SVZ (Young et al., 2007). The embryonic origin thereby determines 
the localization of generated adult neuronal stem cells. Whereas descendants of the medial 
ganglionic eminence localize to the ventral parts of the SVZ, those of the lateral ganglionic 
eminence are present in the lateral SVZ during adulthood (Young et al., 2007). Adult 
neuronal stem cells originating from the embryonic cerebral cortex localize to the dorsal parts 
of the SVZ (Young et al., 2007). In addition, recent data also indicates a heterogeneous fate of 
newly generated precursors which depends on the localization of the initial stem cell (Merkle 
et al., 2007). It was shown that adult neuronal stem cells of a given localization generate only 
a specific subset of GABAergic interneurons. For example, whereas Calretinin expressing 
periglomerular layer interneurons originate from stem cells in the lateral parts of the anterior 
SVZ, Calbindin expressing cells are generated by stem cells in the ventral parts of the more 
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posterior SVZ (Merkle et al., 2007). Also the localization of mature granule cells is dependent 
on their origin, as deep granule cells are generated by stem cells in the ventral SVZ, whereas 
superficial granule cells are descendants of dorsal SVZ stem cells (Merkle et al., 2007). 
However, heterotopical grafting of respective SVZ stem cells does not change the cell types 
they generate, indicating that these features are intrinsically determined and not dependent on 
local signals (Merkle et al., 2007). In conclusion, the further identity of newborn neurons in 
the olfactory bulb seems to be already determined by their originating SVZ stem cells. 
Whereas a correlation among stem cell localization and neuron subpopulations derived 
thereof was nicely shown, there is a lack of knowledge concerning molecular factors 
determining these fate decisions. At the level of Type C intermediate precursors, some 
respective genes have been identified. For example, a subset of these cells, expressing the 
basic helix-loop-helix transcription factor OLIG2, differentiates into astrocytes and 
oligodendrocytes (Hack et al., 2005; Marshall et al., 2005). In contrast, only three genes, 
DLX2, PAX6 and SP8, are so far known to be important for the specification of the numerous 
neuronal subtypes, namely dopamine/GABA double positive periglomerular interneurons in 
the case of DLX2 as well as PAX6 and non-dopaminergic Calretinin positive cells in the case 
of SP8 (Hack et al., 2005; Kohwi et al., 2005; Waclaw et al., 2006). 
 
1.2.2 Migration in the rostral migratory stream 
Upon the differentiation of a Type C intermediate precursor into a Type A neuronal precursor, 
this cell migrates along the rostral migratory stream towards the olfactory bulb. The mode of 
migration in the RMS is unique, as the Type A neuronal precursors migrate as chains, sliding 
along each other in the RMS (Lois and Alvarez-Buylla, 1994). This chain migration is 
different to the glial- or axonal-guided modes of neuronal migration in the developing brain, 
because the substrate for motility is provided by the migrating cells themselves (Ghashghaei 
et al., 2007). The existence of astrocytes, which encapsulate the migrating cells by forming a 
glial tube, raises the possibility that migrating neurons might use them as an additional 
substrate for oriented migration (Lois et al., 1996). However, as isolated RMS cells can also 
migrate as chains in vitro in the absence of glial cells, they do not seem to be essential 
(Wichterle et al., 1997). Several molecules have been identified which are probably involved 
in this migratory process (Ghashghaei et al., 2007; Pennartz et al., 2004). 
The initiation of migration is probably regulated by a dynamic balance of chemorepulsive and 
chemoattractive signals. However, it has been shown that the existence of an olfactory bulb is 
not essential for correct migration of Type A precursors, therefore it seems that 
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chemorepulsion is the main force in this case (Kirschenbaum et al., 1999). The 
chemorepulsive Slit-Robo pathway represents one key signal important for the initiation of 
migration. In SLIT1-deficient mice, clusters of Type A precursors migrate caudally into the 
corpus callosum, instead of into the RMS (Nguyen-Ba-Charvet et al., 2004). SLIT1 and 
SLIT2 are secreted by cells surrounding the SVZ and both proteins have been shown to 
repulse the ROBO1, ROBO2 and ROBO3-receptor expressing Type A neuronal precursors 
(Wu et al., 1999). Besides its initial role, Slit-Robo signaling may modulate the polarity of 
SVZ neuroblasts during migration by regulation of the cell-polarity factors glycogen synthase 
kinase-3β and protein kinase Cζ, which are needed for centrosome reorientation and process 
stabilization (Higginbotham et al., 2006). Although long-distance chemoattractive signals 
appear to be not necessary for the initiation of migration (Kirschenbaum et al., 1999), local 
chemoattraction may be involved. Netrin1-DCC signaling can attract migrating Type A cells 
in vitro and therefore represents one candidate pathway for this process (Mason et al., 2001). 
In addition, the start of migration may be partially supported by the highly polarized 
processes of radial glia or neurogenic astrocytes, which could direct the neuronal precursors 
towards the RMS (Ghashghaei et al., 2006). 
Once the cells left the SVZ and joined the RMS, their polarity and migratory speed have to be 
regulated continuously in order to direct them towards the olfactory bulb. A migration speed 
of up to 120 µm/h has been observed in wild type Type A cells in vitro (Wichterle et al., 
1997). A complex interaction of extracellular matrix signals, secreted guidance- or motogenic 
signals, cell adhesion molecules, and cell-surface tyrosine kinase- or integrin signaling is 
necessary for correct maintenance of migration (Juliano, 2002). One key factor for the chain 
organization of Type A cells is the polysialated form of the neuronal cell adhesion molecule 
(PSA-NCAM). NCAM-knockout mice show an enlarged RMS and smaller olfactory bulb 
containing fewer newly generated neurons (Cremer et al., 1994; Rutishauser, 1996; 
Tomasiewicz et al., 1993). The tyrosine kinase receptor ERBB4 and its ligands, neuregulin1 
and neuregulin2, are expressed by the migrating cells themselves. It has been shown that these 
molecules are involved in the regulation of orientated migration in the RMS and dysfunction 
of this pathway leads to a lack of oriented processes (Anton et al., 2004). Besides ErbB4, also 
the Eph tyrosine kinase receptors and their ephrin ligands have been identified as indirect 
modifiers of neuroblast migration in the RMS (Ghashghaei et al., 2007). Blocking of integrin 
α1, α5, α6, β1 or β4 function modulates neuronal migration in the RMS, probably by 
interrupting the transmission of extracellular matrix signals into the cells (Emsley and Hagg, 
2003; Schmid et al., 2005). These integrins are differently expressed by migrating Type A 
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precursors dependent on the age of mice. Whereas the α1, β1 and β8 subunits are expressed 
mainly during early postnatal periods, β3 and β6 integrin expression persists in until 
adulthood (Ghashghaei et al., 2007). Putative ligands for these receptors are the laminin 
subunits α5 and γ1, which have been identified in the RMS as well as tenascin-C, which is 
expressed by the astroglial tube (Murase and Horwitz, 2002). As for the initiation of 
migration, again the microtubule associated proteins GSK3β and PKCζ are essential for the 
ability of migrating cells to reorient their centrosomes and stabilize their processes 
(Higginbotham et al., 2006). Furthermore, the protein Doublecortin (DCX), which localizes to 
the microtubule cage around the nucleus as well as the leading processes, was shown to be 
important for regulating the velocity of migration, branching of leading processes and nuclear 
translocation towards the centrosome in the direction of migration (Koizumi et al., 2006a; 
Koizumi et al., 2006b). 
In conclusion, the coordinated actions of several signaling pathways allow the migrating 
Type A neuronal precursors to arrive in the olfactory bulb, where they stop the tangential 
migration phase. 
 
1.2.3 Migration and differentiation within the olfactory bulb 
Upon arrival in the center of the olfactory bulb, Type A neuronal precursors change their 
migration mode from tangential chain migration into a radially, individual and glial-
independent migration towards their final positions in the granule and periglomerular layers 
(Ghashghaei et al., 2007). The transcription factor ARX (aristaless-related homeobox gene) is 
essential for the entry of cells into the olfactory bulb, as mutations in ARX lead to the 
accumulation of Type A cells at the junction between the end of the RMS and the olfactory 
bulb (Yoshihara et al., 2005). However, the molecular mechanism of this process is not 
known. One factor, the extracellular matrix protein Reelin, was shown to be critical for the 
change from tangential chain- to radial individual migration as it acts as a detachment signal 
for the migrating neuronal precursors (Hack et al., 2002). Whereas Reelin is expressed and 
secreted by the mitral cells of the olfactory bulb, its receptor apolipoprotein-E receptor 2 and 
its downstream signaling target, the adaptor protein disabled-1 are present in the migrating 
neuroblasts (Ghashghaei et al., 2007). In addition to Reelin, the extracellular matrix protein 
tenascin-R seems to modulate the initiation of detachment and radial migration of precursor 
cells (Saghatelyan et al., 2004). Interestingly, the expression of tenascin-R is olfactory 
sensory-activity dependent, suggesting that tenascin-R might be important for the recruitment 
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of new neurons to regions of the olfactory bulb where network activity demands incorporation 
and input from new neurons (Saghatelyan et al., 2004). 
About 80% to 90% of the Type A neuronal precursor cells stop their radial migration in the 
deep- or superficial granule layer and become granule neurons (Kohwi et al., 2005). The 
remaining precursors migrate further to periglomerular layer, where they become post-
migratory, late precursors and differentiate into periglomerular interneurons (Fig. 1.4). 
Granule neurons as well as periglomerular neurons can be further divided into several 
subpopulations based on the expression of marker genes (see also 1.1.1). The three main 
subtypes of periglomerular layer interneurons are bifunctional GABAergic/dopaminergic cells 
(16%), and either Calbindin- (14%) or Calretinin- (44%) expressing populations (Panzanelli 
et al., 2007; Parrish-Aungst et al., 2007). The granule cell population is further divided 
concerning the localization into deep- and superficial granule neurons, with a subpopulation 
of superficial granule neurons also being dopaminergic and GABAergic (Saino-Saito et al., 
2004). During the differentiation of granule neurons as well as periglomerular neurons, a 
typical expression pattern of known marker genes, correlating with the differentiation status 
of many neuronal cell types, can be observed. Whereas the expression of PSA-NCAM, DCX, 
TUJ1 (β-III-tubulin) and TUC4 is downregulated, that of NeuN in general and of Calbindin, 
Calretinin or TH in the respective subpopulations is upregulated (Lledo et al., 2006). The first 
functional sodium current spikes in newborn granule and periglomerular neurons appear about 
14 days after the initial generation of their progenitors in the SVZ (Belluzzi et al., 2003; 
Mizrahi, 2007). In contrast to these markers, which correlate with the differentiation status, 
only three genes, namely DLX2, PAX6 and SP8, have been identified to regulate the 
differentiation of olfactory bulb interneuron subpopulations. Expression of PAX6 was shown 
to be necessary for the differentiation of periglomerular interneurons with a GABA/dopamine 
bifunctional neurotransmitter phenotype (Hack et al., 2005; Kohwi et al., 2005). Recent data 
indicates that this function of PAX6 is dependent on a direct interaction with the transcription 
factor DLX2 (Brill et al., 2008). In contrast, expression of SP8 is required for the 
development of non-dopaminergic Calretinin positive cells in the periglomerular layer 
(Waclaw et al., 2006). 
However, all these genes act during earlier time windows, whereas almost nothing is known 
about the factors that regulate the final differentiation of newly generated olfactory bulb 
interneurons. 
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Figure 1.4: Differentiation of newly generated olfactory bulb interneurons 
Upon arrival in the center of the olfactory bulb, Type A neuronal precursors (red in RMS) change their 
migration mode from tangential chain migration into a radially, individual migration towards their final 
positions in the granule and periglomerular layers. The majority of Type A neuronal precursor cells 
stop their radial migration in the granule layer and differentiate into granule neurons (red in GCL), 
whereas the remaining precursors migrate further to periglomerular layer, become post-migratory and 
differentiate into periglomerular interneurons (red in GL). However, it is not known if adult-born cells 
only replace each other or if they fulfill a more general role by replacing the functions of much older 
neurons (brown). Modified from Lledo et al. (Lledo et al., 2006). Abbreviations: GL = periglomerular 
layer; EPL = external plexiform layer; GCL = granule cell layer; RMS = rostral migratory stream 
 
 
1.2.4 Neurodegenerative diseases affecting the subventricular zone 
The human subventricular zone is specifically affected in several neurological diseases, like 
Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, epilepsy and stroke. In 
response to neurodegeneration in Huntington’s disease, epilepsy and stroke, there is an 
upregulation of progenitor cell production, cytokine levels and migratory proteins in the SVZ, 
leading to an increase in the number of adult-born neurons (Curtis et al., 2007a). In contrast, 
in Alzheimer’s disease and Parkinson’s disease fewer proliferating cells are found in the SVZ 
(Curtis et al., 2007a). 
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Huntington’s disease, an autosomal dominant disorder caused by expanded CAG repeats in 
the huntingtin gene, results in a loss of GABAergic projection neurons of the striatum 
(Vonsattel et al., 1985). The loss of neurons next to the localization of adult neuronal stem 
cells induces an increased progenitor cell production in the SVZ (Phillips et al., 2005). It was 
suggested that enriched expression of NPY and NOS upon the development of Huntington’s 
disease are possible mechanisms initiating increased mitosis in the SVZ (Hansel et al., 2001; 
Reif et al., 2004). 
Parkinson’s disease is characterized by a degeneration of dopaminergic neurons in the 
substantia nigra pars compacta, which is part of the basal ganglia circuitry that projects to the 
striatum and synapses on GABAergic projection neurons in this region (Curtis et al., 2007a). 
Progenitor proliferation in the SVZ was shown to be reduced in animal models as well as 
human patients with Parkinson’s disease which leads to impaired odor discrimination in 
rodents and is also a common and early sign of this disease in humans (Lledo et al., 2006). 
The molecular mechanisms are not fully understood yet. However, it was shown that 
synaptically released dopamine enhances Type C cell proliferation via activation of 
D2 receptors and a lack of this signaling may therefore reduce the amount of new cells 
(Hoglinger et al., 2004). 
During Alzheimer’s disease, an accumulation of neurofibrillary tangles and amyloid plaques, 
composing of β-amyloid peptides, is observed. This probably causes the massive cell death of 
mature neurons (Mattson, 2000). Animal studies that were based on presenilin 1 transgenes as 
well as intraventricular infusion of β-amyloid peptides were found to result in an impairment 
of adult neurogenesis (Donovan et al., 2006; Haughey et al., 2002a). Besides the reduction of 
adult stem cell proliferation, β-amyloid peptides can directly promote apoptosis in neuron 
restricted neural progenitor cells (Haughey et al., 2002b). In addition, an immunotherapy 
against the N-terminus of the β-amyloid peptide in a transgenic mouse model of Alzheimer’s 
disease was shown to stimulate endogenous neurogenesis (Becker et al., 2007). 
The involvement of the SVZ in major neurodegenerative diseases and its modulation by 
defined factors may offer new opportunities for specific therapies. However, the molecular 
basis underlying adult neurogenesis has to be understood in order to identify possible targets 
and mechanisms for subsequent approaches. 
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1.3 Aim of this study 
Several attempts have been made to categorize subpopulations of GABAergic neurons at 
different developmental stages. This included, amongst others, the analyses of their major 
functional role, spatiotemporal placement, plasticity, morphology, discharge properties, 
connectivity pattern, neurochemistry, as well as protein, sugar, and lipid markers. However, 
while all these parameter allow for a valuable, detailed and partly functional description of 
different GABAergic neurons they have not led to a systematic dichotomy so far. Therefore, 
new marker genes as well as factors important for the differentiation and general functionality 
of GABAergic neurons have to be identified. Furthermore, the molecular analysis of 
GABAergic neurons from different brain regions is a promising approach to classify these 
cells and define region specific characteristics. However, due to the lack of a specific surface 
marker for GABAergic neurons it is not possible to purify these cells, which is a prerequisite 
for a subsequent molecular characterization. 
Therefore, the first aim was to establish a protocol for the isolation of GABAergic neurons in 
general as well as from defined brain regions. Subsequently, these cells had to be analyzed on 
a molecular level by comprehensive whole genome expression profiling. This method has 
emerged as a reliable tool for the description of cells. Based on the expression of thousands of 
genes, each cell type or cell stage is assigned an unambiguous and specific pattern. 
Furthermore, bioinformatic analyses offer the opportunity to quantify the relationship of 
individual cell populations by calculating correlation matrices. Moreover, by assessing 
prominent transcription pathways, functional explanation of the observed differences can be 
given and new single gene markers identified. Analyzing the transcriptomes of GABAergic 
neurons in general as well as subpopulations of these cells should give new insights into the 
topics mentioned above. 
 
In a parallel approach, the focus was to identify novel factors that regulate interneuron 
differentiation. The postnatal generation of olfactory bulb GABAergic interneurons offers a 
promising model system to study the development of these cells in detail. As this system is 
affected in major neurodegenerative diseases, a detailed understanding of the molecular 
mechanisms regulating defined steps during the differentiation process is essential for the 
development of cell- or drug based therapeutic approaches. In addition, the identification of 
novel fate determinants, important for the differentiation of specific neuronal subtypes, may 
offer new possibilities for the in vitro generation of these cells from neuronal- or even 
embryonic stem cells in order to replace lost neurons after neurodegeneration caused by injury 
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or disease. Several factors that regulate the proliferation of adult stem cells in the SVZ as well 
as the migration of progenitor cell towards the olfactory bulb have been identified. However, 
there is a striking lack of known factors that are involved in the further differentiation of these 
progenitors. 
Therefore, novel genes that are important for the differentiation of olfactory bulb GABAergic 
neurons had to be identified. Again, whole genome expression profiling was the most 
promising approach to address this point. To identify genes that are significantly regulated 
during differentiation, a protocol for the isolation of mature olfactory bulb interneurons as 
well as their progenitor cells had to be established in order to analyze and compare the 
transcriptomes of these subpopulations. In addition, promising candidates had to be examined 
for their functional relevance in vivo to distinguish marker genes, which are regulated as a 
consequence of the differentiation state, from those which are fate determinants and are 
important for the regulation of this process. 
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2 Material and Methods 
2.1 Enzymes and Reagents 
ABI Prism Big Dye Terminator Cycle  
Sequencing Kit       Applied Biosystems / Perkin Elmer  
SUPERSCRIPT II RT-Kit     Invitrogen 
RNA 6000 Pico Assay     Agilent Technologies 
Total RNA Isolation NucleoSpin®RNAII   Macherey Nagel 
Gel extraction NucleoSpin®ExtractII   Macherey Nagel 
RNA Clean-up NucleoSpin®RNA Clean-up   Macherey Nagel 
Rediprime DNA labeling system     GE Healthcare 
BCATM Protein Assay Kit      Pierce 
ECL+-Kit        GE Healthcare 
Terminal deoxynucleotidyl transferase   GE Healthcare 
Taq-Polymerase      Invitrogen  
Elongase-Enzyme-Mix     Invitrogen 
DNaseI       Ambion, Roche 
Proteinase K       Roche  
RNaseA       Roche 
RNaseH       Invitrogen 
Alkaline Phosphatase      Roche 
DNA Polymerase I, large (Klenow) fragment  NEB 
T4-DNA-Ligase      Promega 
Allophycocyanine (APC)     Cyanotech 
Papain        Worthington 
Trypsin       Gibco 
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2.2 Antibodies and MicroBeads 
Mouse IgG anti-NeuN     Invitrogen 
Mouse IgM anti-A2B5     G. Rougon 
Mouse IgG1 anti-Calb2     Sigma 
Mouse IgG2a anti-PSA 735     R. Gerardy-Schahn 
Rabbit anti-GAD65/67     Sigma 
Rabbit anti-NeuroD1      Abcam 
Rabbit anti-NeuroD2      Abcam 
Rabbit anti-GAPDH      Assay Designs 
Rabbit anti-TUJ1      Covance 
Rabbit anti-GFAP      Sigma-Aldrich 
Guinea pig IgG anti-DCX     Chemicon 
Swine anti-rabbit HRP     Dako Cytomation 
Goat anti-mouse IgM Alexa 488    Molecular Probes/Invitrogen 
Goat anti-rabbit IgG Cy5     Cambridgeshire 
Goat anti-guinea pig IgG Cy5    Abcam 
Goat anti-mouse IgG Alexa 633    Molecular Probes 
Goat anti-mouse IgM Alexa 633    Molecular Probes 
Goat anti-mouse IgG Fc Cy3     Jackson 
Goat anti mouse IgM Texas Red     Abcam 
Donkey anti-mouse IgG Cy3     Jackson 
Donkey anti-rabbit Cy3     Jackson 
AffiniPure Goat-anti-rabbit IgG (H+L)    Dianova 
R-PE-goat-anti-rabbit      Molecular Probes 
full length A. v. EGFP Polyclonal AB   Clontech 
Goat-anti-rabbit-FITC, F2765    Molecular Probes 
anti-Dig. fab fragments phosphatase    Roche 
anti-rabbit IgG MicroBeads     Miltenyi Biotec 
anti-mouse IgM MicroBeads     Miltenyi Biotec 
anti-mouse IgG MicroBeads     Miltenyi Biotec 
anti-PE MicroBeads       Miltenyi Biotec 
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2.3 Chemicals and expendable items 
All chemicals, unless otherwise specified in the text, were purchased at Merck. All buffers 
and media for cell culture were purchased at Invitrogen. NanoPURE DiamontTM ultrapure 
water (Barnstead) was used for experiments. 
 
10-20% Tris/Glycine-gel     Anamed 
1 kb-PLUS-DNA-LadderTM     Invitrogen 
GeneRulerTM 100bp DNALadder Plus   NanoDrop Technologies 
MagicMarkTM Western Protein Standard   Invitrogen 
PAGE-RulerTM Prestained Protein Ladder   Fermentas 
Extra thick Blot Paper (Mini Blot size)   BioRad 
Hybond-P PVDF-Membrane     GE Healthcare 
Hybond-XL Nylon-Membrane    GE Healthcare 
Electroporation Cuvette (Type 165-2107)    BioRad 
NAP-10-Column      GE Healthcare 
PD-10-Column      GE Healthcare 
Superdex 200 16/60- Column     GE Healthcare 
Microcons Type YM-10     Millipore 
Neubauer chamber      Brand 
µ-MACS® Separation column    Miltenyi Biotec 
Pre-Separation filter      Miltenyi Biotec 
Syringe needle 26G ½“, short    Braun 
SuperFrost® Plus microscope slides    Menzel 
Sigma Fast BCIP/NBT     Sigma 
CpG ODNs 1668      Metabion 
PHA-Lectin       Sigma 
Azaserine       Sigma 
Freunds Adjuvant incomplete    Sigma 
Polyethylenglycol      Roche 
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2.4 Instruments 
NanoDrop       NanoDrop Technologies 
Agilent 2100 Bioanalyzer     Agilent Technologies 
Trans-Blot SD SemiDry Transfer Cell   BioRad 
LSM 510        Carl Zeiss 
Axioskop 2+       Carl Zeiss 
Axioplan 2 equipped with ApoTome   Carl Zeiss 
Cryo 1°C-freezing container      Nalgene 
Gene Pulser II       BioRad 
Electroporator CUY21 edit device    Nepagene 
Electrodes CUY650P10     Nepagene 
Flow cytometer FACScaliburTM     BD Biosciences 
Flow cytometer FACSvantageSETM     BD Biosciences  
µ-MACS-Separator      Miltenyi Biotec 
Cell culture hood: Hera Safe     Heraeus 
Incubator: Hera Cell      Heraeus 
Scale APX-200      Denver Instruments 
Scale SPB61       Scaltec 
Heating block BT 1301     HLC 
Bacteria incubator      WTB Binder 
Water bath       Julabo 
Centrifuge Eppendorf 5415D     Eppendorf 
Centrifuge Megafuge 1.0     Heraeus 
Cyclone Storage Phosphor System    Packard 
Thermocycler: PTC-225     MJ Research 
Multiplate reader Genios     Tecan  
Cell culture incubator Labotec Gasboy C40   Labotec 
Vibratome microtome     Microm 
Cryostat CM3050      Leica 
Binocular MZFLIII      Leica 
Peristaltic pump Lamda Preciflow    Lambda Laboratory Instruments 
Stereotaxic rig      Kopff 
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2.5 E. coli strains 
 
Table 2.1 E. coli strains 
E. coli 
strain 
Genotype Reference 
DH5αTM 
 
F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 
endA1 hsdR17(rk-, mk+) phoA  
supE44 thi-1 gyrA96 relA1 λ- 
Invitrogen 
 
 
2.6 Molecular biological methods 
Unless otherwise specified, standard molecular biological methods were carried out according 
to Sambrook and Russell (Sambrook and Russell, 2001).  
 
2.6.1 Isolation of RNA 
RNA was isolated using the NucleoSpin® RNA Clean-up Kit (Macherey Nagel) according to 
the manufacture’s instructions. RNA quality was confirmed using Agilent Bioanalyzer Pico 
chip gel electrophoresis (Agilent). RINs (RNA Integrity Numbers) and ratios of 28S/18S 
rRNA served as quality controls. 
 
2.6.2 Isolation of DNA 
2.6.2.1 Plasmid preparation from E. coli 
Preparation of plasmid DNA from E. coli was done using alkaline lysis followed by column 
purification (Birnboim and Doly, 1979). For small scale preparations the NucleoSpin® 
Plasmid Kit (Macherey Nagel) and for large scale preparations the EndoFree Plasmid Kit 
(Qiagen) was used according to the manufacture’s instructions. DNA was dissolved either in 
elution buffer (10 mM Tris/HCl, pH 8.5) or PBS (pH 7.2, Invitrogen) and stored at -20°C. 
 
2.6.2.2 DNA preparation from agarose gels 
DNA was isolated from agarose gels using the NucleoSpin® Extract II Kit (Macherey Nagel) 
according to the manufacture’s instructions. DNA was dissolved either in elution buffer 
(10 mM Tris/HCl, pH 8.5) or distilled water and stored at -20°C. 
Material and Methods 
   
26 
2.6.2.3 DNA preparation from mouse tails 
Tail biopsies of four to six week old mice were incubated in 700 µl lysis buffer (50 mM 
Tris/HCl pH 8.0, 100 mM EDTA pH 8.0, 100 mM NaCl, 1% SDS) containing 35 µl 
Proteinase K (10 mg/ml) over night at 55°C. After centrifugation (10 min, 14000 g), the 
supernatant was transferred into a new tube and DNA was precipitated using isopropyl 
alcohol at a final concentration of 60%. After centrifugation (10 min, 14000 g), the DNA was 
desalted using 1 ml 70% ethanol (centrifugation for 10 min, 14000 g) and dissolved in 300 µl 
TE buffer. 
 
2.6.3 Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) allows the amplification of precise parts from a DNA 
template by using primers specific for both ends of the sequence (Mullis et al., 1986; Saiki et 
al., 1988). The target sequence is amplified by the factor 2n, where n is the number of cycles. 
For standard PCRs the Taq-Polymerase (Invitrogen) and for cloning approaches the 
Elongase-Enzyme-Mix (Invitrogen) was used.  
 
Table 2.2 Constitution of standard PCRs  
 Taq-Polymerase Elongase-Enzyme-Mix 
   
DNA template 1-100 ng 1-100 ng  
1. primer  200 nM 200 nM  
2. primer  200 nM 200 nM 
dNTP-mix (10 mM) 200 µM 200 µM 
10 x PCR-Buffer 1 x 1 x 
MgCl2 1,5 - 2,8 mM 1,5 - 2,0 mM 
DNA-Polymerase 1 U 1 µl**  
Distilled H2O up to 30-50 µl up to 30-50 µl 
** Activity (U/µl) not known 
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Table 2.3 PCR programs  
Step Taq-Polymerase Elongase-Enzyme-Mix 
     
1. Denaturing 95°C 4 min 95°C 4 min 
2. Annealing 57 - 63°C 30 s 50-68°C 30 s 
3. Primer extension 72°C 60 s 68°C 2 min 
4. Denaturing 94°C 30 s 94°C 30 s 
5. Cycles (step 2.-4.) 20-34 x 34 x 
6. Annealing 57 - 63°C 30 s 50-68°C 30 s 
7. Final extension 72°C 5 min 68°C 5 min 
8. Cooling 10°C stop 10°C stop 
 
The Thermocycler PTC-225 (MJ Research) was used for all PCRs. Size determination and 
purification of the PCR products was done using agarose gel electrophoresis (Loeb and 
Chauveau, 1969; Takahashi et al., 1969). 
 
2.6.4 DNA sequencing 
The method of chain termination was used for DNA sequencing (Sanger et al., 1977). During 
this method (also called “cycle sequencing”) cyclic, PCR-based DNA amplification is 
combined with base specific chain termination (Carothers et al., 1989; Murray, 1989). For all 
sequencing reactions, the ABI Prism Big Dye Terminator Cycle Sequencing Kit (PE Applied 
Biosystems) was used. Amplified fragments were purified using 96-well-G50-Superfine 
plates (GE Healthcare). Subsequently, the purified fragments were separated and analyzed in 
an ABI PrismTM 377 DNA Sequencer (PE Applied Biosystems). 
Raw data was processed with Sequence Analysis 3.0 software (PE Applied Biosystems). 
Sequence data was analyzed with Lasergene (DNASTAR, London, UK). 
 
2.6.5 Restriction hydrolysis 
Sequence specific hydrolysis of DNA was achieved by incubation for at least 1 h with 
restriction enzymes at a concentration of 1 Unit/µg DNA template. Buffers and incubation 
temperatures were chosen referring to the manufacture’s instructions. Subsequently, the DNA 
fragments were separated in an agarose gel electrophoresis and purified with the NucleoSpin® 
Extract II Kit (Macherey Nagel, see 2.6.2.2). 
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2.6.6 DNA dephosphorylation 
Prior to ligation of insert fragments with vector-DNA, the vector-DNA was dephosphorylated 
to prevent internal ligation. The target DNA was incubated with alkaline Phosphatase (Roche, 
1 Unit/µg DNA) in dephosphorylation buffer (Roche) for 30 min at 37°C. For removal of the 
enzyme, DNA was precipitated with isopropyl alcohol (see 2.6.2.3) and resolved in distilled 
water. 
 
2.6.7 DNA ligation 
DNA fragments were ligated by incubation with 10 Units T4-DNA-Ligase (Promega) per µg 
of DNA in Ligation Buffer (Promega) at 16°C over night. To obtain highest ligation 
efficiency, vector- to insert-DNA ratios from 1:1 to 1:5 were tested. 
 
2.6.8 Transformation of E. coli 
For amplification, plasmids were transformed into DH5α-cells (Invitrogen) using the “heat 
shock”-transformation protocol of the manufacturer. 
 
2.6.9 Cloning of expression vectors 
2.6.9.1 Generation of an expression vector for NeuroD1 
The coding sequence for Neurogenic Differentiation 1 (NeuroD1, GeneID: 18012) was 
obtained from the SwissProt Database (http://www.expasy.ch/sprot/). As the complete open 
reading frame is spanning only one exon of the gene, the coding sequence was amplified from 
genomic DNA using the following primers: 
 
Forward primer: 
5’ GGGGGAAGCTTCACCATGACCAAATCATACAGCGAGAG 3’ 
(red: HindIII recognition site, blue: Start-codon) 
 
Reverse primer: 
5’ GGGGGGGATCCGAAACTGACGTGCCTCTAATCGTG 3’ 
(red: BamHI recognition site) 
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After amplification (see 2.6.3) and purification (see 2.6.2.2), the PCR fragment was incubated 
with the restriction enzymes BamHI (NEB) and HindIII (Fermentas) in SureCut B restriction 
buffer (Roche) followed by purification (see 2.6.5). A eukaryotic expression vector based on 
the chicken β-actin promoter and the CMV enhancer, pCX-MCS2 (see Fig. 2.1), a gift from 
Xavier Morin (Morin et al., 2007), was treated the same way. After dephosphorylation of the 
vector DNA, the NeuroD1 PCR fragment was ligated with pCX-MCS2 (see 2.6.7) and 
transformed into DH5α-cells (see 2.6.8). The final construct, pCX-ND1, was verified by 
sequencing (see 2.6.4 and 6.1). 
 
 
Figure 2.1: The expression vector pCX-MCS2 
Map showing the main modules and restriction endonuclease binding sites of the pCX-MCS2 
expression vector. 
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2.6.9.2 Generation of an expression vector for NeuroD2 
The coding sequence for Neurogenic Differentiation 2 (NeuroD2, GeneID: 18013) was 
obtained from the SwissProt Database (http://www.expasy.ch/sprot/) and amplified from 
whole brain cDNA (a gift from Sonja Gemmel), using the following primers: 
 
Forward primer: 
5’ GGGGGAAGCTTCTCTCTGAGGCACCATGCTGAC 3’ 
(red: HindIII recognition site, blue: Start-codon) 
 
Reverse primer: 
5’ GGGGGGGATCCGTCGGCGCGAGGTCTCAGTTATG 3’ 
(red: BamHI recognition site) 
 
Cloning of the PCR fragment into pCX-MCS2 was equal to NeuroD1 (see 2.6.9.1). The final 
construct, pCX-ND2, was verified by sequencing (see 2.6.4 and 6.1). 
 
2.6.10 Microarray analysis 
2.6.10.1 Amplification of RNA 
For the generation of amplified cDNA after MACS- (see 2.8.4) or FACS-purification (see 
2.8.5), the SuperAmp Protocol (Miltenyi Biotec) was applied. Briefly, 5000-10000 cells per 
approach were collected in 6.4 µl SuperAmp Lysis Buffer, the mRNA was extracted using 
magnetic beads and transcribed into cDNA using tagged random and oligo(dT) primers. First 
strand cDNA was 5’ tagged by incubation with 21.5 Units terminal deoxynucleotidyl 
transferase (GE Healthcare) for 60 min at 37°C. The enzyme was inactivated at 70°C for 
5 min. Tagged cDNA was globally amplified using primer complementary to the tag sequence 
using the PCR program in Table 2.4. The PCR Products were purified using the NucleoSpin® 
Extract II Kit (Macherey Nagel, see 2.6.2.2) and cDNA yield was quantified by OD 
measurement (NanoDrop, NanoDrop Technologies). Length distribution of amplified cDNA 
was analyzed by capillary electrophoresis (Bioanalyzer, Agilent). 
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Table 2.4 PCR program for SuperAmp amplification of cDNA  
Step Parameters 
   
1. Sample prewarming 78°C 30 s
2. Denaturing 95°C 15 s
3. Annealing 65°C 30 s
4. Primer extension 68°C 2 min
5. Cycles (step 2.-4.) 20 x
6. Denaturing 94°C 15 s
7. Annealing 65°C 30 s
8. Primer extension 68°C 2 min + 10 s/cycle
5. Cycles (step 6.-8.) 21 x
6. Annealing 65°C 30 s
7. Final extension 68°C 10 min
8. Cooling 10°C stop
 
 
2.6.10.2 Fluorescent labeling of RNA 
To detect hybridized cDNA after microarray hybridization, 250 ng of the purified PCR 
product (see 2.6.10.1) was labeled with either Cy5- or Cy3-dCTP (GE Healthcare) in a 
Klenow Fragment (10 Units per sample) reaction for 2 h at 37°C before heat inactivation at 
70°C for 5 min. Labeled cDNA was purified using the CyScribe GFX Purification Kit (GE 
Healthcare) and quantified by OD measurement (NanoDrop, NanoDrop Technologies). 
 
2.6.10.3 Microarray hybridization 
Agilent whole mouse genome 44k microarrays were hybridized according to the 
manufacture’s instructions (http://www.chem.agilent.com/scripts). Briefly, 2.5 µg of 
combined Cy3-/Cy5-labeled and purified cDNAs (see 2.6.10.2) were adjusted with dH2O to a 
volume of 200 µl and denatured for 5 min at 95°C. After adding 50 µl control targets 
(Agilent) and 250 µl 2x Hybridization Buffer (Agilent), samples were incubated on the 
microarrays at 65°C for >16 h. Afterwards, microarrays were washed with Wash Buffer I 
(Agilent) for 1 min at 37°C, with Wash Buffer II (Agilent) for 1 min at 25°C and dried after 
30 s incubation in acetonitrile. Scanning was performed using the Agilent DNA-Microarray 
Scanner. 
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2.6.10.4 Microarray data analysis 
Scanned images were analyzed using the Agilent Feature Extraction software (Version 9.1) by 
which the local background was subtracted and a rank consistency based probe selection for 
Lowess normalization was done. After filtering the data with respect to signal significance a 
two-tailed t test was used to determine signal versus background significance. Spots with a P-
value of >0.01 were omitted. Exported raw data were further processed by the Luminator 
software (Agilent) yielding expression values. Subsequently, only expression ratios of genes 
with a P-value of <0.001 were used. After log2-transformation of the ratios, data were 
imported in TIGR MeV Version TM4 (Saeed et al., 2003). Average linkage clustering of 
genes was done using Euclidean Distance (Eisen et al., 1998). Significantly different 
expressed genes among the analyzed brain areas were identified by SAM (Serial Analysis of 
Microarrays) using the Tusher et al. method (Tusher et al., 2001) with at least 100 
permutations per analysis. Gene Ontology (GO) analysis was carried out using TreeRanker 
(Schacherer, F., unpublished) at a significance level of 0.005. Interactions between genes and 
pathway analysis were computed with PathwayArchitect software (Stratagene) interpreting 
only verified interactions. 
 
2.6.11 Quantitative real-time PCR 
Transcript levels were measured by quantitative real-time PCR using PerkinElmer Applied 
Biosystems prism model 7000 sequence detection system (PE ABI 7000 SDS). Forward and 
reverse primer sequences are listed in table 2.5. GAPDH was used to normalize the 
expression data. Four ng of globally amplified cDNA libraries (see 2.6.10.1) were used as 
template for each PCR analysis, all assays were performed with four replicates. Threshold 
cycle, Ct, was measured as the cycle number at which the SYBR green emission increases 
above threshold level. The following cycle conditions were used: 95°C for 10 min followed 
by 50 cycles of 95°C for 15 s, 60°C for 1 min. For each amplified product, melting curves 
were determined according to the supplier’s guidelines ensuring specific amplification. For 
each run, negative controls were performed by omitting the template. 
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Table 2.5 Primers for qPCR 
Strain Forward primer Reverse primer 
DLX1 CCACCGAGTCCTGGACCAC CCCTCCCTCTGATTTCCCC 
DLX2 TATTGGAAGTGGCGACCAGG TGGCACTAAAGGATCCCACG 
DLX5 TCAATCAATTCCCACCTGCC AAACTGAGCAAGAGAAAGTAGCCC 
FOXG1 CGATGTATGTGGTCACTAACAGGTC GCGCAACACAGGTTACATATTTG 
ZIC1 TGCAAACATTTCGTCCCAAAG TGACACGTAGATCCAGGCTCG 
ZIC2 CCACGGTGATTTTAACGGCT AAGGGAAATGGGAGAAAGGC 
LHX5 AAGAGGTTGCTATGGCCACG TCCTCATCTTTGTCTGGCCG 
GAPDH GACCTGACCTGCCGTCTAGAA TCAGTGTAGCCCAGGATGCC 
 
2.7 Protein biochemical methods 
2.7.1 Isolation of proteins 
Cells or tissues were lysed by sonification in RIPA buffer (150 mM NaCl, 1%NP-40, 0.5% 
Sodiumdeoxycholate, 0.1% SDS, 1 mM EDTA, 50 mM Tris pH 8.0) and subsequent 
incubation for 1-2 h at 4°C. Concentration of the protein solutions was determined in a 
Bradford assay (Bradford et al., 1970). 
 
2.7.2 Polyacrylamide gel electrophoresis (PAGE) 
Proteins were separated according to their mass by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) (Laemmli, 1970). Samples (5-20 µg) were diluted in loading 
buffer (2% SDS; 60 mM Tris/HCl, pH 6.8; 10% glycine; 5% β-mercaptoethanole; 0.02% 
bromophenol blue) and loaded onto 10-20% Tris/Glycine-gels (Anamed). Gel electrophoresis 
was performed using an X-cell Sure Lock Novex Mini cell System (Invitrogen) in running 
buffer (50 mM Tris/HCl pH 8.3; 380 mM glycine; 0.1% SDS). Protein sizes were determined 
by referring to the PAGE-RulerTM Prestained Protein Ladder (Fermentas).  
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2.7.3 Western-blotting 
After separation by SDS-PAGE (see 2.7.2), Proteins were blotted onto PVDF membranes 
(Hybond-P, Amersham Biosciences), which were activated with methanol for 30 s and 
equilibrated with transfer buffer for 5 min. Before blotting, protein gels were equilibrated with 
distilled water for 5 min. Proteins were transferred onto the PVDF membrane via a Trans-Blot 
SD SemiDry Transfer Cell (BioRad). 
 
2.7.4 Immunodetection of proteins 
Detection of proteins on PVDF membranes was carried out by binding of specific antibodies. 
To block unspecific binding-sites, membranes were incubated in 5% BSA in TBST (0.9% 
NaCl; 10 mM Tris/HCl, pH 7.4, 0.05% Triton TX100). Subsequently, membranes were 
incubated with the primary antibody in blocking buffer for 2 h at room temperature. 
Membranes were washed 3 times for 10 min in TBST and incubated with a secondary 
antibody, coupled to horseradish peroxidase, in blocking buffer for at least 1 h. The ECL+-Kit 
(GE Healthcare) was used for visualization of bound antibodies. 
 
2.8 Cell biological methods 
2.8.1 Dissociation of brain tissue 
Brain tissue was enzymatically dissociated to obtain a single-cell suspension by using the 
Neuronal Tissue Dissociation Kit (Papain or Trypsin, Miltenyi Biotec). For some 
applications, the concentration of Papain or Trypsin was varied to prevent loss of cell surface 
epitopes. In this case, the protease concentration is specified in the respective section. 
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2.8.2 Cultivation of eukaryotic cells 
2.8.2.1 Cell lines 
All cell lines were cultured in 25-175 cm2 flasks or 6-96 well flat- or round-bottom culture 
plates (BD Falcon). Murine 1881 cells (Promochem) were cultured in Dulbecco’s modified 
Eagles medium (DMEM; Miltenyi Biotec or Invitrogen) supplemented with 10% FCS 
(Biochrom), 15 mM HEPES (Invitrogen) and 2 mM L-Glutamine (Invitrogen) in a humidified 
incubator with a 5% CO2 atmosphere at 37°C. SP2/0 cells (Promochem) were cultured in 
DMEM containing 20% FCS (PAA Laboratories), 20 mM HEPES and 2 mM L-Glutamine in 
a humidified incubator with a 9% CO2 atmosphere at 37°C. 
 
2.8.2.2 Primary brain cells 
Dissociated brain cells (see 2.8.1) were cultured in DMEM/Ham's F12 medium (3/1) 
containing 2 mM Glutamax, 1% N2 supplement, 1% B27 and 1% penicillin/streptomycin (all 
from GIBCO) in poly-l-lysine-coated (0.01%, Sigma) 24-96 well flat-bottom culture plates 
(BD Falcon). For immunocytochemistry, 50.000 cells per well were seeded on poly-l-lysine-
coated (0.01%, Sigma) glass coverslips in 4-well plates containing 500 μl culture medium. 
 
2.8.3 Transfection of cell lines 
Cell lines were transfected by electroporation. During the exponential proliferation phase, 
suspension cells were harvested by centrifugation (150-300 g, 10 min) and resuspended in 
fresh medium without FCS. After transfer into a sterile electroporation cuvette (Type 165-
2107, BioRad), 0.5-1x107 cells were mixed with 15-50 µg pre-diluted DNA and incubated on 
ice for 15 min. Electroporation was performed using the Bio-Rad Gene Pulser II instrument 
with the following settings:  
 
210-270 V 
0.975 µF 
Time constant 15-25 ms 
 
After the pulse, cells were kept at 37°C for 10 min before subsequent culturing (see 2.8.2.1). 
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2.8.4 Magnetic cell separation (MACS®) 
The MACS® technology allows the separation of cells according to specific cell surface 
markers (Abts et al., 1989; Miltenyi et al., 1990; Radbruch et al., 1994). In principle, 
monoclonal antibodies which are covalently linked to superparamagnetic microbeads are 
incubated with single cell suspensions. These antibodies bind to cell surface markers directly 
or indirectly (via specific primary antibodies) and thereby magnetically label the target cell. 
After extensive washing, cell suspensions are separated with high gradient magnetic columns. 
Cells labeled with the microbeads retain in the column, whereas unlabeled cells pass through 
and can be collected as untouched fraction. Subsequently, the labeled cells can be eluted by 
displacing the column from the magnetic field. In general, this technology can be used in two 
ways: either depletion of unwanted cells by collection of the eluted, unlabeled fraction, or 
direct enrichment of labeled cells. After magnetic separation, purity of isolated cell subsets 
can be analyzed by flow cytometry or immunostaining. 
 
The MACS® technology was used for the purification of glomerular layer precursors and 
interneurons. Coronal sections (300 μm) of olfactory bulbs from 20 postnatal day 2 mouse 
brains were serially cut using a vibratome (Leica, see 2.9.1). The glomerular layers of these 
slices were dissected and dissociated (see 2.8.1). Afterwards, the cells were centrifuged at 
300 g for 7 min and the pellet (about 1.1x106 cells) was resuspended in 200 µl HBSS-BSA 
(Miltenyi Biotec) containing 0.6 µl c-ganglioside-specific mouse IgM A2B5 ascites (ATCC 
CRL-1520, kindly provided by G. Rougon, Marseille) and incubated on a gently rocking 
rotator for 30 min at 4°C. Subsequently, the cells were washed in 10 ml HBSS-BSA and 
centrifuged for 7 min at 300 g. The same incubation and washing conditions were applied for 
all further antibodies. The pellet was resuspended in 20% (v/v) anti-mouse IgM MicroBeads 
(Miltenyi Biotec) in 200 µl and, after incubation and washing, resuspended in 1 ml HBSS-
BSA. Cells were separated using an MS Column and a MiniMACSTM Separator (Miltenyi 
Biotec) according to the manufacture’s instruction. The A2B5+ fraction, retained in the 
column, was eluted and kept on ice, while the flow-through was incubated with 5 μg/ml PSA-
specific mouse IgG2a 735 antibody (kindly provided by R. Gerardy-Schahn, Hannover). 
Using 20% (v/v) anti-mouse IgG MicroBeads (Miltenyi Biotec) in 100 µl HBSS-BSA as 
secondary antibody directed against 735, the marked PSA+ cells were selected by retention in 
a column placed in a MiniMACSTM Separator, whereas the PSA- cells were collected from the 
flow-through. Type A early precursor cells were purified similar, by using SVZ- instead of 
glomerular layer-tissue as starting material. 
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2.8.5 Flow cytometry 
The flow cytometric analysis of cells or particles allows the analysis of physical- (cell size, 
cell granularity) and fluorescent-properties (after immunostaining with antibodies coupled to 
fluorescent dyes or internal expression of fluorescent markers). Therefore, singularized 
labeled cells are excited in a fluid stream by Argon- (488 nm) and diode-lasers (633nm). 
Depending on their label, the cells emit light which can be detected. The combination of 
scattered and fluorescent light emissions is detected and analyzed to define information about 
the physical structure and expression pattern of different molecules for each single cell. The 
flow cytometric analysis was done using a FACSCaliburTM combined with the CellQuest 
software version 3.1 or version 3.3 (Becton Dickinson).  
 
Table 2.6 Fluorochromes used for FACS  
Fluorochrome Absorption maximum (nm) Emission maximum (nm) 
EGFP 488 509 
FITC 495 517 
Phycoerythrin (PE) 565 576 
Propidium-Iodid (PI) 538 617 
Allophyconcyanin (APC) 651 660 
 
Besides the analysis of cells, the FACS-technology also allows the separation of a 
heterogeneous cell population (Cantor et al., 1975). This fluorescence-activated cell sorting is 
based on the same flow cytometric principle as mentioned before. In addition, the fluid stream 
is fractionated into single drops containing a maximum of one cell per drop. The drops which 
contain target cells, defined by their scattered and fluorescent light emissions, are electrically 
charged and deflected into reaction tubes based upon their charge.  
 
For the isolation of GFP+ GABAergic cells from whole brains, 4 transgenic GAD67-GFP 
mice at postnatal day 1 were sacrificed and their brains recovered. For the isolation of cells 
from different brain areas, the brains of 6 postnatal day 1 old GAD67-GFP mice were 
dissected into olfactory bulb, cortex, striatum, and cerebellum. GFP+ GABAergic cells for 
immunization were isolated from brains of 8 to 12 postnatal day 1 old GAD67-GFP mice. The 
tissues were then dissociated to a single cell suspension (see 2.8.1). Cells were resuspended in 
PBS (Gibco) and sorted on a FACSVantage SETM cell sorter (Becton Dickinson) for their 
FSC (forward scatter), SSC (side scatter) and FL-1 (EGFP) signals. Background signals were 
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set using dissociated brain cells from wild-type mice (C57Bl/6 / 6NCrl). Dead cells were 
excluded using PI (Sigma, 20 µg/ml), which intercalates into the DNA of dead cells. 
 
2.8.6 In vivo electroporation 
The technology of postnatal electroporation was initially established by Camille Boutin 
(Boutin et al., 2008). This method allows the targeted transfection of radial glia cells in the 
postnatal ventricular zone. At that stage, radial glia cells still represent the stem cell 
population of the SVZ/RMS/olfactory bulb system. Transfection of these cells induces strong 
expression of transgenes in the stem cell population as well as their progeny, neuronal 
precursors and mature neurons of the olfactory system. 
Animals were treated according to guidelines approved by the French ethical committee. 
Postnatal day 1 old mice (CD1 strain, Charles-River) were anesthetized by hypothermia (4 
min) and fixed to a support using band-aid. The skin and the skull covering the lateral 
ventricle were opened for about 2 mm using an ophthalmic scalpel. As a general positional 
marker, a virtual line connecting the right eye with lambda (visualized by a strong cold light 
source) was used and the incision was positioned 1 mm caudal to the midpoint of this line. 
Subsequently, the animal was placed in a stereotaxic rig (Kopff) under a Hamilton syringe 
connected to a glass capillary (diameter 200 µm, pulled out manually, GC100-15, Clark) 
containing 2 µl of plasmid solution (5 µg/µl, in PBS containing 1% Fast Green). The syringe 
was placed over the incision, positioned at the level of the skull, then lowered between 
2.5 mm to 3.0 mm into the lumen of the right lateral ventricle and the stained DNA solution 
was injected. An injection was considered correct when the shape of the now slightly dark 
stained lateral ventricle was visible under the light source. Only successfully injected animals 
were subjected to five electrical pulses (100 V, 50 ms, separated by 950 ms intervals) using 
the CUY21 edit device (Nepagene) and 10 mm tweezer electrodes (CUY650P10, Nepagene) 
coated with conductive gel (Control Graphique Medical). Electroporated animals were 
reanimated for several minutes on a 37°C heating plate before being returned to the mother. 
 
To transfect a different population of neuronal progenitor cells, cortical projection neuron 
precursors were electroporated at embryonic day 14 in utero (Saito and Nakatsuji, 2001; 
Shimogori and Ogawa, 2008). 
Timed pregnant mice (with embryos at E14) were anesthetized with xylazin/ketamin 
(4.6 mg/kg body weight). After cleaning the abdomen with 70% ethanol, a midline lapratomy 
was performed and the uterus taken out. For DNA microinjection, a pulled out glass capillary 
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(diameter 200 µm, GC100-15, Clark) containing 1 µl of plasmid solution (3 µg/µl, in PBS 
containing 1% Fast Green) was used. The DNA was injected into the lateral ventricle using a 
mouth controlled pipette system. The correct injection site was visible through the uterine 
wall by illuminating with a fiber optics light source. Square electric pulses (50 ms, at 25 V, 
5 pulses) were delivered to embryos through the uterus by using the CUY21 edit device 
(Nepagene) and 10 mm tweezer electrodes (CUY650P10, Nepagene). The uterus was kept 
wet by dropping saline. Subsequently, the uterine horns were repositioned in the abdominal 
cavity, filled with prewarmed saline at 37°C, and the abdominal wall and skin were sewed up 
with surgical sutures. The pregnant mice were sacrificed 4 days after electroporation and the 
embryos removed. The embryonic brains were dissected, fixed with 4% PFA over night at 
4°C and cut using a vibratome at 50 µm (see 2.9.1). 
 
2.8.7 Immunization  
Contralateral footpad immunization was used to induce monoclonal antibody production in 
rats (Brooks et al., 1993; Yin et al., 1997). For all immunization approaches, GFP+ 
GABAergic neurons were isolated from dissociated brain tissue (see 2.8.1) of 8 to 12 
GAD67-GFP mice by FACS (see 2.8.5). Subsequently, about 0.8-1.3 x 107 purified cells were 
injected subcutaneously (s.c.) into the left hind footpad of Lewis rats (LEW/HanHsd, Harlan). 
To minimize the unspecific immunoresponse, in most cases a decoy was injected into the 
right hind footpad in parallel. Boosts were administrated at days -3, 0, 4, 7, 11 and 14, with 
only a decoy injection at day -3. In different immunization attempts, several different decoys 
and adjuvants were tested. Either the GFP- fraction after FACS (see 2.8.5), dissociated brain 
tissue of Actin-GFP mice (see 2.8.1) or EGFP protein (a gift from Gritt Günther) served as 
decoy. Detailed immunization schemes are listed in the results section. 
 
2.8.8 Cell fusion 
One day after the last immunization (see 2.8.7), cells from the popliteal lymph node of the one 
hind footpad were isolated and used for the fusion with a murine myeloma partner (Sp2/0 
cells) based on the HAT system (Cotton and Milstein, 1973; Kohler and Milstein, 1975). 
After fusion, cells were seeded into 96 well flat-bottom culture plates (BD Falcon) in 150 µl 
DMEM containing 20% FCS (PAA Laboratories), 20 mM HEPES, 2 mM L-Glutamine, 
0,1 mM Hypoxanthin (Sigma) and 2 µg/ml Azaserine (Sigma). Mouse peritoneal 
macrophages had been isolated 2 days before and cultured in the same wells to increase the 
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survival after fusion. The plates were incubated in a humidified incubator with a 9% CO2 
atmosphere at 37°C. After 5 to 7 days, 50 µl of culture medium was added to each well 
followed by subsequent incubation. 
 
2.8.9 Screening of hybridoma supernatants 
Screening of hybridoma supernatants was carried out by immunolabeling followed by flow 
cytometric analysis (see 2.8.5). Wells containing clones (see 2.8.8) of more than 1 mm 
diameter were marked and 50 µl supernatant was transferred into a new well of a 96 well 
round-bottom culture plate (BD Falcon). About 1 x 104 dissociated cells from brains of 
GAD67-GFP mice (see 2.8.1) were added to each supernatant. After 15 min at 4°C, the plates 
were centrifuged (200 g, 10 min) and washed with 150 µl PBS for three times. The cells were 
resuspended in 50 µl PBS containing mouse anti-rat (mar) kappa (κ) monoclonal antibody 
(1:700, clone 18.5, mouse IgG2a, Miltenyi Biotec) coupled to APC and incubated at 4°C for 
10 min. After three washing steps (150 µl PBS, 200 g, 10 min), the cells were resuspended in 
300 µl PBS containing PI (Sigma, 20 µg/ml) and analyzed by flow cytometry (see 2.8.5). If a 
hybridoma clone had produced an antibody which recognizes a cell surface antigen on 
GABAergic cells, the cells would be double positive for GFP and APC. 
 
2.9 Histological methods 
2.9.1 Preparation of brain tissue 
For histological analysis, pups were deeply anaesthetized with an overdose of xylazin/ketamin 
(more than 10 mg/kg body weight). Perfusion was performed intracardiacally with a solution 
of 4% paraformaldehyde in PBS. The brain was removed and immersed overnight in the same 
fixative at 4°C. For vibratome sectioning, brains were washed three times for 10 min in PBS 
and stored at 4°C. Sections were cut at 50 µm using a microtome (Microm). For cryostat 
sectioning, brains were cryoprotected in 25% sucrose over night and frozen at -80°C. 
Afterwards, 10 µm sections were cut on a CM3050 cryostat (Leica), collected on Superfrost 
Plus slides (Menzel) and stored at -80°C. 
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2.9.2 In situ hybridization 
Labeled antisense RNA probes were generated by T7 based in vitro transcription from 
EasyProbeTM templates (Miltenyi Biotec) using the Dig-RNA labeling kit (Roche) according 
to the manufacture’s instructions. The EC10 EasyProbeTM template (Miltenyi Biotec) 
fragment, homologous to the bacterial ABC transporter YgaD, served as negative control. For 
hybridization, 10 µm cryostat sections were incubated in RIPA buffer (150 mM NaCl, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 50 mM Tris pH 8.0) twice 
for 10 min and post-fixed in 4% paraformaldehyde in PBS for 10 min at room temperature. 
After washing in PBS for 5 min, the slides were hybridized using the a-HybTM hybridization 
station (Miltenyi Biotec) at a continuous pump rate of 1 ml/min. After washing with PBS for 
1 min, the tissue was acetylated for 10 min with 0.25% acetic anhydride in 0.1 M 
triethanolamin/HCl (pH 8.0). After an additional incubation in PBS, the sections were 
prehybridized with hybridization solution (50% formamide, 4x SSC, 1x Denhardt’s, 
2 mM EDTA, 10% dextrane sulphate, 0.5 mg/ml yeast t-RNA, and 0.5 mg/ml salmon sperm 
DNA) for 30 min at 37°C. The labeled probe was dissolved in hybridization solution, 
denatured at 82°C and applied to the sections. Hybridization was carried out for 150 min at 
temperatures from 42°C to 65°C, depending on the probe. After washing twice for 1 min in 
2x SSC/50% formamide at 25°C and twice for 1 min in 1x SSC, the a-HybTM was blocked 
using 0.1% BSA in 1x SSC for 5 min. Following a washing for 1 min in 
2.5x SSC/0.2% Tween 20, the sections were blocked in detection solution (2% sheep serum in 
2.5x SSC/0.2% Tween 20) for 15 min and incubated in detection solution containing 
phosphatase-conjugated anti-Dig fab fragments (Roche) for 30 min. Slides were then washed 
twice in 4x SSC/0.2% Tween 20 for 1 min and twice in AP buffer (100 mM Tris/HCl, 
100 mM NaCl and 50 mM MgCl2) for 1 min. Visualization was performed using NBT/BCIP 
(Sigma) dissolved in AP buffer containing Levamisol (1 mM) until the staining became 
visible, whereas the negative control staid clear. The reaction was stopped by rinsing the 
slides in PBS for 5 minutes. Sections were mounted with Aquamount (DAKO). Microscopy 
was done using a Zeiss Axioskop 2+ equipped with an AxioCam HRc digital camera and the 
AxioVison 3.1 software (all from Zeiss). 
 
2.9.3 Immunocytochemistry 
For immunocytochemistry, 50.000 cells were seeded per well on poly-l-lysine-coated (0.01%, 
Sigma) glass coverslips in 4-well plates containing 500 μl culture medium (see 2.8.2.2). A2B5 
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ascitic fluid was added 1:400 to the living cells for 20 min. The cells were fixed after 1 h to 
avoid in vitro differentiation. After fixation in 3.8% PFA in PB (0.5% BSA in PBS) for 
20 min at room temperature, cells were washed and 3% BSA in PB was added as blocking 
buffer for 30 min. Primary antibodies (A2B5, Mouse IgM, kindly provided by G. Rougon, 
1:400; Calb2, Mouse IgG1, Sigma, 1:1000; GAD65/67, Rabbit, Sigma, 1:400; Polysialic acid 
(PSA) 735, Mouse IgG2a, kindly provided by R. Gerardy-Schahn, 1:400; TUJ1, Rabbit IgG, 
Covance, 1:2000) were diluted in blocking buffer and applied for 2 h at room temperature. 
After washing, the cells were incubated 1 h with secondary antibodies (Goat anti-mouse IgM 
Alexa 488, Molecular Probes/Invitrogen, 1:2000; Goat anti-mouse IgG Fc Cy3, Jackson 
ImmunoResearch Laboratories, 1:1000; Goat anti-rabbit IgG Cy5, Cambridgeshire, 1:800; 
Donkey anti-mouse IgG Cy3, Jackson, 1:400; Donkey anti-rabbit Cy3, Jackson, 1:400; Goat 
anti-mouse IgG Alexa 633, Molecular Probes, 1:1000; Goat anti-mouse IgM Alexa 633, 
Molecular Probes, 1:800). After application of secondary antibodies, the cells were washed 
twice for 10 min in PB, one time for 10 min in distilled water, air-dried and mounted with 
Fluorescence Mounting Medium (DAKO). Fluorescence microscopy was performed using an 
Axioplan 2 equipped with an ApoTome imaging module, an AxioCam MRc digital camera 
and the AxioVison 4.2 software (all from Zeiss).  
 
2.9.4 Immunohistochemistry 
For immunohistochemistry, 50 µm vibratome sections (see 2.9.1) were used. Staining was 
done on floating sections as described previously (Hack et al., 2002). Briefly, sections were 
first incubated overnight at 4°C with primary antibodies (MenB against PSA, 1:250, provided 
by G. Rougon, Marseille, France; DCX, 1:200, Chemicon; Mash1, 1:200, Upstate) before 
incubation with the corresponding fluorescently labeled secondary antibody (Goat anti-guinea 
pig IgG Cy5, Abcam, 1:200; Goat anti mouse IgM Texas Red, Abcam 1:800; Goat anti-
mouse IgG Fc Cy5, Jackson, 1:1000). Cell nuclei were stained with Hoechst 33258 and the 
samples were mounted with Fluorescence Mounting Medium (DAKO). Optical images were 
taken either using an Axioplan 2 equipped with an ApoTome or a LSM510 laser confocal 
scanning microscope (all from Zeiss). 
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2.10 Mouse breeding 
Animals were maintained at a 12 h light-dark circle in an SPF animal facility. All protocols 
were in accordance to the German “Tierschutzgesetz”. Experiments were partially performed 
at the IBDML (Marseille, France) in accordance to protocols approved by local authority 
guidelines. 
 
Table 2.7 Mouse strains 
Name Strain background Reference 
CD1 Crl:CD1 (ICR) Charles River Laboratories 
Bl6 C57Bl/6 / 6NCrl Charles River Laboratories 
Balb/c BALB/cAnNCrl Charles River Laboratories 
GAD67-GFP GAD67-GFP (∆neo), C57Bl/6 / 6NCrl Tamamaki et al., 2003 
TH-GFP TH/EGFP, C57Bl/6 / 6NCrl Matsushita et al., 2002 
Actin-GFP TgN(GFPU)5Nagy, C57Bl/6 / 6NCrl Hadjantonakis et al., 1998 
 
Genotyping was done by PCR (see 2.6.3) using strain specific primers (see Tab. 2.8). 
 
Table 2.8 Primers for genotyping 
Strain Forward primer Reverse primer 
GAD67-GFP GCTGTGAGCCTCACTCGGAGC TGCTCAGGTAGTGGTTGTCG 
TH-GFP AAGTTCATCTGCACCACCG TGCTCAGGTAGTGGTTGTCG 
Actin-GFP AAGTTCATCTGCACCACCG TGCTCAGGTAGTGGTTGTCG 
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3 Results 
Part I: Molecular analysis of region-specific fore- and 
hindbrain GABAergic neuron subpopulations 
GABAergic neurons are a diverse group of inhibitory neurons. Different subpopulations are 
present in all brain regions and several attempts have been made to categorize these 
subpopulations (Markram et al., 2004). While some of these results allow for a valuable, 
detailed and partly functional description of different GABAergic neurons, they have not led 
to a systematic dichotomy. Whole genome gene expression profiling has emerged as a method 
for the molecular description of cell populations. Based on the expression of genes, an 
unambiguous and specific pattern is assigned to each cell type or cell stage. Besides the pure 
categorization of cell types, the interpretation of their specific expression pattern may also 
help to get an understanding of functional properties and to identify novel markers which can 
be used for their isolation. To analyze GABAergic neuron subpopulations on a molecular 
level, first of all a method to isolate the respective cells had to be established. 
 
3.1 Analysis and isolation of GABAergic neurons by flow cytometry 
So far, no surface markers suitable for the isolation of GABAergic neurons by FACS or 
MACS® have been described. However, GAD67-GFP mice express GFP under the control of 
the endogenous glutamate decarboxylase 67 isoform-promotor (Tamamaki et al., 2003). A 
specific expression of GFP in all GABAergic neurons throughout the brain of this mouse 
strain was shown (Tamamaki et al., 2003). To check the suitability of this model system for 
flow cytometric analysis and purification of GABAergic neurons, an appropriate method for 
the dissociation of brain tissue to a single cell suspension was established. 
 
3.1.1 Dissociation and flow cytometric analysis of GABAergic neurons 
Different protocols for an optimal dissociation of brain tissue yielding high recovery rates of 
viable and singularized neural cells were tested. The total number of cells per brain, the 
efficiency for removal of tissue clumps and the percentage of dead cells, measured by 
propidiumiodide (PI) staining (see 2.8.5), served as criteria. Several Trypsin and Papain 
concentrations in combination with mechanical dissociation and filtration by cell strainers of 
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different mesh diameters (Miltenyi Biotec) were assayed. At postnatal day 1, the best results 
were obtained with a Papain based enzyme mix (NTDK Papain, Miltenyi Biotec) at standard 
concentration in combination with a 30 µm cell strainer (data not shown). No additional loss 
of GFP+ GABAergic cells was observed compared to cell strainers with higher mesh sizes. 
However, the use of cell strainers with higher mesh sizes, e.g. 50 or 70 µm, was less 
compatible with flow sorting, due to frequent plugging of the microfluidic parts inside the 
cytometer. Subsequent to the dissociation of either wild-type or GAD67-GFP postnatal day 1 
mouse brains, flow cytometric analysis was used to determine the GFP-fluorescence signals 
of single cells (Fig. 3.1). Whereas cells isolated from wild-type mice showed no GFP-
fluorescence, about 15.8% (Δ = 2.1%, n = 6) of the cells originated from GAD67-GFP mice 
were strongly GFP positive. The rate of dead cells, as identified by PI staining, was 2-3%. 
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Figure 3.1: Flow cytometric analysis of dissociated brain tissue from GAD67-GFP mice 
Brains of postnatal day 1 wild-type (A-C) or GAD67-GFP (D-F) mice were removed and dissociated to 
a single cell suspension. Flow cytometric analysis was used to determine the physical and fluorescent 
properties of each cell. Only events that were identified to have cell typical forward and side scatter 
properties (region in A and D) and showed low fluorescence in the PI channel (region in B and E) were 
considered as viable singularized cells and analyzed for their GFP expression (C and F). Cells 
isolated from wild-type mice showed no GFP fluorescence (C), whereas a subpopulation of cells 
(15.8%, ∆ = 2.1%, n = 6) from GAD67-GFP mice was strongly GFP positive (G). 
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3.1.2 Quantification of GABAergic neurons from different brain regions 
So far, the appearance of GABAergic neurons in distinct brain areas was analyzed mainly by 
immunohistochemistry (Kosaka and Kosaka, 2005). This method comprises several 
disadvantages like the time consuming staining procedures, inhomogeneous staining and the 
unequal distribution of marker proteins in distinct cell compartments, for example in the 
synaptic termini. It was reasoned that by using flow cytometry, it should be possible to 
investigate the regional distribution of GABAergic neurons at a much higher significance 
level, because higher cell numbers can be analyzed. To determine the proportion of 
GABAergic neurons in the major parts of the brain, tissue from olfactory bulb, cortex, 
striatum and cerebellum of twelve P1 old GAD67-GFP knock-in mice was dissected. 
Subsequently, tissues of two mice were pooled, dissociated enzymatically to a single cell 
suspension and analyzed by flow cytometry (Fig. 3.2). The number of EGFP-positive cells 
varied among different brain areas. The highest amount of positive cells was observed in the 
olfactory bulb with 58.8% (Δ = 3.2%, n = 6) reflecting that the largest population in the OB 
are inhibitory granule neurons. Striatal and cortical tissues contained 45.1% (Δ = 5.1%, n = 6) 
and 15.1% (Δ = 2.7%, n = 6) positive cells, respectively. The lowest number of GABAergic 
cells was found in the cerebellum (3.2%; Δ = 0.5%, n = 6).  
 
 
Figure 3.2: Quantification of GABAergic neurons among distinct brain areas 
Flow cytometric analysis of GFP+ cells in the olfactory bulb (A), the cortex (B), the striatum (C) the 
cerebellum (D) and subsequent quantification of positive cells (E). Error bars indicate the standard 
deviation of the mean value (n = 6 replicates from 12 mice). 
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3.1.3 Isolation of GABAergic neurons by FACS 
Based on the results above, it was now tested whether it is also possible to purify GABAergic 
neurons by FACS (see 2.8.5). Cells of dissociated brains from postnatal day 1 old GAD67-
GFP knock-in mice were sorted on a FACSVantage SETM cell sorter (Becton Dickinson) for 
their FSC (forward scatter), SSC (side scatter) and GFP (FL-1) signals. Background signals 
were defined by using dissociated brain cells from wild-type mice (C57Bl/6 / 6NCrl). Dead 
cells were excluded using PI. Each brain yielded around 1.0-1.2 x 106 GFP+ GABAergic 
neurons with purity higher than 99% (Fig. 3.3). The rate of dead cells, as identified by PI 
staining, was again 2-3%. Aliquots of FACS purified cells were successfully cultivated for 
seven days. Neither extensive cell death nor loss of GFP fluorescence was observed, 
indicating that the procedure is not harmful to the cells (data not shown). 
 
 
Figure 3.3: FACS purification of GABAergic neurons 
Flow cytometric purification of GFP labeled GABAergic neurons. No background fluorescence was 
observed in cells from wild type mice (A), whereas in cells from GAD67-GFP mice a clear GFP+ 
population could be identified (B). The purity of GFP+ cells after sorting was above 99% (C). 
 
 
3.2 Molecular analysis of GABAergic neurons 
The possibility to obtain populations of highly pure GABAergic neurons allowed for the 
subsequent analysis of these cells on a molecular level. Whole genome gene expression 
profiling has emerged as a method for the description of cell types. The expression of 
thousands of genes allow for each cell type or cell stage to be assigned an unambiguous and 
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prominent transcription pathways, functional explanation of the observed differences can be 
given and new single gene markers can be identified. To analyze GABAergic neurons in 
general and the relationship of these cells among distinct brain regions, their gene expression 
profiles were assayed using Agilent whole mouse genome 44k microarrays (see 2.6.10 and 
Fig. 3.4). 
 
 
 
Figure 3.4: Experimental setup 
(A) Scheme of the experimental setup for enzymatic dissociation of whole brains or brain areas from 
GAD67-GFP knock-in mice and purification of GFP+ cells by FACS. RNA of these cells was used to 
generate amplified cDNA, which was labeled with Cy5 in a Klenow reaction (red) and hybridized on 
Microarrays. Cy3 labeled cDNA (green) originated from whole brain mRNA served as a reference in all 
experiments. Furthermore, the number of replicates (B) and origin of the isolated cells (C) are 
indicated. 
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results matched with those of conventional gene expression profiling as well as those of cells 
which were not FACS purified (data not shown). 
Directly after flow cytometric sorting, 10000 cells per experiment were lysed in SuperAmp 
Lysis Buffer and stored at -20°C until RNA extraction and amplification. For quality control, 
capillary chromatography of total RNA, isolated from FACS purified GABAergic neurons, 
was performed, revealing no signs of degradation (Fig. 3.5). Microarray analyses of 
GABAergic neurons isolated from either whole brain (n = 4), olfactory bulb (n = 3), cortex 
(n = 3), striatum (n = 3) or cerebellum (n = 3) was performed, amounting to a total of 16 array 
data sets (Fig. 3.4 B and C). Global PCR amplification of mRNA from 10000 flow sorted 
GFP positive cells yielded 2.5-3.5 µg cDNA. 250 ng of cDNA was labeled and hybridized on 
Agilent whole mouse genome 44k microarrays (see 2.6.10). RNA isolated from wild type 
mice whole brains (n = 4) at postnatal day 1 was amplified in the same way and served as a 
common reference for all hybridizations. Correlation coefficients of independent replicates 
ranged from 0.90 to 0.97, demonstrating high reproducibility. The Gene Expression Omnibus 
(GEO) series entry GSE8984 provides access to all data from this analysis 
(http://www.ncbi.nlm.nih.gov/projects/geo/). Furthermore, supplementary files are available 
for download by FTP (File Transfer Protocol) using the series accession number at 
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/. 
 
 
Figure 3.5: Quality control of isolated total RNA after FACS purification 
For quality control, capillary chromatography of total RNA, isolated from FACS purified GABAergic 
neurons, was performed. No sign of degradation was observed. RINs (RNA Integrity Numbers) were 
between 7.8 and 8.7. Samples 1 to 3 show representative examples. The two major bands represent 
the 18S and 28S ribosomal RNA. The RNA ladder (L) spans 0.2-4.0 kb. 
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3.2.1 Global gene expression of GABAergic neurons 
The primary goal was to analyze similarities in gene expression of all subpopulations and 
thereby define a general genomic signature of GABAergic neurons. Factors involved in the 
late differentiation and functionality of these cells as well as new marker genes, also with a 
focus on cell surface proteins, should be identified. The general approach was validated by 
assessing the gene expression results of known marker genes (Fig 3.6). As expected, mRNAs 
encoding the two key enzymes for GABA synthesis, GAD67 (GAD1) and GAD65 (GAD2), 
were strongly enriched in purified GABAergic neurons compared to the whole brain 
reference. Furthermore, the vesicular inhibitory amino acid transporter (VIAAT), responsible 
for the transport of GABA into synaptic vesicles, was enriched, whereas mRNA for the 
glutamate transporter SLC1A4 was not. TH, a marker for catecholaminergic neurons, showed 
decreased expression. Consistently, established markers of glial cells, like GFAP, GLT1 
(SLC1A2), GLAST (SLC1A3), OLIG1, OLIG2, VIM, CD44 and PLP were decreased in 
GABAergic neurons. 
Taken together, the expression of known neuronal and glial marker genes matched with the 
purification of GABAergic neurons. 
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Figure 3.6: Expression analysis of known marker genes 
The expression of known marker genes was analyzed to validate the microarray experiments. GAD1 
(GAD67), GAD2 (GAD65) and VIAAT served as markers for GABAergic neurons and showed 
enriched expression. Markers for other neuronal cell types, like the glutamate transporter SLC1A4 and 
TH, a marker for catecholaminergic neurons, showed decreased expression. Also established markers 
of glial cells, like GFAP, GLT1 (SLC1A2), GLAST (SLC1A3), OLIG1, OLIG2, VIM, CD44 and PLP 
were decreased in GABAergic neurons. Expression values were calculated as normalized log2 ratios. 
Error bars indicate the standard deviation of the mean value (n = 16). 
 
 
To analyze if there was a bias towards genes of specific functional classes in the fraction of 
transcripts showing increased or decreased expression, a Gene Ontology (GO) analysis was 
carried out. The 550 strongest enriched genes in GABAergic neurons of all origins or the 
whole brain reference were sorted according to their functional classes as defined by the Gene 
Ontology database (Fig. 3.7). The functional classes “Cell proliferation/differentiation” and 
“Cell adhesion/skeleton” were significantly over-represented in GABAergic neurons, 
indicating a lower developmental stage compared to other brain cells. In contrast, genes which 
are important for general metabolism were enriched in the whole brain reference. 
Additionally, genes coding for different receptors were predominantly found in the whole 
brain reference fraction, reflecting the larger receptor diversity among different cell types 
compared to GABAergic neurons. 
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Figure 3.7: Grouping of genes according to Gene Ontology 
Grouping of genes enriched in GABAergic neurons compared to whole brain enriched genes. The 550 
strongest enriched genes in GABAergic neurons of all origins (black) or the whole brain reference 
(grey) were sorted according to their functional classes as defined by the Gene Ontology (GO) 
database. The absolute number of genes per GO class is depicted. The functional classes “Cell 
proliferation/differentiation” and “Cell adhesion/skeleton” were significantly over-represented in 
GABAergic neurons, whereas more genes which are important for general metabolism as well as 
genes coding for different receptors were found to be enriched in the whole brain reference. 
 
 
To identify the transcripts most significantly expressed in all GABAergic neuron subtypes, 
the data was filtered for probes showing more than 3-fold higher signals in GABAergic cells 
than in the total brain reference in at least 14 of the 16 experiments. Using these criteria, an 
over-representation of genes expressed in the cortex and striatum, which are the regions 
containing the major part of GABAergic neurons in the brain, was avoided. The 55 targets 
which were identified and could be unambiguously annotated to characterized genes are listed 
in table 3.1. 
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Table 3.1: Genes enriched in GABAergic neurons 
    
 
      
 
Gene name GeneBank ratio SD Gene Ontology annotation 
      
 
    
 
Chd7 AK042727 3.5 0.2 
Fos NM_010234 5.7 0.3 
Hoxa1 NM_010449 4.2 0.4 
LOC432637 NM_001004167 6.4 0.8 
Mkx NM_177595 3.5 0.2 
Mll3 AY138582 5.9 0.7 
Myst4 AK129129 13.8 1.4 
Pcgf3 AK033609 6.5 0.5 
Phf21b BC067021 18.9 1.6 
Sox7 NM_011446 7.1 1.0 
Zfpn1a2 NM_011770 4.0 0.5 
Transcription 
Angptl2 AK011976 11.7 1.2 
CD72 AF543214 6.5 1.0 
Cd84 NM_013489 3.8 0.2 
Eps15-rs BC015259 4.9 0.5 
Ifitm5 NM_053088 5.8 1.2 
Ncr1 NM_010746 5.7 0.4 
Prlpc2 NM_023332 3.4 0.4 
Tnfsf5 NM_011616 6.1 0.4 
Trip11 AK077954 3.4 0.2 
Wisp1 NM_018865 5.3 0.8 
Receptor signaling 
Fpr-rs4 NM_008041 5.1 0.7 
Olfr1052 NM_147010 4.1 0.4 
Olfr1269 NM_146342 6.3 0.3 
Olfr560 NM_147113 5.8 1.4 
Olfr672 NM_146760 13.2 4.1 
Olfr700 NM_146600 4.8 0.6 
Olfr849 NM_146527 6.7 0.3 
V1rc30 NM_134185 7.8 0.9 
G-protein signaling 
Gria2 BC048248 3.3 1.0 
Slc34a1 NM_011392 6.3 0.8 
Tnpo3 AK049446 7.2 0.3 
Cellular import/export 
Klk9 NM_010116 3.3 0.1 
Kng2 NM_201375 4.6 0.4 
Usp49 AK019130 8.6 1.0 
Protein degradation 
2900006B13Rik AK085984 5.4 0.6 
Fgb NM_181849 5.1 0.4 
Saps2 AK083335 3.5 0.6 
Other metabolism 
Hamp NM_032541 11.9 2.6 
Zswim6 BC021311 3.7 0.1 Metal ion homeostasis 
Adipor2 AK046591 5.8 1.4 
Pla2g4b BC042758 6.4 1.0 Lipid metabolism 
C330018K18Rik NM_177352 7.1 1.7 Carbohydrate metabolism 
Gp1ba NM_010326 3.8 0.3 Cell adhesion 
Crkl BC023080 6.6 1.1 Cell cycle 
Eml5 AK047762 3.4 0.4 Cytoskeleton 
Gad1 AK054554 3.3 1.1 Neurotransmitter metabolism 
Adarb2 NM_052977 4.4 0.3 Nucleotide metabolism 
Gpx5 NM_010343 3.7 0.3 Response to oxidative stress 
Trspap1 BC055454 4.4 0.3 Translation 
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Table 3.1: continued 
    
 
      
 
Gene name GeneBank ratio SD Gene Ontology annotation 
      
 
    
 
1700081L11Rik BC053389 4.7 0.4 
2810403A07Rik AK038617 3.8 0.6 
2810407A14Rik NM_175156 12.1 1.4 
5330439B14Rik NM_177314 5.1 1.2 
6430706D22RIK BC004768 4.2 0.1 
A430057M04Rik NM_176925 4.9 0.7 
AK040702 AK040702 5.1 0.4 
B230325K18Rik NM_176936 4.4 0.6 
C130023O10Rik NM_177110 14.5 0.8 
LOC385154 AK041326 3.5 0.2 
LOC544848 AK032716 5.1 0.6 
Speer4f NM_027609 6.2 0.2 
Sprrl9 NM_026335 8.9 0.5 
Unknown 
      
 
    
 
List of genes which were >3-fold enriched in GABAergic cells versus whole brain in at least 14 of 16 
experiments. The mean expression ratios of 4 independent experiments using whole brain GABAergic 
cells are shown. The genes are sorted according to their Gene Ontology annotations. Abbreviations: 
SD = standard deviation of the mean value 
 
 
The transcriptional regulator MYST4 (Qkf, Querkopf), which was shown to be required for 
the development of forebrain interneurons, was one of the strongest overrepresented genes 
(Thomas et al., 2000). Furthermore, the homeobox transcription factor HOXA7, which has 
been implicated in neural tube formation in Xenopus (Wright et al., 1989), was strongly 
represented, as were SOX7 and the signaling protein WISP1 which both interfere with WNT 
signaling (Takash et al., 2001). High expression of RNA-editing molecules like ADARB2 
and SECP43 was found. ADARB2 is a double-stranded RNA adenosine deaminase that has 
been suggested to edit defined brain-specific transcripts. It is considered to be a candidate for 
involvement in genetic forms of epilepsy (Melcher et al., 1996; Mittaz et al., 1997). 
Interestingly, the highly expressed cytoplasmatic protein CRKL complexes with the adaptor 
protein Dab1 (Chen et al., 2004), pointing towards an activity of the reelin signaling pathway 
in interneurons. This suggests that several of the here isolated neurons are still migratory. In 
addition to the described genes, many uncharacterized genes and EST-sequences were found 
to be enriched. 
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In a second round of data filtering, less stringent criteria were applied by focusing on genes 
which were enriched in GABAergic neurons in at least 12 of the 16 experiments. In this 
approach, further genes belonging to the GO-groups “cytoskeleton” (e.g. MTAP4, EHD2, 
CAPZA2, PPFIA1, MOBKL1A, MTSS1), “RNA-processing” and “RNA-editing” (e.g. 
SFRS3, PDCD11, THOC1, THOC2, GLE1L, CSDE1, SRPK2), “neuron development” (e.g. 
PTCK3, MYT1, SOX11, LOXL2, SNAP91, POGZ) and “protein-glycosylation” (e.g. 
GALNT11, B3GALT2) were identified. 
In conclusion, a specific genetic signature representative for all major populations of 
GABAergic neurons was generated and considerable amounts of candidate factors maybe 
involved in the generation and regulation of these cell populations were identified. 
 
3.2.2 General differences among distinct brain regions 
After defining the global transcriptome of GABAergic neurons, the gene expression profiles 
of cortical, striatal, olfactory bulb and cerebellar interneurons were compared by calculating 
Pearson correlation coefficients of pairwise comparisons. Unsupervised hierarchical 
clustering of correlation coefficients most strikingly grouped the regions of the forebrain, 
olfactory bulb, cortex and striatum, together but separated them from the cerebellum 
(Fig. 3.8 A). Furthermore, replicates for each brain area clustered together, indicating a 
specific expression profile, which differs from other parts of the brain. Within the forebrain 
regions, there was a subgrouping of striatal and cortical interneurons pointing towards a closer 
relationship among these populations compared to the olfactory bulb. This observation was 
supported by the fact that 31% of all genes which were at least 4-fold enriched in the olfactory 
bulb were found to be overexpressed in this area only. In contrast, in cortex (11%) and 
striatum (3%) considerably smaller amounts of genes showed an exclusive expression. In 
general, only 155 of 2104 (7%) enriched genes were present in all areas, indicating that each 
subgroup displays a unique expression pattern. (Fig. 3.8 B).  
In summary, the approaches applied in this study identified minor differences among 
GABAergic neurons from distinct forebrain regions but major differences between fore- and 
hindbrain GABAergic neurons. 
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Figure 3.8: Correlation analysis 
(A) Correlation matrix showing the relationship of gene expression profiles in all experiments. The 
matrix was generated by unsupervised hierarchical clustering of global expression data. Correlation 
coefficients are indicated by their color from blue (0.5) to yellow (1.0). Replicates for each brain area 
clustered together, indicating a specific expression profile, which differs from other parts of the brain. 
Groups belonging to the forebrain subclustered together and displayed the most significant differences 
compared to the cerebellum, which is part of the hindbrain. (B) Venn diagram showing shared and 
unique expression of genes enriched in GABAergic neurons from different brain areas. Focusing on 
the most important differentially expressed genes, only transcripts with at least 4-fold enrichment 
compared to whole-brain reference in any of the cell groups were selected. Only 155 of 2104 (7%) 
genes were enriched in all areas, indicating that each subgroup displays a unique expression pattern. 
Abbreviations: OB = olfactory bulb 
 
 
3.2.3 Differential gene expression reflects distinct functions of 
GABAergic neurons in specific forebrain regions 
After this general statistical classification of the global relationship between GABAergic cells 
from different brain areas, it was analyzed, which genes were specifically expressed in 
selected forebrain regions. To this end, discriminatory gene analysis using two class unpaired 
SAM (Serial Analysis of Microarrays) with at least 100 permutations per analysis (Tusher et 
al., 2001) was performed. The brain region of interest was compared to the group of all 
remaining areas. Delta value was always chosen to result in 0% median number of false 
significant genes (see 2.6.10.4). 
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The first evaluation focused on genes specifically expressed in the cortex. Using the above 
criteria only 5 genes were found that were significantly higher represented in the cortex than 
in all other brain regions, while 62 were expressed at lower levels. Most of these genes were 
either functionally uncharacterized or not reported in relation to brain function (Fig. 3.9 A-C). 
The rather low number of cortex GABAergic neuron specific genes may reflect the high 
number of different interneuron subpopulations in this area, which maybe suppresses the 
identification of differently expressed genes in distinct subpopulations. 
Next, SAM for olfactory bulb GABAergic neurons led to 272 genes with increased and 265 
with decreased expression compared to other brain regions. Gene Ontology analysis of these 
genes using TreeRanker (Schacherer, F., unpublished) at a significance level of 0.005 
identified enrichment of the GO groups “Development” and “Pattern”. Within the genes 
showing strongest enrichment in this structure, FGF2 and FGF2-receptor as well as PIK3R1 
and ROBO2 were found (Fig. 3.9 D and E). The high expression of these migration and 
differentiation associated genes, as well as the relatively low abundance of the differentiation 
correlated gene ATBF1 (Fig. 3.9 F), is in good agreement with the continuously ongoing 
neurogenesis in the olfactory bulb.  
In striatal cells, the expression of 111 genes was increased compared to other brain regions, 
while not a single gene was found to be notably decreased. GO annotation identified a 
significant enrichment of genes belonging to the GO-groups “Extracellular region”, 
“Extracellular space”, “Signal”, “Secreted”, “Glycoprotein” and “Morphogenesis”. 
The significant enrichment of differently regulated genes (Fig. 3.9 G and H) with an impact 
on morphogenesis correlates with the specific connectivity and function of GABAergic 
neurons in the striatum. In contrast to other forebrain regions, where GABAergic neurons are 
generally found as local projecting interneurons, they represent almost exclusively projection 
neurons in the striatum. Factors regulating cell-cell and cell-matrix adhesion, like CSF1, 
LAMA1 and EDG1 (Matter and Laurie, 1994; Paik et al., 2004; Yang et al., 2006), were 
highly expressed. The same was true for transcription factors, either implicated in long-range 
axonogenesis in corticospinal motor neurons (BCL11B), in the regulation of cytoskeletal 
organization (FOXJ1) or in cell migration (TITF1) (Arlotta et al., 2005; Gomperts et al., 
2004; Pan et al., 2007). 
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Figure 3.9: Expression ratios of selected genes identified by discriminatory gene analysis 
(DGA) for forebrain GABAergic neuron populations 
The expression values of selected genes, identified by DGA to be differently enriched in a distinct 
brain region compared to all others, are depicted. ANKRD27 (A), BC054438 (B) and LOH11CR2A (C) 
were found to be differentially expressed in the cortex, PIK3R1 (D), ROBO2 (E) and ATBF1 (F) in the 
olfactory bulb, and FOXJ1 (G) as well as TTR (H) in the striatum. The columns represent the log2-
transformed expression ratios for each replicate. Abbreviations: OB1-3 = olfactory bulb replicates 1-3; 
ST1-3 = striatum replicates 1-3; CX1-3 = cortex replicates 1-3; CB1-3 = cerebellum replicates 1-3 
 
 
Finally, pathway analysis of genes enriched in the striatum and not related to morphogenesis 
led to the identification of a large number of genes interacting directly or indirectly with IGF2 
(Fig. 3.10). This gene, as well as some of its interaction partners, has been implicated in the 
development of Huntington’s disease, a neurodegenerative disorder that affects primarily 
striatal GABAergic neurons. 
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Figure 3.10: Pathway analysis for genes enriched in striatal GABAergic neurons 
A network of genes, interacting directly or indirectly with IGF2, that where identified to be significantly 
enriched in striatal GABAergic neurons compared to populations of other brain regions, is depicted. 
The molecular network was generated using the PathwayArchitect software. Only manually validated 
interactions where taken into consideration. Interaction legend: light blue square = expression; dark 
blue square = binding; green square = regulation; rotated square = metabolism; circle = protein 
modification; triangle = transport 
 
 
3.2.4 Comparison of fore and hindbrain GABAergic neurons 
As mentioned above, hierarchical clustering demonstrated a grouping of forebrain versus 
hindbrain GABAergic neurons. The genes showing aberrant expression were analyzed in 
more detail. Differential gene analysis of GABAergic neurons from the cerebellum versus the 
three forebrain regions led to the identification of many transcripts showing increased or 
decreased expression levels compared to the other group. 241 genes were significantly 
enriched in forebrain GABAergic neurons. In contrast, 269 genes were expressed notably 
higher in the cerebellar population than in those of the forebrain. Subsequent GO analysis 
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revealed many candidates, involved in the development, migration and differentiation of 
neuronal cells. Expression patterns of these candidates are depicted in figure 3.11.  
 
 
Figure 3.11: Cluster analysis 
Cluster analysis of genes identified by discriminatory gene analysis of GABAergic neurons from the 
cerebellum compared to those of the forebrain. Discriminatory gene analysis (DGA) was done by the 
SAM (Serial Analysis of Microarrays) algorithm using the Tusher et al. method (Tusher et al., 2001). 
Resulting genes and samples were grouped by similarities in gene expression patterns using two-
dimensional hierarchical clustering (Pearson correlation, average linkage). Levels of log2-transformed 
expression ratios are indicated from -3 (green) to 3 (red). (A) Genes identified by DGA show higher 
expression levels in GABAergic cells of the cerebellum compared to the forebrain. (B) Genes identified 
by DGA are highly expressed in GABAergic cells of the forebrain compared to the cerebellum. 
Abbreviations: OB = olfactory bulb 
 
 
GO annotation of the 241 genes, enriched in forebrain GABAergic neurons, identified groups 
connected to the regulation of transcription with a strong bias towards homeobox transcription 
factors. Subsequent pathway analysis revealed three main groups. First, a group connected to 
the Distal-less-family (DLX) comprising DLX1, DLX2, DLX5 and DLX6, ARX, MSX3 and 
VAX1 (Fig. 3.12 A and B). Such genes are well known regulators of GABAergic 
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differentiation in the forebrain (He et al., 2001). Second, transcripts linked to POU-
transcription factors were identified which have been involved in the regulation of cortical 
neuron migration by interfering with Cdk5/Reelin signaling (McEvilly et al., 2002). Third, the 
ETS and forkhead box-family members ETS1, ETV1, FOXG1, FOXO6, FOXP2 and FOXP4, 
as well as MRG1, PBX1 and PBX3 are connected to this group (Fig. 3.12 C and D). These 
transcriptional regulators play an important role in brain development from zebrafish to 
humans (Hoekman et al., 2006; Shah et al., 2006; Wijchers et al., 2006). 
 
0.0
1.0
2.0
3.0
4.0
5.0
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
-1.0
0.0
1.0
2.0
3.0
4.0
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
-1.5
-0.5
0.5
1.5
2.5
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
-1.5
-1.0
-0.5
0.0
0.5
1.0
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
-2.0
-1.0
0.0
1.0
2.0
3.0
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
-3.0
-2.0
-1.0
0.0
1.0
2.0
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
-1.5
-1.0
-0.5
0.0
0.5
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
-5.0
-3.0
-1.0
1.0
3.0
OB
1
OB
3
Co
rte
x2
Str
iat
um
1
Str
iat
um
3
Ce
reb
ell
um
2
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
ZIC2
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
ZIC5
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
LHX1
DLX1
DLX2
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
LHX5
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
FOXG1
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
FOXP4
A
B
C
D
E
F
G
H
CX
 1
ST
 1
CB
 1
OB
 1
OB
 2
OB
 3
CX
 2
CX
 3
ST
 2
ST
 3
CB
 2
CB
 3
 
Figure 3.12: Expression ratios of selected genes identified by discriminatory gene analysis 
(DGA) for hindbrain GABAergic neuron populations 
The expression values of selected genes, identified by DGA to be differently enriched specifically in 
either fore- or hindbrain populations are depicted. The expression of DLX1 (A), DLX2 (B), FOXG1 (C) 
and FOXP4 (D) was decreased in GABAergic neurons of the cerebellum compared to forebrain 
GABAergic neuron populations. In contrast, ZIC2 (E), ZIC5 (F), LHX1 (G) and LHX5 (H) were found to 
be differentially overrepresented in cerebellar GABAergic neurons. The columns represent the log2-
transformed expression ratios for each replicate. Abbreviations: OB1-3 = olfactory bulb replicates 1-3; 
ST1-3 = striatum replicates 1-3; CX1-3 = cortex replicates 1-3; CB1-3 = cerebellum replicates 1-3 
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GO-annotation of the 269 genes, expressed notably higher in cerebellar cells than in cells of 
the forebrain, led to a significant higher representation of the groups “Nervous System 
Development”, “Neuron Differentiation”, “Cell Migration”, “Cell-Cell Signaling”, “Synaptic 
Transmission” and “Calcium Ion Binding”. Pathway analysis displayed striking interactions 
either associated with homeobox transcription factors or with the Somatostatin (SST) pathway 
(Fig. 3.13). Expression of three transcription factors of the Zinc-finger protein of the 
cerebellum-family (ZIC1, ZIC2 and ZIC5), shown to be important for cerebellar development 
(Titomanlio et al., 2005), was increased in the cerebellum but decreased in the forebrain 
(Fig. 3.12 E and F). Similarly, the LIM homeobox-family members LHX1, LHX5 and LHX9 
were enriched (Fig. 3.12 G and H). The second group of strongly interacting genes found in 
the pathway analysis were SST receptors 1 and 2, as well as several related genes, including 
MATH-2 (NeuroD6), EPHB1, CDKN1C, NEF3 and NEFL (Fig. 3.13). 
In conclusion, the comprehensive comparison of fore- and hindbrain GABAergic neurons 
suggests different transcriptional pathways used in these compartments to generate neurons 
with the same neurotransmitter phenotype. 
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Figure 3.13: Pathway analysis for genes enriched in cerebellar GABAergic neurons 
A network of genes, interacting directly or indirectly with the Somatostatin (SST) pathway that where 
identified to be significantly enriched in cerebellar GABAergic neurons compared to populations of the 
forebrain, is depicted. The molecular network was generated using the PathwayArchitect software. 
Only manually validated interactions where taken into consideration. Interaction legend: light blue 
square = expression; dark blue square = binding; green square = regulation; rotated 
square = metabolism; circle = protein modification; triangle = transport 
 
 
3.2.5 Expression analysis of selected GABAergic neuron specific genes 
by in situ hybridization and quantitative real-time PCR 
A general technical validation of the method used in this study, including flow cytometric 
sorting and rare cell gene expression profiling, e.g. by qPCR has been described before in 
detail (Appay et al., 2007). As a biological validation of the results described above and for 
confirmation of newly identified marker genes of GABAergic neurons, in situ hybridization 
(see 2.9.2) was used as it represents an mRNA-amplification independent approach. The cell-
type dependent expression patterns within functionally distinct regions for eleven selected 
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genes (GAD65, GAD67, K19, GATA4, FOS, GRIK3, WISP1, GPX5, ADARB2, CD72 and 
CD84) that showed enriched expression in GABAergic neurons were investigated. In situ 
hybridization patterns in postnatal day 1 old mice were compared to the GFP fluorescence of 
respective sections from GAD67-GFP knock-in mice. In situ hybridizations using a probe for 
GAD67 mRNA served as additional positive control (Fig. 3.14). Furthermore, we assessed the 
gene expression in adult mice by referring to the Allan Brain Atlas (Lein et al., 2007). 
 
 
Figure 3.14: In situ hybridization for GAD67 and colocalization with GFP 
As a further control, in situ hybridizations and colocalization studies using a probe for GAD67 were 
done. Examples of GAD67 in situ hybridization signals and colocalization with fluorescently labeled 
GABAergic neurons in serial brain sections of GAD67-GFP knock-in mice at postnatal day 1. No signal 
was observed in the negative control. 
 
 
In general, in situ signals were in good agreement with the microarray results. All probes 
showed a colocalization of in situ hybridization signal and GFP-fluorescence, whereas no 
signal was observed in the negative control (Fig. 3.15). Exceptions were CD84 and GAD65, 
where no signal was detected.  
One interesting observation was that the widespread expression of ADARB2 in GABAergic 
neurons of the early postnatal brain was strongly retained in the neurogenic regions of the 
adult nervous system, namely the olfactory bulb and the dentate gyrus of the hippocampus. 
This suggests that the gene may be more important during development/maturation of 
GABAergic neurons, than in their functional properties In contrast, many other genes, like 
GRIA2, USP49, CRKL, CD72 and ANGPTL2, maintained their specific expression in 
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GABAergic neurons also in the adult mouse brain. Although the transcript of CD72 was 
highly abundant in GABAergic neurons from early to adult stages, an antibody staining 
showed no labeling, even after dissociation with low protease concentrations (data not 
shown). This could be due to high protease sensitivity, post-transcriptional regulation or post-
translational modification, as the antibody was tested only for CD72 expression on blood cells 
so far. 
The region specific expression of many genes was maintained in 56-day old mice (Lein et al., 
2007). For example, in situ hybridization of DLX genes showed a strong signal in forebrain 
GABAergic neurons. On the other hand, factors like the ZIC-family members, LHX1, LHX5 
and EN2 showed a highly specific expression in the cerebellum. In addition, the differential 
expression of seven genes (DLX1, DLX2, DLX5, FOXG1, LHX5, ZIC1 and ZIC2) among 
fore- and hindbrain GABAergic neurons, as observed in the discriminatory gene analysis, was 
validated by quantitative real-time PCR (see 2.6.11). In all cases, the expression pattern upon 
qPCR reproduced that of the microarray experiments (data not shown). 
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Figure 3.15: Independent validation of gene expression by in situ hybridization 
Examples of tested candidates and colocalization of the signals with fluorescently labeled GABAergic 
neurons in serial brain sections of GAD67-GFP knock-in mice at postnatal day 1 are depicted. The 
slides represent the cortex (A to D), the striatum (E to H), the olfactory bulb (I) and the cerebellum (J). 
(A and F) In situ hybridization using a probe specific for ADARB2 mRNA. (B and G) In situ 
hybridization using a probe specific for GATA4 mRNA. (C) In situ hybridization using a probe specific 
for GPX5 mRNA. (D) In situ hybridization using a probe specific for GRIK3 mRNA. (E and I) In situ 
hybridization using a probe specific for WISP1 mRNA. (H and J) In situ hybridization using a probe 
specific for CD72 mRNA. All probes showed a colocalization of in situ hybridization signal and GFP-
fluorescence. 
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3.3 Generation of monoclonal antibodies specific for GABAergic 
neuron cell surface markers 
In parallel to the molecular analysis of purified GABAergic neuron subpopulations, 
alternative methods for the isolation of these cells or even subpopulations should be 
established. By using FACS, it is only possible to purify GABAergic neurons from 
genetically modified animals like the GAD67-GFP mouse strain. To overcome the need of a 
transgenic background, monoclonal antibodies that recognize cell surface molecules specific 
for these neurons would be very helpful. Such antibodies would allow the direct isolation of 
GABAergic neurons from different genetic backgrounds, e.g. disease models, by using 
magnetic or flow cytometric based cell sorting technologies. As GABAergic neurons could be 
isolated at high purities (see 3.1.3), it was decided to use the purified cells directly as 
immunogenic material. 
Lewis rats were immunized (see 2.8.7) by contralateral footpad immunization to induce 
monoclonal antibody production (Brooks et al., 1993; Yin et al., 1997). About 0.8-1.3 x 107 
purified GABAergic cells were injected subcutaneously into the left hind footpad of the rats. 
Several decoys, containing unspecific epitopes of the target- but also other cells, were injected 
into the right hind footpad in parallel to minimize the unspecific immunoresponse of the 
target lymph node. To increase the immunogenic potential of the injected cells, different 
adjuvants were tested. The immunization schemes are summarized in Table 3.2. 
To screen specifically for antibodies that recognize cell surface molecules, brains of GAD67-
GFP mice were dissociated and intact cells used for staining. By using living cells, the 
antibodies can not pass the membrane and therefore only stain epitopes outside the cell. An 
antibody which specifically binds to a cell surface molecule on GABAergic neurons should 
label all or at least a subgroup of the GFP+ population but no cells from the GFP- fraction. 
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Table 3.2: Immunization schemes  
 Protease Decoy Adjuvant No. of clones 
1 5 U/ml Papain Actin-GFP brain / GFP- fraction FAI / PHA 15 
2 5 U/ml Papain Actin-GFP brain / GFP- fraction FAI / PHA 9 
3 5 U/ml Papain Actin-GFP brain / GFP- fraction FAI / PHA 57 
4 5 U/ml Papain Actin-GFP brain / GFP- fraction FAI / PHA 35 
5 5 U/ml Papain Actin-GFP brain / GFP- fraction FAI / PHA 48 
6 5 U/ml Papain 50 µg recombinant GFP FAI / PHA 74 
7 5 U/ml Papain Actin-GFP brain / GFP- fraction 15 µg/µl CpG >1000 
8 5 U/ml Papain Actin-GFP brain / no decoy 15 µg/µl CpG >1000 
9 0.5 U/ml Papain or  
0.1% Trypsin 
GFP- fraction 15 µg/µl CpG >1000 
10 0.5 U/ml Papain or  
0.1% Trypsin 
50 µg recombinant GFP 15 µg/µl CpG >1000 
Actin-GFP brain and FAI were only used for the first boost. All further administrations were combined 
with the other decoys/adjuvants mentioned. Abbreviations: No. = number; FAI = Freunds Adjuvant 
incomplete; PHA = Leucoagglutinin PHA-L Lectin from Phaseolus vulgaris (red kidney bean); 
CpG = CpG ODNs 1668 
 
The first 5 immunization approaches were carried out using a protease concentration of 
5 U/ml Papain for brain tissue dissociation prior to FACS purification. As the purified 
GABAergic neurons are GFP+, and GFP has a high immunogenic potential, brain tissue of 
Actin-GFP transgenic mice served as decoy during the first boost to guide the unspecific anti-
GFP immune response into the contralateral lymph node. For all further boosts, the GFP- 
fraction from FACS purified GAD67-GFP brain cells was used as decoy to prevent the 
appearance of target cells in the decoy population. As Freunds Adjuvant incomplete (FAI) is a 
very potent stimulator of the immune system, it was co-injected the first day of immunization 
for generally activation of the host immune response. For subsequent boosts, instead of using 
FAI, the cells were coated with PHA-L, a lectin from Phaseolus vulgaris, to increase their 
immunogenic potential. Only very few hybridoma clones, less than 100 per fusion (see 2.8.8), 
were generated by using this strategy. None of the produced antibodies was specific for cell 
surface molecules of GABAergic neurons. 
Results 
   
69 
It was observed that the lymph node on the decoy injection site was always 3 to 5 times larger 
than that of the GABAergic fraction injection site. Probably, this is due to highly 
immunogenic epitopes in the GFP- fraction. To prevent that the major immune response takes 
place only at the decoy side, the sixth immunization was carried out using recombinant GFP 
protein as decoy. Therefore, only the unspecific anti-GFP immune response should be guided 
into the contralateral lymph node. Again, the lymph node on the decoy injection site was 
approximately 3 times larger, less than 100 hybridoma clones were obtained, and no specific 
staining was observed. The conclusion was that the immunogenic potential of the GFP+ 
fraction itself was rather low. 
To increase the immune response at the GABAergic fraction injection site, CpG ODNs 1668, 
a synthetic pathogen DNA fragment, was co-injected in all further immunizations. 
Immunization approach no. 7 was, except for the different adjuvant, equal to immunizations 
no. 1 to 5. In approach no. 8 only the Actin-GFP decoy during the first boost was 
administrated without any further decoy injections. Both injections yielded in more than 1000 
hybridoma clones per fusion, but again no specific antibody could be identified. During the 
last 2 approaches, the protease concentration of Papain was reduced to 0.5 U/ml and 50% of 
the brains were dissociated using 0.1% Trypsin. Thereby, more protease sensitive surface 
epitopes should be saved. The GFP- fraction served as decoy during approach 9, while 
recombinant GFP protein was used during approach 10. Both injections resulted in more than 
1000 hybridoma clones per fusion, but again no specific antibody could be identified. 
In conclusion, none of the immunization approaches resulted in the generation of an antibody 
specific for GABAergic neurons. One explanation for this result could be that GABAergic 
neurons do not express highly immunogenic epitopes, at least those which are protease 
resistant, on their cell surface. An alternative to continue with further immunizations was to 
identify target proteins in these cells directly by proteome analysis. 
 
3.4 Defining the surface proteome of GABAergic neurons 
As a result of the gene expression analysis, many genes were identified which were highly 
and specifically expressed in GABAergic neurons and therefore may serve as new marker 
genes for these cells. However, only very few of these candidates were located in the plasma 
membrane and could serve as cell surface markers for the isolation of GABAergic neurons. 
To overcome this problem and focus directly on the identification of such markers, the cell 
surface proteome of GABAergic neurons was analyzed in collaboration with the group of 
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Dr. Bernd Wollscheid at the ETH in Zurich (Zhang et al., 2003). Using this approach, 
proteins that contain N-linked carbohydrates and are localized in the plasma-membrane are 
labeled and identified by tandem mass spectrometry (MS/MS). The specificity is based on the 
conjugation of glycoproteins to a solid support using hydrazide chemistry on intact cells and 
the specific release of formerly N-linked glycosylated peptides via peptide-N-glycosidase F 
(PNGase F). Using this approach, the amount of identified membrane proteins is much higher 
than by conventional proteome analysis of whole membrane fractions. One limitation is the 
huge number of 1x108 cells that is needed for optimal results.  
The brains of 49 GAD67-GFP brains were resected. Half of the brains were dissociated with 
0.5 U/ml Papain, the other half by using 0.1% Trypsin. Subsequently, the GFP+ and GFP- 
fractions were isolated by FACS (see 2.8.5), yielding approximately 3x107 positive and 7x107 
negative cells. The cells were labeled and the glycoproteins isolated using the “Cell Surface 
Glycopeptide Capture Protocol” (Tao et al., 2005). Peptides from both populations were 
identified by tandem mass spectrometry. 
As expected from the low cell numbers used, only 25 proteins were identified in the GFP+ 
fraction, whereas 79 proteins were identified in the GFP- fraction. Seventeen proteins were 
found in both fractions. The 25 proteins that were specific for the GABAergic fraction are 
listed in table 3.3. Indeed, 22 (88%) of these proteins were GO annotated to the membrane 
fraction, whereas 3 of the proteins were fully uncharacterized. However, for some of the 
candidates the definitive membrane compartment was still not known, therefore a fraction 
may localize to intracellular membranes. Most of the identified candidates were sparsely 
characterized in general and no antibodies, or at least none suitable for flow cytometric 
analysis, are available. When compared to data from the transcriptome profiling, many 
correlations were observed. Several identified proteins, like Vcork1, 4732465J04Rik, Mpzl1, 
Siglece, Tmpo and Ndufa4, also displayed enrichment on the transcriptome level. In contrast, 
several candidates, like Atp1a3, P2ry1, Cxadr, Slc35c2 and Stx1b2, were not enriched in the 
microarray analysis. This was expected, as it is well known that due to post-transcriptional 
regulation many differences among the transcriptome and the proteome of a cell could be 
observed. 
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Taken together, a number of proteins were identified which are presumably expressed on the 
cell surface of GABAergic neurons. Besides new insights on the specific function for these 
proteins in inhibitory neurons, they may serve as target proteins for the generation of 
antibodies specific for extracellular epitopes. In addition, the proteins which were found only 
in the GFP- fraction might represent novel surface markers for other populations of brain cells 
and may therefore be used for the purification or depletion of these cells. 
 
Table 3.3: Proteins identified by mass spectrometry 
   
 
 
     
 
 
Protein name IPI link Entrez accession Number of Peptides Score 
     
 
 
   
 
 
Atp1a3 IPI00122048 232975 4 1.0000 
Pgrmc1 IPI00319973 53328 3 0.9996 
Armc10 IPI00137460 67211 2 0.9966 
Stx1b2 IPI00113149 56216 2 0.9962 
Acsl3 IPI00169772 74205 2 0.9955 
Tmpo IPI00320399 21917 2 0.9952 
Tmed2 IPI00127983 56334 1 0.9942 
Fkbp8 IPI00130833 14232 2 0.9942 
Dcakd IPI00221828 68087 1 0.9935 
Slc25a5 IPI00127841 11740 1 0.9894 
Vamp3 IPI00132276 22319 2 0.9844 
Ndufa4 IPI00125929 17992 1 0.9827 
Vkorc1 IPI00133579 27973 1 0.9737 
Lrrc59 IPI00123281 98238 1 0.9645 
EG639162 IPI00113394 639162 2 0.9325 
4732465J04Rik IPI00402943 414105 1 0.7431 
Siglece IPI00172333 83382 1 0.6712 
Por IPI00621548 18984 1 0.6425 
P2ry1 IPI00116191 18441 1 0.6411 
Syt13 IPI00111520 80976 1 0.6321 
Cxadr IPI00270376 13052 1 0.5571 
AI464131 IPI00464256 329828 1 0.5398 
Slc35c2 IPI00756392 228875 2 0.5395 
Mpzl1 IPI00620858 68481 1 0.5347 
Col24a1 IPI00551234 71355 1 0.5136 
     
 
 
   
 
 
List of proteins which were identified by tandem mass spectrometry peptide fingerprinting. The number 
of peptides indicates how many peptides were identified matching to a respective protein. The score 
indicates the statistically probability of a unique identification. 
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Part II Molecular analysis of interneuron development 
In the previous part, a molecular analysis of GABAergic neurons in general as well as the 
relationship among subpopulations of these cells from different brain regions was carried out. 
In a second part, the aim was to analyze the differentiation of progenitor cells into 
GABAergic neurons. As several neurodegenerative disorders, like Huntington’s disease, show 
a loss of inhibitory neurons, a promising therapeutic approach is to replace these neurons to 
retain functionality. One possibility is to generate specific neuronal cell types in vitro before 
grafting, the other opportunity may be the activation and targeted differentiation of persistent, 
brain localized adult stem cells directly in vivo. For both approaches there is a prerequisite in 
deep understanding of the underlying mechanisms involved in neuronal differentiation. The 
goal was therefore to identify new candidate genes involved in the differentiation of 
GABAergic interneurons. Therefore, the transcriptome of mature GABAergic neurons as well 
as their progenitor cells was analyzed to identify genes which are differentially regulated 
during differentiation and may act as regulatory factors. 
As a model system, the generation of inhibitory interneurons in the olfactory bulb was 
analyzed. These interneurons are generated from adult neuronal stem cells, localized in the 
subventricular zone (SVZ), throughout live (Lledo et al., 2006). Interestingly, about 16% of 
these GABAergic interneurons show a bifunctional neurotransmitter phenotype as they are 
also dopaminergic (Panzanelli et al., 2007). As the loss of dopaminergic neurons is the major 
phenotype at the onset of Parkinson’s disease, understanding of their development is also of 
broad interest. 
In this case, the use of dissociated brain tissue from GAD67-GFP mice in combination with 
flow cytometry sorting was not possible, as the precursor population already expresses GFP. 
The polysialylated form of NCAM (PSA-NCAM) serves as a marker for the differentiation 
status in this system as it is only present in precursor cells but absent in mature interneurons 
(Durbec and Cremer, 2001). Therefore, the expression profile of PSA- mature periglomerular 
layer interneurons was compared to that of late PSA+ precursors localized also in the 
periglomerular layer (Fig 3.16 C and D). Furthermore, both cell populations were compared 
to their earlier progenitors, the Type A neuronal precursor cells, which migrate from the SVZ 
to the olfactory bulb via the rostral migratory stream and represent a mixed population that 
can give rise to granule as well as periglomerular interneurons (Fig 3.16 A and B). 
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Figure 3.16: Immunohistochemistry of glomerular layer interneurons and their precursors 
An immunostaining for the precursor marker PSA (green) and the GABAergic marker GAD65/67 (red) 
in the SVZ and the periglomerular layer is shown. Cell nuclei were stained with Hoechst (blue). In the 
SVZ, most of the cells were PSA+/GAD65/67+ Type A early neuronal precursor cells (stars), whereas 
only few mature PSA-/GAD65/67+ cells (arrows) were present (A and B). In contrast, a mixed 
population of PSA+/GAD65/67+ late precursor cells (stars) and mature PSA-/GAD65/67+ interneurons 
(arrows) were found in the PGL (C and D). Scale bar = 20 µm for A and C; 10 µm for B and D; 
Abbreviations: SVZ = subventricular zone; PSA = polysialic acid; PGL = periglomerular layer 
 
 
3.5 Isolation of olfactory bulb interneurons and their precursors 
As already mentioned, one major requirement for a molecular analysis of a cell population is 
the usage of pure starting populations. Using the postnatal generation of olfactory bulb 
interneurons as a model system, it was possible to isolate all required cell types at high 
purities. The established purification strategy combined a selective magnetic cell sorting 
based approach for known surface markers with a prior reduction of the starting tissue 
complexity (see 2.8.4 and Fig. 3.17). 
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Figure 3.17: Scheme for purification of glomerular layer interneurons and their precursors 
Glomerular layer interneurons and their progenitors were purified using a two step MACS® strategy. 
The glomerular layer of olfactory bulbs from 20 postnatal day 1 mice was dissected and dissociated to 
a single cell suspension. Subsequently, A2B5+ glial cells (violet) were depleted by using magnetic 
antibodies specific for A2B5. In the remaining neuronal fraction, magnetic antibodies specific for PSA 
were used to separate PSA+ late precursor cells (light blue) from PSA- mature interneurons (orange). 
The nissl stained olfactory bulb was adopted from the Allan Reference Atlas (Lein et al., 2007). 
Abbreviations: PSA = polysialic acid; P1 = postnatal day 1 
 
 
The reduction of the starting material complexity prior to magnetic cell sorting was done by 
microdissection of the periglomerular layer. This step was crucial to deplete tissue containing 
cell types that could not be selectively sorted by MACS®. Subsequently, the periglomerular 
layer tissue was dissociated to a single cell suspension and sorted using a two step magnetic 
cell sorting strategy. In the first step, magnetic antibodies specific for A2B5 were used to 
deplete A2B5+ glial cells yielding a population of mature interneurons and late precursor 
cells. In the second step, magnetic antibodies specific for PSA were used to separate PSA+ 
late precursor cells from PSA- mature interneurons. Dissection and sorting of 20 mouse 
olfactory bulbs yielded 1.1x105 PSA+ precursor cells and 1.4x105 PSA- interneurons with 
good purities (Fig. 3.18). In the PSA+ enriched fraction, 94% of all cells showed 
immunoreactivity for PSA. 71% were double positive for PSA and GAD65 and 8% were still 
PSA+
neuronal 
mature 
glomerular layer 
interneurons 
immature 
glomerular layer 
precursors 
MACS for A2B5 
MACS for PSA
dissect 
20 P1 mice
single cell 
suspension
glomerular layer 
tissue 
A2B5- A2B5+ 
glial 
PSA- 
Results 
   
75 
positive for A2B5. In the PSA- fraction, 72% were positive for GAD65, 10% for A2B5 and 
2% were still PSA+.  
The PSA+ Type A early precursor cells were purified using an equal approach, but with 
dissected SVZ- instead of periglomerular layer tissue as starting population. Subsequent 
immunolabeling of isolated cells indicated purities above 95% (data not shown). 
 
 
Figure 3.18: Purification of glomerular layer interneurons and their precursors 
Immunostainings for the precursor marker PSA (red) and the interneuron marker CALB2 (green) in the 
olfactory bulb are shown (A and B). Cell nuclei were stained with DAPI (blue, A to E). In addition, 
immunostainings for the precursor marker PSA (green) and the interneuron marker GAD65/67 (red) 
after dissociation (C) and MACS® purification are shown (D and E). The dissociation of periglomerular 
layer tissue from the olfactory bulb is indicated by the grey area (A and B). Subsequent to dissociation 
(C), the single cell mixture contained PSA+/GAD65/67+ late precursor cells (arrows) and mature PSA-
/GAD65/67+ interneurons (stars). The two step MACS® separation yields purified populations of 
PSA+/GAD65/67+ periglomerular layer precursor cells (D) and mature PSA-/GAD65/67+ interneurons 
(E). 
 
 
3.6 Molecular analysis of olfactory bulb interneurons and their 
precursors 
As mentioned above, dissection and sorting of periglomerular layer tissue from 20 mouse 
olfactory bulbs yielded 1.1x105 PSA+ precursor cells and 1.4x105 PSA- interneurons. The 
yield of Type A precursor cells, isolated from SVZ tissue, was in the same range. As this cell 
numbers did not allow for standard gene expression profiling, all experiments were carried 
out using SuperAmp amplification of mRNA. For each experiment, 7000-10000 cells were 
directly lysed in lysis buffer after MACS® sorting and stored at -20°C until further processing. 
RNA amplification, cDNA labeling and microarray processing of Agilent whole mouse 
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genome 44k microarrays were carried out as described for the FACS purified cells (see 
2.6.10). RNA, isolated from postnatal day 1 old wild type mice brains (n = 4), was amplified 
in the same way and served as a common reference for all hybridizations. Olfactory bulbs of 
20 mice were pooled and used in each experiment. Two replicate hybridizations including a 
dye-swap were done for each of the 3 cell types, namely the Type A early precursors, the 
periglomerular late precursors and the mature periglomerular interneurons. Merged dye-swap 
data were used for further analysis. Correlation coefficients within replicates ranged from 
0.92 to 0.98, demonstrating a good reproducibility. 
 
3.6.1 Global changes during differentiation 
In a first step, the general relationship among the 3 cell types was analyzed. Therefore, the 
gene expression profiles of the Type A early neuronal precursors, the periglomerular late 
precursors and the mature periglomerular interneurons were compared by calculating Pearson 
correlation coefficients of pairwise comparisons. Unsupervised hierarchical clustering of 
correlation coefficients grouped both cell types isolated from the periglomerular layer 
together and separated them from the Type A cells (Fig. 3.19 A). The correlation coefficients 
between Type A cells and periglomerular layer cells were 0.64 in comparison to PSA+ cells 
and 0.60 in comparison to PSA- cells. This result is in agreement with the model that PSA+ 
periglomerular layer precursors represent an intermediate state between SVZ precursors and 
PSA- periglomerular layer interneurons. Furthermore, the high similarity between the two 
periglomerular layer cell types (correlation coefficient of 0.97) indicates that the major 
changes during the development of olfactory bulb GABAergic interneurons occur during the 
migration of Type A precursor cells from the SVZ to the olfactory bulb, whereas only minor 
changes occur during the late step of differentiation in the periglomerular layer. 
In addition, a multiclass SAM analysis was computed. Using this approach, the significant 
enrichment of genes showing a similar expression pattern is calculated. Enrichment for three 
groups of patterns was identified (Fig 3.19 B to D): first, genes which are downregulated 
during the migration of Type A precursor cells from the SVZ to the olfactory bulb that stay 
downregulated; second, genes which are upregulated during the migration of Type A 
precursor cells from the SVZ to the olfactory bulb that stay upregulated; third, genes which 
are upregulated during the last step of differentiation in the periglomerular layer. No 
significant enrichment of genes that are upregulated first and subsequently downregulated 
again or vice versa was observed. This result is again in good agreement with the proposed 
model.
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Figure 3.19: Correlation and multiclass SAM analysis 
(A) Correlation matrix showing the relationship of gene expression profiles in all experiments. The 
matrix was generated by unsupervised hierarchical clustering of global expression data. Correlation 
coefficients are indicated by their color from blue (0.0) to yellow (1.0). The correlation coefficients 
between Type A cells and periglomerular layer cells were 0.64 when compared to PSA+ cells and 0.60 
when compared to PSA- cells. In combination with the high similarity between the two periglomerular 
layer cell types (correlation coefficient of 0.97), this correlates to the model that PSA+ periglomerular 
layer precursors represent an intermediate state between SVZ precursors and PSA- periglomerular 
layer interneurons. (B to D) A multiclass SAM analysis to calculate significant enrichment of genes 
showing similar expression patterns is shown. The relative change of expression ratios for each 
analyzed cell type compared to the common reference is depicted. Groups of genes which are 
downregulated during the migration of Type A precursor cells from the SVZ to the olfactory bulb that 
stay downregulated (B), which are upregulated during the migration of Type A precursor cells from the 
SVZ to the olfactory bulb that stay upregulated (C) and which are upregulated during the last step of 
differentiation in the periglomerular layer were significantly enriched. Abbreviations: 
SVZ = subventricular zone; PSA = polysialic acid; PGL = periglomerular layer 
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3.6.2 Changes in gene expression during the migration of Type A 
precursor cells from the SVZ to the olfactory bulb 
To obtain further information about the molecular changes which occur during the migration 
of Type A early neuronal precursor cells from the SVZ into the olfactory bulb and their 
differentiation to periglomerular cells, genes were analyzed that altered the expression 
patterns during these stages. As expected from the rather low correlation coefficients between 
Type A cells and olfactory bulb cells of 0.64 (compared to PSA+ cells) and 0.60 (compared to 
PSA- cells), many genes were found to be significantly regulated. The 110 strongest 
upregulated as well as the 110 strongest downregulated genes are listed in supplementary 
tables 1 and 2 (see Tab. 6.1 and 6.2). Selected candidates are described below. 
Many genes showed strong enrichment in both periglomerular cell types compared to their 
SVZ progenitors and may therefore represent candidates important for the differentiation of 
GABAergic interneurons. The enrichment of NeuropeptideY, which has signal modulating 
function and may be involved in many diseases, in these later stages of differentiation, is in 
concordance to its expression in mature subtypes of GABAergic interneurons (Kanatani et al., 
2000; Rohner-Jeanrenaud et al., 1996). A huge number of genes was identified which are 
involved in synaptogenesis and synaptic plasticity. Examples are PTN, VTN, APOE, APOD, 
FBLN2, S100A1 and S100A13, NRXN1 and NLGN2 (Comoletti et al., 2003; Hartmann et 
al., 1994; Missler et al., 2003; Okazaki et al., 2002). Furthermore, NLGN2 is specific for 
inhibitory synapses (Varoqueaux et al., 2004), which correlates with the observation that it is 
upregulated during differentiation. All these genes may play important roles during the 
synaptogenesis of olfactory bulb interneurons. 
In addition, genes like EphrinA5, Semaphorin4A, Vimentin and CSPG3 act as axon guidance 
and cell motility factors (Lampa et al., 2004; Li et al., 2005; Menet et al., 2003; Moretti et al., 
2006). Even more enriched genes, which were shown to be functional in mature neurons, like 
the glutamate receptors GRIK1 and GRINL1A, CALB1, CALR, GLUD, SLC13A3, MT2 and 
DBI correlate with an increased state of differentiation in periglomerular layer cells (Pajor et 
al., 2001; Stankovic, 2005). As an example, mice deficient for TNC have a delayed onset of 
odor detection, again showing that genes identified in this screen have important functions 
during olfactory bulb neurogenesis (de Chevigny et al., 2006). Upregulation of extracellular 
matrix components like MATN2, FBLN2, TNC, PTN, VTN and CSPG3 by periglomerular 
layer precursors and interneurons suggests also an active role of these cells in building up the 
neurogenic environment of the olfactory bulb (Mates et al., 2002). A number of transcription 
factors, upregulated in periglomerular cells compared to SVZ precursors, indicate a function 
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of these molecules in the late phase of interneuron differentiation. Examples are OLIG1, 
XBP1, NFI/A, ZFP277, ZMYND11, GTF2B and E4F1. Several of them, like 
Nuclear Factor I/A, are already known to be involved in neuronal development but not linked 
to the olfactory bulb (Shu et al., 2003; Wang et al., 2004). 
 
3.6.3 Genes differentially expressed during the maturation from 
periglomerular layer precursors to interneurons 
After identifying candidates that may be involved in early stages of differentiation, genes 
which were differently regulated among the 2 periglomerular layer cell types were further 
analyzed. These genes may be important for late differentiation steps. Although a high 
correlation coefficient of 0.97 between PSA+ periglomerular layer precursors and PSA- 
periglomerular layer interneurons indicated a high similarity of these cell types, several 
interesting genes with strong expression differences were found. The >5-fold upregulated as 
well as the >5-fold downregulated genes are listed in supplementary tables 3 and 4 (see 
Tab. 6.3 and 6.4). 
Comparable to the results for periglomerular layer- against Type A cells, genes with functions 
in mature neurons were identified to be enriched in the PSA- fraction showing their advanced 
differentiation status. Examples of these genes were GAD2, SST, NEFL, NRXN, HTR3B, 
SLC1A1, CALB1 and CALR. Additionally, markers of neuronal progenitor cells, like 
TUBB3, Nestin and DCX were downregulated. Some of them, for example DCX and Nestin, 
had already been downregulated in late PSA+ periglomerular layer precursors compared to 
early Type A precursors and than even more in mature PSA- periglomerular layer 
interneurons. Enriched expression of several OLFR- and other rhodopsin like receptors in 
mature olfactory bulb interneurons was consistent to results from the expression profiling of 
GABAergic neurons.  
Several upregulated genes, like STX3, STX6, SYT4 and SLC1A1, are important for 
vesicular- and neurotransmitter transport (Ferguson et al., 2004a). Many genes with functions 
in the regulation of the cytoskeleton, especially involved in axon outgrowth and guidance, like 
KTN1, NTRK3, NTRK3, C130076O07Rik, TBCE, BC050903 (DCAMKL1) and Ablim1 
were identified (Bommel et al., 2002; Deuel et al., 2006; Erkman et al., 2000; Martin et al., 
2002; Stenqvist et al., 2005). But also in the fraction of downregulated transcripts, many 
genes connected to the cytoskeleton, like CRMP1, MAPT, KIF5A, TUBB3 and EPB4.2 were 
found (Bretin et al., 2005; Kanai et al., 2000; Yamashita et al., 2006). The interaction of these 
Results 
   
80 
genes probably regulates the final positioning, morphological changes and axonal 
innervations during the final differentiation of olfactory bulb interneurons. 
As before, a number of transcription factors with expression differences among the 2 
periglomerular populations were found that may be important for the regulation of this 
differentiation step. The transcription factors BHLHB9, PAX6 and PAX8, OBOX2 and 3, 
PMS1, SFPI1, GABPB1, MTF1, ZHX3 and ISL2 were enriched in PSA- cells. For example, 
ISL2 specifies RGC laterality by repressing an ipsilateral pathfinding program (Pak et al., 
2004). In contrast, the transcription factors PNMA1, SOX30, ZFP219 and NFKBIE were 
downregulated in PSA- interneurons. Interestingly, an oppositional regulation of DLX1 and 
DLX2 was found. DLX2 was upregulated in PSA- interneurons, whereas DLX1 was 
downregulated. In contrast, DLX5 and 6 were already downregulated in periglomerular layer 
cells compared to Type A precursors, suggesting that DLX genes are important for the early 
and late differentiation of olfactory bulb interneurons. 
In addition, also oppositional regulation of the basic helix-loop-helix transcription factors 
NeuroD1 (ND1) and NeuroD2 (ND2) was found. Whereas NeuroD1 became highly 
upregulated in mature interneurons, NeuroD2 was downregulated during this step. Both genes 
are already known as important factors for the development of the nervous system (Cho and 
Tsai, 2004; Noda et al., 2006). The PAX6 gene, which was also enriched in mature 
interneurons, is activated by NeuroD1 (Marsich et al., 2003). PAX6 plays a role in the 
establishment of a postmitotic phenotype and periglomerular differentiation, but not in 
olfactory granule cell differentiation (Cartier et al., 2006; Hack et al., 2005). This data 
represents the first evidence for an involvement of NeuroD1 and NeuroD2 in olfactory bulb 
interneuron differentiation, which may be partially mediated by PAX6. 
In conclusion, many genes were identified to be differently expressed during early or late 
stages of periglomerular interneuron differentiation. Several of them, especially the 
transcription factors, may play important roles in the control of differentiation. Others, like 
the cytoskeletal proteins and regulators, probably represent essential downstream effectors. 
 
3.6.4 Independent validation of gene expression 
To validate the microarray hybridization results, the expression data were compared to 
already published expression patterns for several marker genes. Expression patterns of the 
genes CALB1, CALR, TUBB3 and DCX in the analyzed cell populations matched with 
published data (Lledo et al., 2006). Furthermore, expression of known marker genes like TH, 
GAD65, SST and Nestin was nicely reproduced by the microarray results and the differential 
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expression of CRMP1 among the periglomerular layer cell types also matches with published 
data (Veyrac et al., 2005). 
As adult neurogenesis takes place throughout live in mice, the results should match with 
expression patterns observed in the SVZ/RMS/olfactory bulb-system of adult mice. 
Therefore, the microarray results were compared with in situ hybridization data obtained from 
the Allan Brain Atlas (Lein et al., 2007). The expression signals of in situ hybridizations for a 
number of genes (NPY, GRIK1, VTN, APOD, APOE, FBLN2, S100A1, NRXN1, GLUD, 
FABP7, DBI, SEPT4, SLC13A3, SCD2, IGF1 and PEA15), found to be enriched in 
periglomerular layer cells compared to Type A precursors, were checked and showed the 
expected patterns. In addition, in situ hybridizations for KIF5A and TUBB3 showed high 
expression in the SVZ and RMS but no signals in the glomerular layer, also in concordance to 
the microarray data. Furthermore, the differential expression of several genes (GAD2, NEFL, 
NeuroD1, NeuroD2, CRMP1, GPR103, NTRK3, STX3, KTN1, C130076O07Rik, NFKBIE, 
GREM1, PAX6, SFPI1, GABPB1 and MTF1) in PSA+ late precursors and PSA- mature 
interneurons could be reproduced by in situ data (Lein et al., 2007). As an example, the in situ 
signal for NeuroD1 was only detectable in the periglomerular layer. In contrast, the signal for 
NeuroD2 was also abundant in the centre of the olfactory bulb. This pattern would also be 
expected from the microarray results, which showed that NeuroD1 became highly upregulated 
in mature interneurons, whereas NeuroD2 was enriched in the progenitor population. In 
addition, the number of positive cells for NeuroD1 observed in the in situ hybridization 
suggests that this gene is highly expressed in only a subpopulation of periglomerular 
interneurons rather than all of these cells (Fig. 3.20). The specific expression of NeuroD1 was 
also validated by the observation of an equal expression pattern in the NeuroD1-GFP mouse 
strain (strain Tg(Neurod1-EGFP)1Gsat/Mmcd, http://gensat.org/). 
The results of this screen yielded many interesting candidates for an involvement in olfactory 
bulb interneuron differentiation. Two particularly interesting genes were further analyzed for 
their functional relevance in vivo. 
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Figure 3.20: In situ hybridization for NeuroD1 and NeuroD2 
Expression patterns of NeuroD1 and NeuroD2 from in situ hybridizations in adult mice were analyzed 
(Lein et al., 2007). The square in the nissl stained olfactory bulb (A) indicates the region depicted in 
B to D. The in situ hybridization signals (B and D) were automatically quantified and plotted as 
expression strength (C and E) from low (blue) to high (red). A specific signal for NeuroD1 was only 
detectable in the periglomerular layer, where the mature interneurons are localized (B and C). In 
contrast, the signal for NeuroD2 was also abundant in the centre of the olfactory bulb, where the 
precursors arrive (D and E). Abbreviations: ISH = in situ hybridization 
 
 
3.7 Functional in vivo analysis of NeuroD1 and NeuroD2 
As mentioned above, an oppositional regulation of the basic helix-loop-helix transcription 
factors NeuroD1 and NeuroD2 was found. Whereas NeuroD1 was upregulated in mature 
PSA- periglomerular layer interneurons, NeuroD2 was downregulated at the same time. These 
two genes were selected for functional analysis, as both are involved in several differentiation 
processes during the development of the central nervous system. This was also true for DLX1 
and DLX2, but in contrast to genes of the DLX-family, no impact on inhibitory interneuron 
differentiation was known so far for NeuroD1 and NeuroD2. To address the question, if these 
genes function as key regulators in the control of interneuron development, or if they are only 
downstream markers correlating with the stage of differentiation, the functional relevance of 
NeuroD1 and NeuroD2 expression in vivo was analyzed. 
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3.7.1 In vivo electroporation 
A novel method, allowing the targeted transfection of adult neuronal stem cells in the SVZ 
(see 2.8.6), was established by Camille Boutin (Boutin et al., 2008) Expression vectors are 
injected into the lateral ventricle of early postnatal mice. Subsequently, a series of defined 
electrical currents causes transfer of the plasmid DNA into radial glia cells, the stem cells in 
the SVZ/RMS/olfactory bulb system of adult neurogenesis. Therefore, transfection induces 
strong expression of transgenes in radial glia, neuronal precursors and mature neurons of the 
olfactory system. Using this method, the effects upon expression of specific genes during 
adult neurogenesis can be analyzed in vivo. 
In this study, postnatal day 1 mice were used for in vivo electroporation. For each transgene 
and time point, always 10 biological replicates were analyzed. Electroporation of empty 
expression vector (pCX-MCS2, see 2.6.9) served as control. Control electroporations were 
carried out at the same day and as for the transgene, always 10 replicates were analyzed. To 
visualize transfected cells, transgenes and controls were co-electroporated with either GFP 
(pCX-GFP) or RFP (pCX-RFP, both gifts from Camille Boutin). The efficiency of co-
electroporation was always higher than 95% (Boutin et al., 2008). 
Between 6 and 8 hours after electroporation, only radial glia cells expressed the transgene 
(Fig. 3.21 B). After 1 to 2 days, many Type A neuronal precursor cells (Fig. 3.21 C) were 
labeled in the SVZ. After 4 days, most of these cells were localized in the RMS or already 
arrived in the olfactory bulb. Differentiated granule neurons (Fig. 3.21 D) and periglomerular 
interneurons (Fig. 3.21 E) were found in the olfactory bulb 15 days post electroporation. As 
the cells only proliferate during the first days, the expression of transgenes is stable for more 
than 30 days (data not shown). 
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Figure 3.21: In vivo electroporation of a GFP expression construct 
(A) Scheme of the injection and electroporation process. A virtual line (red), connecting the right eye to 
the craniometrical landmark lambda, served as positional marker for DNA injection. The incision point 
is indicated as a dot. Lateral bars indicate the position of the electrodes. Between 6 and 8 hours after 
electroporation, only radial glia cells expressed GFP (B). After 1 to 2 days, many Type A neuronal 
precursor cells (C) were labeled in the SVZ. After 4 days, most of these cells were localized in the 
RMS or already arrived in the olfactory bulb. Differentiated granule neurons (D) and periglomerular 
interneurons (E) were found in the olfactory bulb 15 days post electroporation. Abbreviations: 
LV = lateral ventricle 
 
 
3.7.2 Overexpression of NeuroD1 and NeuroD2 
To analyze the effects of an ectopic and strong expression of either NeuroD1 or NeuroD2 by 
in vivo electroporation, constructs for overexpression of both genes were generated (see 
2.6.9). To test the functionality of the resulting constructs, pCX-ND1 and pCX-ND2, the 1881 
cell line was transfected with the respective vector by electroporation (see 2.8.3). One day 
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after transfection, the cells were lysed and protein expression was analyzed by Western Blot 
(see 2.7.1 to 2.7.4). Both constructs showed strong expression of either NeuroD1 in the case 
of pCX-ND1 or NeuroD2 in the case of pCX-ND2 (Fig. 3.22). 
 
 
Figure 3.22: Validation of the expression constructs 
The 1881 cell line was transfected with an overexpression plasmid containing the cDNA of either 
NeuroD1 (A) or NeuroD2 (B). After 24 h, the cells were lysed and protein expression analyzed by 
Western blot. Both constructs showed strong expression of either NeuroD1 in the case of pCX-ND1 
(A) or NeuroD2 in the case of pCX-ND2 (B). A coomassie staining of the gel and expression of the 
housekeeper gene GAPDH served as loading controls. Abbreviations: CM = coomassie staining 
 
 
3.7.3 Effects of NeuroD2 overexpression 2 days post electroporation 
NeuroD2 was found to be downregulated during differentiation of periglomerular 
interneurons. This suggests an early role of this transcription factor during the development of 
olfactory bulb interneurons. However, it had to be examined, if the downregulation of 
NeuroD2 is a result of increasing differentiation, or if it is necessary to allow differentiation. 
To check the effect of an early NeuroD2 overexpression, radial glia were transfected with 
pCX-ND2 in vivo. After 2 days, the mice were perfused with 4% PFA, the brains removed 
and cut at 50 µm on a vibratome (see 2.9.1). Fluorescence microscopy did not reveal any 
obvious morphological differences of transfected cells between NeuroD2 (n = 10) and control 
(n = 10) electroporations. Furthermore, also quantification of identified cell types did not 
reveal significant differences (Fig 3.23). 
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In conclusion, overexpression of NeuroD2 neither led to a morphological nor to a quantitative 
alteration of transfected cells after short time periods. 
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Figure 3.23: Quantification of cell types after NeuroD2 expression for 2 days 
Radial glia cells were electroporated with pCX-ND2 in vivo. After 2 days, GFP+ transfected precursor- 
and radial glia cells were quantified. The ratio of both cell types is depicted. No significant difference 
between NeuroD2 (n = 997 cells from 10 mice) and control (n = 1360 cells from 10 mice) 
electroporations was observed. 
 
 
3.7.4 Effects of NeuroD2 overexpression 4 days post electroporation 
After this short time period, the same experiment was carried out with a survival time of 
4 days after electroporation to check for effects of NeuroD2 overexpression at this time point. 
A very strong difference between the NeuroD2 and control electroporation was observed 
(n = 10 mice for NeuroD2 and 10 mice for control electroporation). In the control 
electroporation, the majority of GFP+ cells were found to be Type A neuronal precursors. 
These cells were mainly localized in the anterior part of the RMS or already in the core of the 
olfactory bulb, whereas some radial glia cells remained in the SVZ (Fig. 3.24 A). In contrast, 
cells overexpressing NeuroD2 showed normal morphology but were localized in much more 
caudal parts, especially the posterior SVZ (Fig. 3.24 A). Quantification of transfected cells 
along the anterior-posterior axis of the brain revealed significant differences in their 
distribution (Fig. 3.24 B; n = 2168 cells from 6 mice for the control; n = 2022 cells from 
6 mice for NeuroD2). In the control, most of the cells already reached the anterior- (21.3%, 
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Δ = 1.5%) or posterior core (37.5%, Δ = 2.8%) of the olfactory bulb, whereas only few cells 
remained in the anterior- (18.7%, Δ = 3.1%) or posterior SVZ (8.4%, Δ = 1.4%). Upon 
overexpression of NeuroD2 for 4 days, few cells were localized in the anterior- (1.4%, 
Δ = 0.8%) and only a small percentage in the posterior olfactory bulb (2.8%, Δ = 0.8%). In 
contrast, most of the Type A precursors were found in the anterior- (29.6%, Δ = 3.1%) or 
posterior SVZ (57.6%, Δ = 2.7%). 
All together, strong expression of NeuroD2 for 4 days in vivo decelerates or even impairs the 
migration of Type A precursor cells from the SVZ to the olfactory bulb. In addition, neither 
the morphology nor the overall number of transfected cells seemed to be affected. 
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Figure 3.24: Analysis NeuroD2 transfected cells after 4 days in vivo 
Figure legend on the next page 
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Figure 3.24: Analysis NeuroD2 transfected cells after 4 days in vivo 
The localizations of respective coronal sections I to V are indicated by the black lines crossing the 
sagittal overview of a brain (A). In the control electroporation, the majority of GFP+ cells were Type A 
neuronal precursors, localized mainly in the anterior part of the RMS or already in the core of the 
olfactory bulb, whereas only several radial glia cells remained in the SVZ. In contrast, cells 
overexpressing NeuroD2 showed normal morphology but were localized to much more caudal parts, 
especially the posterior SVZ. Subsequently, the transfected cells of control (n = 2168 cells from 
6 mice) and NeuroD2 (n = 2022 cells from 6 mice) electroporations were quantified and displayed with 
their relative abundance in each slice (B). In the control, most of the cells were found in the anterior- 
(21.3%, ∆ = 1.5%) or posterior core (37.5%, ∆ = 2.8%) of the olfactory bulb, whereas only few cells 
remained in the anterior- (18.7%, ∆ = 3.1%) or posterior SVZ (8.4%, ∆ = 1.4%). Upon overexpression 
of NeuroD2 for 4 days, nearly no cells were localized in the anterior- (1.4%, ∆ = 0.8%) and only a 
small percentage in the posterior olfactory bulb (2.8%, ∆ = 0.8%). In contrast, most of the Type A 
precursors were found in the anterior- (29.6%, ∆ = 3.1%) or posterior SVZ (57.6%, ∆ = 2.7%), 
indicating decelerated or impaired migration upon NeuroD2 overexpression. Scale bar = 200 µm 
 
 
3.7.5 Effects of NeuroD2 overexpression 15 days post electroporation 
Considering the strong phenotype after 4 days of NeuroD2 overexpression, the influence of 
the observed differences on the further fate of transfected cells was investigated. To 
distinguish, if the onset of migration was completely blocked, or if the defect was rescued 
after a certain time, a time point 15 days after the initiation of NeuroD2 overexpression was 
analyzed. In the control condition, nearly all GFP+ cells had reached the olfactory bulb and 
were differentiated in the granule- or the periglomerular layer (Fig. 3.25 A). In contrast, after 
NeuroD2 overexpression many of the cells still showed a bipolar, precursor like morphology 
and were localized in the center of the olfactory bulb (Fig. 3.25 B). Relative quantification of 
the specific cell types, namely the precursor like cells, the granular neurons and the 
periglomerular neurons, yielded significant variation with and without NeuroD2 
overexpression (Fig. 3.25 C; n = 1184 cells from 8 mice for the control; n = 645 cells from 
10 mice for NeuroD2). Most of the transfected cells were differentiated into granule cells or 
periglomerular interneurons in the control (77.8%, Δ = 2.9% for granule cells; 9.9%, 
Δ = 1.2% for periglomerular interneurons), whereas about 12.4% (Δ = 2.5%) still had a 
precursor like morphology. In the NeuroD2 electroporated mice, the portion of differentiated 
granule neurons but more strikingly that of periglomerular neurons was reduced (53.7%, 
Δ = 4.1% for granule cells; 2.0%, Δ = 1.0% for periglomerular interneurons), whereas the 
number of precursor like cells was significantly increased (44.3%, Δ = 4.8%). Indeed, the 
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final differentiation of periglomerular layer interneurons was affected most drastically with a 
reduction of about 80% in this subpopulation. 
 
 
Figure 3.25: Analysis NeuroD2 transfected cells after 15 days in vivo 
Figure legend on the next page 
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Figure 3.25: Analysis NeuroD2 transfected cells after 15 days in vivo 
Coronal sections from the olfactory bulb of control (A) or NeuroD2 (B) electroporated mice showed 
differing distributions of transfected cells. Whereas in the control condition, nearly all GFP+ cells had 
reached the olfactory bulb and were differentiated in the granule- or the periglomerular layer, after 
NeuroD2 overexpression many of the cells still showed a bipolar, precursor like morphology and were 
localized in the center of the olfactory bulb. The relative abundance of a specific cell types is indicated 
in C (n = 1184 cells from 8 mice for the control; n = 645 cells from 10 mice for NeuroD2). Most of the 
transfected cells differentiated into granule cells (77.8%, ∆ = 2.9%) or periglomerular interneurons 
(9.9%, ∆ = 1.2%) in the control, whereas about 12.4% (∆ = 2.5%) still had a precursor like 
morphology. In the NeuroD2 electroporated mice, the portion of differentiated granule neurons (53.7%, 
∆ = 4.1%) but more strikingly that of periglomerular neurons (2.0%, ∆ = 1.0%) was reduced, whereas 
the number of precursor like cells (44.3%, ∆ = 4.8%) was significantly increased. Scale bar = 50 µm; 
Abbreviations: GCL = granule cell layer; IPL = internal plexiform layer; MCL = mitral cell layer; 
EPL = external plexiform layer; PGL = periglomerular layer; GC = granule cell; PGC = periglomerular 
layer cell 
 
 
The morphological analysis revealed that not only the ratio between differentiated and non-
differentiated cells was shifted but that the morphology of the cells, especially that of 
periglomerular interneurons, was affected. In the control, GFP+ cells that were localized in the 
periglomerular layer showed a differentiated morphology with multiple neurite branches 
innervating the glomeruli (Fig. 3.26 A). Upon NeuroD2 overexpression, cells in this area still 
showed a more precursor like morphology, as they had only few branches (Fig. 3.26 B). 
Several cells showed bipolar morphology, which was never observed in the control 
periglomerular layer after 15 days. Quantification of neurite branches revealed a significant 
reduction in case of NeuroD2- (8.7, Δ = 5.6; n = 52 cells from 10 mice) compared to control 
electroporated (52.8, Δ = 13.6; n = 52 cells from 8 mice) cells (Fig. 3.26 C). 
To summarize these results, NeuroD2 overexpression decelerated the migration and changed 
the final differentiation of Type A neuronal precursor cells. This was particularly evident for 
the differentiation of periglomerular interneurons. 
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Figure 3.26: Analysis of periglomerular layer interneurons upon NeuroD2 overexpression 
In the control, GFP+ cells that were localized in the periglomerular layer 15 days post electroporation 
showed a differentiated morphology with multiple neurite branches innervating the glomeruli (A). Upon 
NeuroD2 overexpression, cells in this area still showed a more precursor like morphology with only 
few branches (B). Quantification of neurite branches revealed a significant reduction in NeuroD2- (8.7, 
∆ = 5.6; n = 52 cells from 10 mice) compared to control electroporated (52.8, ∆ = 13.6; n = 52 cells 
from 8 mice) cells (C). Scale bar = 20 µm 
 
 
3.7.6 Effects of NeuroD1 overexpression 2 days post electroporation 
The transcription factor NeuroD1 was found to be upregulated during the final differentiation 
of periglomerular precursors to mature interneurons, indicating the involvement of NeuroD1 
in the late stage of olfactory bulb interneuron differentiation. However, it had to be examined, 
if the increased expression was only a marker of differentiation, or if NeuroD1 is involved in 
the regulation of this final transition step. 
As for NeuroD2, radial glia were transfected with the NeuroD1 expression vector pCX-ND1. 
The SVZ of electroporated mice was analyzed after 2 days (n = 10 mice for the control and 
10 mice for NeuroD1). In the control, the morphology showed radial glia stem cells in the 
ventricular zone (VZ) and neuronal precursor cells in the SVZ (Fig. 3.27 A). In contrast, a 
dramatic reduction of radial glia cells was observed upon overexpression of NeuroD1 for 
2 days (Fig. 3.27 B). No morphological differences were observed in the SVZ. 
In conclusion, the expression of NeuroD1 is not compatible with radial glia identity. 
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Figure 3.27: Analysis of NeuroD1 overexpression in vivo after 2 days 
Two days after electroporation of either a control- or a NeuroD1 expression vector, the brains were 
sectioned coronally (n = 10 mice for the control and 10 mice for NeuroD1). The area between the 
lateral ventricle and the striatum is depicted. In the control, radial glia stem cells (stars) in the VZ as 
well as neuronal precursor cells (arrows) in the SVZ could be identified according to their morphology 
(A). Upon overexpression of NeuroD1, a dramatic reduction of radial glia cells was observed (B). No 
morphological differences were observed in the SVZ. Scale bar = 100 µm; Abbreviations: 
SVZ = subventricular zone; VZ = ventricular zone; LV = lateral ventricle 
 
 
3.7.7 Effects of NeuroD1 overexpression 4 days post electroporation 
Subsequently, the effect of NeuroD1 expression after an extended time period was examined. 
Sagittal and coronal sections of control- (n = 9 mice) and NeuroD1 (n = 10 mice) transfected 
brains were analyzed 4 days post electroporation. As already shown before, control 
electroporated cells at this time point were Type A neuronal precursors showing a bipolar, 
migratory phenotype (Fig. 3.28 A and B). These cells were mainly localized in the RMS or 
already in the core of the olfactory bulb. In contrast, a population of NeuroD1 expressing cells 
had left the RMS and was found inside the striatum (Fig. 3.28 C). In addition to their ectopic 
localization, also the morphology of these cells was different. Instead of the bipolar Type A 
cell phenotype, a multipolar, differentiated morphology was observed (Fig. 3.29 A and B). 
Furthermore, also cells inside the RMS (Fig. 3.28 D) or the olfactory bulb (Fig. 3.29 C) 
showed a multipolar phenotype which was similar to that of interneurons. Interestingly, there 
was a correlation between the expression level of GFP, and therefore NeuroD1, and the 
degree of altered morphology. Whereas the majority of cells with strong expression displayed 
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a differentiated morphology, cells with only weak expression showed a nearly normal 
phenotype, indicating a dose dependency. 
 
 
Figure 3.28: Analysis of precursor cells after NeuroD1 overexpression in vivo for 4 days 
Sagittal sections of control (A and B) and NeuroD1 (C and D) transfected mice are shown. In the 
control (n = 9 mice), the majority of GFP+ cells were Type A neuronal precursors showing a bipolar, 
migratory phenotype (A and B). The cells in this region were exclusively localized in the RMS. 
Contrarily, a population of NeuroD1 expressing cells (n = 10 mice) had left the RMS and was found 
inside the striatum (C, arrows). This was observed in particular for the cells with highest transgene 
expression. In addition to their ectopic localization, also the morphology of these cells was different. 
Instead of a bipolar phenotype, a multipolar, differentiated morphology was observed (C). 
Furthermore, also cells inside the RMS (D, arrows) showed a multipolar phenotype which was similar 
to that of interneurons. Scale bar = 50 µm for A and C; 20 µm for B and D; Abbreviations: 
RMS = rostral migratory stream; ST = striatum 
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Figure 3.29: Cellular morphology upon NeuroD1 overexpression in vivo for 4 days 
After 4 days of NeuroD1 overexpression, the cellular morphology changed dramatically. In the control, 
the majority of GFP+ cells were Type A neuronal precursors showing a bipolar, migratory phenotype 
(A). In contrast, a population of NeuroD1 expressing cells showed a multipolar, differentiated 
morphology. Some of these cells were found in the striatum (B) or the olfactory bulb (C) and had a 
phenotype which was similar to that of interneurons. Scale bar = 20 µm 
 
 
As the cellular morphology upon NeuroD1 expression changed to a differentiated phenotype, 
the question was, if these transformations were accompanied with a characteristic change in 
the expression of known marker genes that indicate the differentiation status of the cell. To 
address this question, immunohistochemical stainings for the progenitor cell markers 
doublecortin (DCX) and PSA-NCAM were done (n = 4 mice for the control and 4 mice for 
NeuroD1). In the analyzed region of the anterior forebrain, all control transfected cells were 
localized inside the RMS and expressed the characteristic precursor markers DCX and PSA-
NCAM (Fig. 3.30 A to D). In contrast, the differentiated cells transfected with NeuroD1 
showed indeed no expression of these marker genes indicating an advanced state of 
differentiation (Fig. 3.30 E to H). 
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Figure 3.30: Immunohistochemical analysis for the expression of precursor markers 
An immunohistochemical analysis of PSA-NCAM (red) and DCX (yellow) expression was done on 
sections from either control (A to D) of NeuroD1 (E to H) transfected brains after 4 days in vivo 
(n = 5 mice for the control and 5 mice for NeuroD1). In the anterior forebrain, all control transfected 
cells were localized inside the RMS and expressed the characteristic precursor markers DCX and 
PSA-NCAM (A to D). In contrast, the morphologically differentiated cells upon transfection with 
NeuroD1 showed no expression of these marker genes (E to H). Scale bar = 20 µm; Abbreviations: 
DCX = doublecortin; PSA = polysialic acid 
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The observation of an advanced differentiation state was further confirmed by the expression 
of NeuN, a frequently used marker specifically expressed in differentiated neuronal cells. As 
NeuN is upregulated upon differentiation of neurons, it is absent in all types of progenitor 
cells. Therefore, usually no expression of NeuN is found in the SVZ or the RMS. As 
expected, no specific staining was observed to colocalize with control transfected cells 4 days 
after electroporation (Fig. 3.31 A to C). In the SVZ and RMS of NeuroD1 electroporated mice 
however, NeuN was expressed and colocalized with transfected cells that showed a 
differentiated morphology (Fig. 3.31 D to F). 
 
 
Figure 3.31: Immunohistochemical analysis for the expression of NeuN 
An immunohistochemical analysis of NeuN (red) expression was done on sections from either control 
(A to C) of NeuroD1 (D to F) transfected brains after 4 days in vivo. No specific staining was observed 
to colocalize with control transfected cells (A to C, arrows). In the SVZ and RMS of NeuroD1 
electroporated mice, NeuN was expressed and colocalized with transfected cells displaying a 
differentiated morphology (D to F, star). Scale bar = 10 µm 
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As suggested from the in situ hybridization (see Fig. 3.20), NeuroD1 seemed to be highly 
expressed only in a subpopulation of olfactory bulb interneurons. The aim was to determine, 
if cells expressing this transcription factor differentiate into a specific subpopulation of 
periglomerular interneurons. As already mentioned, one of these subpopulations localized in 
the olfactory bulb shows a bifunctional dopaminergic and GABAergic neurotransmitter 
phenotype. It was shown that the transcription factor PAX6 is necessary for the differentiation 
of these cells (Hack et al., 2005). As PAX6 is activated by NeuroD1 (Marsich et al., 2003), it 
was possible that also NeuroD1 is involved in this system. To test this hypothesis, TH-GFP 
mice were transfected with the NeuroD1 expression vector and mice analyzed after 4 days 
(n = 6 mice). TH-GFP mice express GFP under the control of the tyrosine hydroxylase 
promotor which becomes active exclusively in dopaminergic neurons (Sawamoto et al., 
2001). During postnatal neurogenesis, the TH promotor activity is restricted to the anterior 
RMS and the olfactory bulb (Saino-Saito et al., 2004). To identify transfected cells, NeuroD1 
was coelectroporated with a RFP expression vector, since GFP was already used as readout of 
TH promotor activity. 
As expected, SVZ tissue not transfected with NeuroD1 showed no GFP+ cells (Fig. 3.32 A 
to C), whereas upon NeuroD1 expression, GFP fluorescence was observed in this region. 
Colocalization analysis showed that only transfected cells became GFP+ (Fig. 3.32 D to F). In 
addition, quantification of labeled cells in the SVZ (n = 298 cells from 6 mice, Fig. 3.32 G) 
showed that the vast majority of cells were GFP/RFP double positive (96.0%, Δ = 2.1% 
GFP/RFP double positive; 0.7%, Δ = 0.9% only GFP+; 3.3%, Δ = 1.8% only RFP+). 
Therefore, expression of NeuroD1 seemed to induce a differentiation towards a dopaminergic 
fate at ectopical localizations even after 4 days. 
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Figure 3.32: Analysis of effects on dopaminergic differentiation upon NeuroD1 expression 
Figure legend on the next page 
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Figure 3.32: Analysis of effects on dopaminergic differentiation upon NeuroD1 expression 
TH-GFP mice, expressing GFP specifically in dopaminergic neurons, were transfected with a NeuroD1 
expression vector and analyzed after 4 days in vivo (n = 6 mice). Transfected cells were visualized by 
coexpression of RFP. SVZ tissue not transfected with NeuroD1 showed no GFP+ cells (A to C). Upon 
NeuroD1 expression, GFP fluorescence was observed in the SVZ (E). Colocalization analysis showed 
that only cells expressing NeuroD1 became GFP+ (D to F). Quantification of fluorescent cells in the 
SVZ (n = 298 cells from 6 mice) resulted in 96.0% (∆ = 2.1%) GFP/RFP double positive, 0.7% 
(∆ = 0.9%) only GFP+ and 3.3% (∆ = 1.8%) only RFP+ cells (G). Quantification of fluorescent cells in 
the RMS (n = 147 cells from 6 mice) resulted in 77.0% (∆ = 4.6%) only GFP+ cells, reflecting the 
normal activation of the TH promoter in this region. In contrast, only 1.0% (∆ = 1.6%) of the cells were 
only RFP+, whereas 22.3% (∆ = 4.3%) were GFP/RFP double positive, indicating that again nearly all 
transfected cells expressing NeuroD1 induced the TH-promotor. Scale bar = 20 µm; Abbreviations: 
RMS = rostral migratory stream; SVZ = subventricular zone 
 
 
In addition to the TH promotor activation inside the SVZ, nearly all NeuroD1 transfected cells 
in the RMS (Fig. 3.33 A to C) and the striatum (Fig. 3.33 D to F) became GFP positive. 
However, as the TH promotor is naturally activated in the anterior part of the RMS (Saino-
Saito et al., 2004), many not transfected GFP+ cells were found (Fig. 3.33 A to C). 
Quantification of fluorescent cells in the RMS (Fig. 3.32 G, n = 147 cells from 6 mice) 
resulted in 77.0% (Δ = 4.6%) GFP+ only cells. In contrast, only 1.0% (Δ = 1.6%) of the cells 
were only RFP+, whereas 22.3% (Δ = 4.3%) were GFP/RFP double positive, indicating that 
again nearly all transfected cells became dopaminergic. In addition, the GFP fluorescence was 
stronger in double positive cells, probably because the promotor was activated earlier and the 
GFP protein was already accumulated at this time. 
To summarize these results, overexpression of NeuroD1 in neuronal progenitor cells induced 
a premature differentiation into an interneuron like phenotype at ectopic localizations. These 
cells adopted a multipolar morphology, downregulated the expression of precursor markers 
and induced the expression of markers specific for maturated neurons. In addition, nearly all 
NeuroD1 transfected cells induced a differentiation towards a dopaminergic fate. 
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Figure 3.33: Analysis of effects on dopaminergic differentiation upon NeuroD1 expression 
TH-GFP mice, expressing GFP specifically in dopaminergic neurons, were transfected with a NeuroD1 
expression vector and analyzed after 4 days in vivo (n = 6 mice). Transfected cells were visualized by 
coexpression of RFP. Nearly all transfected cells in the RMS (A to C) and the striatum (D to F) 
became GFP positive. As the TH promotor is naturally activated in the anterior part of the RMS, many 
not transfected GFP+ cells were found (A to C, arrows). Scale bar = 20 µm; Abbreviations: 
RMS = rostral migratory stream 
 
 
3.7.8 Effects of NeuroD1 overexpression at later time points 
As already shown, NeuroD1 induced the differentiation of Type A neuronal precursor cells 
already after 4 days and at localizations which naturally do not show neuronal differentiation. 
To investigate the further fate of these cells, it was analyzed if they were able to survive and 
further differentiate in these regions. 
Again, NeuroD1 was electroporated in vivo and the brains were removed and analyzed after 
8 days (n = 10 mice for NeuroD1- and 10 mice for control electroporations). In the control, 
nearly all transfected cells had reached the olfactory bulb and started their final 
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differentiation. Most of them were localized in the granule cell layer and already extended a 
long primary dendrite in lateral direction (Fig. 3.34 A). Upon NeuroD1 transfection, the 
number of cells localized inside the olfactory bulb was strongly reduced (80% reduction 
compared to the control, Fig. 3.34 B). Furthermore, the morphology of cells that reached their 
correct position was different as again an increased number of processes was observed 
(Fig. 3.34 C). In contrast to the control, where no cells remained in the RMS, many NeuroD1 
transfected cells were still found in this region (Fig. 3.34 D and E). In addition, the 
differentiated cells inside the striatum were still present; however, their number was reduced 
compared to the experiment at day 4 (Fig. 3.34 D and E). 
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Figure 3.34: Analysis NeuroD1 transfected cells after 8 days in vivo 
Eight days after electroporation of either a control- or a NeuroD1 expression vector, brains were 
removed and sectioned coronally (n = 10 mice for the control and 10 mice for NeuroD1). In the control, 
nearly all of the transfected cells reached the olfactory bulb and started their differentiation. Most of 
them were localized in the GCL and already extended a long primary dendrite in lateral direction (A). 
Upon NeuroD1 transfection, the number of cells localized inside the olfactory bulb was strongly 
reduced (>80% less cells compared to the control, B). The morphology of some cells that reached 
their correct position was different from the one found also mainly in the control (C, arrow), as again 
multiple processes were observed (C, star). In contrast to the control, where no cells remained in the 
RMS, many NeuroD1 transfected cells were still found in this region (D and E). Also the differentiated 
cells inside the striatum were still present (D and E). Scale bar = 50 µm for A and B, 20 µm for D and 
E; Abbreviations: RMS = rostral migratory stream; ST = striatum; GCL = granule cell layer; 
MCL = mitral cell layer; OB = olfactory bulb 
 
The dramatic loss of NeuroD1 transfected cells was even more obvious after 15 days 
(n = 10 mice for NeuroD1- and 10 mice for control electroporations). Comparable to the 
control electroporation of the NeuroD2 experiment, most of the GFP only transfected cells 
were differentiated into granule- or periglomerular neurons after 15 days (Fig. 3.35 A). In 
contrast, nearly no GFP+ cells were found anymore in NeuroD1 transfected brains 
(Fig. 3.34 B). The small amount of cells that were still present, expressed GFP only very 
Control NeuroD1 
O
B
 
R
M
S 
A 
D 
B
E
C
NeuroD1 
RMSSt RMS St
MCL GCL MCLGCL MCLGCL 
* 
Results 
   
104 
weak. In addition, GFP+ cells in the SVZ of control mice were differentiated into 
ependymocytes or Type B neurogenic astrocytes, whereas only ependymocytes were found in 
the respective tissue upon NeuroD1 transfection (data not shown). 
In conclusion, the number of neuronal precursors that reached their final positions in the 
olfactory bulb and differentiated into granule- or periglomerular layer neurons was strongly 
reduced upon expression of NeuroD1. Whereas after 8 days in vivo many of the cells were 
still present, all of them disappeared after 15 days indicating that massive apoptosis occurred 
in this fraction of prematurely and ectopically differentiated cells. 
 
 
Figure 3.35: Analysis NeuroD1 transfected cells after 15 days in vivo 
Fifteen days after electroporation of either a control- or a NeuroD1 expression vector, brains were 
removed and sectioned coronally (n = 10 mice for the control and 10 mice for NeuroD1). Most of the 
only GFP transfected cells were differentiated into granule- or periglomerular neurons after 15 days 
(A). In contrast, nearly no cells were found anymore in NeuroD1 transfected brains (B). The few cells 
that were still present in the olfactory bulb, expressed GFP only very weakly. Scale bar = 50 µm; 
Abbreviations: GCL = granule cell layer; IPL = internal plexiform layer; MCL = mitral cell layer; 
EPL = external plexiform layer; PGL = periglomerular layer 
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4 Discussion 
4.1 The distribution of GABAergic neurons among different brain 
areas 
As a first step towards the molecular analysis of GABAergic neurons, a new method for the 
isolation of these cells was established. The gentle dissociation in combination with the use of 
fluorescently labeled GABAergic neurons derived from the GAD67-GFP mouse strain 
(Tamamaki et al., 2003) allowed for the quantification as well as the isolation of these cells 
by flow cytometry. The quantification of GABAergic neurons resulted mainly in two 
observations. First, the dynamic range of the cell numbers was very high, with about 3% of 
the total cells in the cerebellum and a 20-fold higher number in the olfactory bulb. Second, the 
number of GABAergic neurons in the olfactory bulb was considerably higher than previously 
reported. Kosaka et al. (Kosaka and Kosaka, 2005) concluded from immunohistochemical 
analyses that only 50% of glomerular neurons in the olfactory bulb are GABAergic, pointing 
to an overall lower number of this cell type than observed in the flow cytometric analysis. 
This may be due to the higher sensitivity of FACS in combination with the enrichment of 
GABA at synapses in the cell periphery, leading to low signal intensities of 
immunohistochemical staining in the cell soma. However, the higher number of GABAergic 
neurons that was found here is in agreement with recent data, claiming that almost all 
periglomerular cells are GABAergic (Panzanelli et al., 2007) and do not represent a mixed 
population of either dopaminergic or GABAergic neurons. In addition, also developmental 
differences between neonatal and adult mice should be considered. 
The dynamic range of GABAergic neuron numbers probably reflects the high degree of 
specialization for different brain regions, especially regarding information processing. For 
instance, while the olfactory bulb is mainly responsible for modulation of incoming sensory 
stimuli and replacement of interneurons might be one way to adapt to a continuously 
changing environment, the cerebellum coordinates motor output which depends on a high 
degree of recurring activity patterns. 
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4.2 The general gene expression signature of GABAergic neurons 
Isolation of GABAergic neurons from whole brain tissue as well as distinct brain areas 
allowed molecular analysis of these populations by gene expression profiling. Combination of 
the transcriptomes of GABAergic neurons from whole brain, cortex, olfactory bulb, striatum 
and cerebellum led to the identification of genes that were expressed in all of these 
populations and may therefore represent genes important for GABAergic cell functionality in 
general. Furthermore, some of these candidates may serve as novel marker genes in addition 
to GAD1, GAD2 and VIAAT. 
The transcriptome signature of general GABAergic neurons assembled, as expected, groups 
of over represented genes acting in GABA metabolism and groups of underrepresented genes 
related to non-GABAergic neurons and glia. Among the genes not described so far to be 
overexpressed in GABAergic neurons were mainly RNA processing enzymes, transcription 
factors and genes coding for cytoskeletal proteins. RNA processing enzymes like ADARB1 
and DRADA have been shown to broaden the repertoire of electrophysiological properties by 
editing the mRNA coding for glutamate receptor subunits (Melcher et al., 1996; Mittaz et al., 
1997). It is tempting to speculate that the closely related homologs ADARB2 and TRSPAP1, 
which were overexpressed in GABAergic neurons, fulfill similar functions to yet unknown 
targets, thereby adding a further level of regulation to input signal modulation. Furthermore, 
RNA editing mechanisms have been linked to different neurological diseases including 
Alzheimer's disease, Huntington's disease and schizophrenia (Akbarian et al., 1995) and it 
would be interesting to address their roles in GABA related dysfunctions. 
An interesting observation was the strong expression of genes that are linked to 
developmental processes in GABAergic neurons. For example, the strong presence of SOX7 
and HOXA1, both genes that have multiple functions in brain development, point to a general 
delayed differentiation of GABAergic neurons. Furthermore, MYST4 (Qkf, Querkopf) plays a 
major role in the development of cortical interneurons and adult neurogenesis in the olfactory 
bulb (Merson et al., 2006; Thomas and Voss, 2004). Although there was a peak of expression 
in the olfactory bulb, a universal and strong expression of MYST4 in interneurons from all 
brain areas was observed, suggesting that this gene might be a general marker for developing 
GABAergic neurons. Due to these observations, it might be interesting to test whether 
transgenic expression of MYST4 in embryonic stem- or adult progenitor cells is sufficient to 
drive GABAergic differentiation. This would allow generating a broader spectrum of 
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GABAergic neurons than it has been shown for DLX, which has a restricted expression in the 
developing mouse forebrain. 
 
4.3 The genomic relationship among GABAergic neurons from 
different brain regions 
In addition to the general genomic signature of GABAergic neurons, differences among 
GABAergic neuron subpopulations from distinct brain regions were defined. 
Unsupervised hierarchical clustering of correlation coefficients pointed to a general genomic 
relationship between regionally defined interneurons. Whereas GABAergic neurons from all 
forebrain regions showed a high degree of similarity, major changes were observed when 
comparing forebrain to hindbrain populations. The major differences among fore- and 
hindbrain populations probably reflect their distinct origins that separate these subpopulations 
early during development. Whereas GABAergic neurons of the forebrain are generated 
mainly in the medial and caudal ganglionic eminences, those of the cerebellum originate from 
the ventricular neuroepithelium (Leto et al., 2006; Xu et al., 2004). 
Nevertheless, a subgrouping among the forebrain populations was found, showing more 
differences between olfactory bulb cells to those of the striatum and cortex. This may be due 
to the general aspect that GABAergic neurons in the striatum and cortex are in late or even 
terminal differentiation stages, whereas in the olfactory bulb, the differentiation of these cell 
types from neuronal Type A precursor cells continues throughout live (Lledo et al., 2006). 
 
4.4 Differential gene expression reflected distinct functions of 
GABAergic neurons in specific forebrain regions 
Unsupervised hierarchical clustering of correlation coefficients pointed to a general genomic 
relationship between regionally defined interneurons of the forebrain. However, differences 
between distinct forebrain populations were also evident. As mentioned above, olfactory bulb 
GABAergic neurons were clearly distinct from those of the striatum and cortex, probably 
because the olfactory bulb contains a considerable amount of type A interneuron precursors 
(Lois et al., 1996). Previous studies showed that these precursors already express the here 
used selection marker GAD67 and would therefore be represented in the olfactory bulb 
samples. This immature cell population shows a particular gene expression profile in which, 
for example, gene clusters involved in cell cycle, apoptosis, axon outgrowth or chemotaxis are 
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highly represented (Pennartz et al., 2004). Thus, the obvious differences might be partially 
due to a high degree of immature precursors in the olfactory bulb.  
This view was exemplified by several factors specifically expressed in the olfactory bulb 
fraction. For example, FGF2 plays an important role in maintaining neural stem cells in the 
subventricular zone where the new interneurons destined for the olfactory bulb are generated. 
As a result of decreased neurogenesis in knockout animals, FGF2-/- mice have smaller 
olfactory bulbs (Zheng et al., 2004). Furthermore, the phosphatidylinositol 3-kinase 
regulatory subunit gene PIK3R1 is crucial for neuronal cell proliferation and survival and a 
role of this isoform in neuronal signaling has been suggested (Horsch and Kahn, 1999). 
Concerning recognition cues defining functional differences, strong expression of SLIT1/2 
and ROBO1/2 in the olfactory bulb GABAergic neuron fraction was found. The Slits and 
ROBO1 have been directly implicated in the migration of precursors in the olfactory bulb 
(Chen et al., 2001; Nguyen-Ba-Charvet et al., 2004) as well as in cortical interneuron 
migration (Andrews et al., 2007). The finding of additional strong ROBO2 expression in 
GABAergic neurons suggests that this receptor might also be involved in the guidance of 
postnatally generated interneurons in the forebrain. 
 
In contrast to other forebrain interneurons, striatal GABAergic neurons are projection 
neurons. This was reflected by the finding that a variety of genes that were linked to cellular 
processes like axonogenesis and cytoskeleton control were differentially expressed compared 
to the other brain areas. Genes like CSF1, LAMA1, EDG1, BCL11B, FOXJ1 and TITF1 
might represent regulators important to distinguish between interneuron and projection neuron 
morphologies. Furthermore, the two genes ACE and NOS were found to be enriched, whose 
expression lead to decreased reactivity of GABAergic neurotransmission, thereby modulating 
also specifically the electrophysiological properties of this subpopulation (Frisch et al., 2000; 
Li and Pan, 2005). 
Interestingly, Insulin-like growth factors and interacting partners were found to be over 
represented in the striatum. During brain development, IGFs act as tropic factors and are 
important for development of the nervous system (Naeve et al., 2000). Although IGF2, IGF-
receptors and binding proteins are expressed in the adult CNS, their role in the adult brain is 
less well understood (Dikkes et al., 2007). Notably, while IGF1 is neuroprotective in mouse 
models of Huntington’s disease, several reports have shown that IGF2 may antagonizes 
neuroprotective effects, possibly by displacing it from IGF-binding proteins (Alexi et al., 
1999; Dikkes et al., 2007; Guan et al., 1996). One important yet not fully understood feature 
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of Huntington’s disease is the early loss of GABAergic neurons in the striatum prior to cell 
death in other brain areas. High expression of IGF2 and IGFBP3 especially in striatal 
GABAergic neurons - as observed in this study - may contribute to an increased sensitivity of 
these cells. 
 
4.5 Forebrain and hindbrain GABAergic neurons are generated by 
different transcriptional mechanisms 
Despite the fact that differences between the different forebrain populations could be clearly 
established, GABAergic neurons from these areas were strongly related concerning the 
transcription factors that regulate their generation and identity. This was particularly obvious 
when comparing forebrain interneurons to such isolated from the cerebellum. 
 
Forebrain GABAergic neuron specific transcription factor families could be arranged in three 
groups, one connected to the Distal-less-family (DLX), a second to POU-transcription factors 
and a third linking ETS and FOX family members. DLX-genes are well known regulators of 
GABAergic differentiation with DLX1 and DLX2 in earlier and DLX5 and DLX6 in later 
stages (He et al., 2001). Ectopic expression of DLX2 and DLX5 is sufficient to induce GAD1 
expression and mice lacking DLX1 show subtype specific loss of interneurons, reduced 
inhibition and epilepsy (Cobos et al., 2005b; Stuhmer et al., 2002a; Stuhmer et al., 2002b). In 
addition, transcription of ARX, the vertebrate homolog of aristaless, is regulated by DLX 
(Cobos et al., 2005a) and essential for the correct formation of interneurons in the olfactory 
system (Yoshihara et al., 2005). Finally, mutations of VAX1, as for other DLX family 
members, have been reported to impair forebrain interneuron generation (Taglialatela et al., 
2004). Also members of the other two families are linked to the development of the central 
nervous system (Hoekman et al., 2006; McEvilly et al., 2002; Shah et al., 2006; Wijchers et 
al., 2006). These transcription factor families may therefore regulate the identity and 
differentiation of forebrain specific GABAergic neurons. 
 
In contrast, cerebellar interneuron identity and function appears to be regulated by 
fundamentally different factors. This was exemplified by the observation that none of the 
above forebrain specific factors was expressed or has been shown to be important for the 
generation of hindbrain GABAergic neurons. Instead, Zinc-finger transcription factors like 
ZIC1, ZIC2 and ZIC5 were found to be cerebellum specific. Furthermore, Engrailed2, LHX1 
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and LHX5 were highly over-represented in this brain region. For all of these genes, striking 
and specific cerebellar phenotypes have been observed in the corresponding murine knockout 
models. Mutations in ZIC1 and ZIC2 are responsible for abnormal cerebellar development 
and a targeted deletion of the Engrailed2 gene leads to an altered cerebellar foliation pattern 
(Titomanlio et al., 2005; Wurst et al., 1994). Besides these general cerebellar defects, mice 
lacking the function of LHX1 and LHX5 show a severe and specific reduction in the number 
of Purkinje cells (Zhao et al., 2007). These genes may extend the knowledge about candidates 
important for differentiation of cerebellar GABAergic neurons, which is very limited so far to 
a few genes like PTF1A. PTF1A is highly expressed in a subpopulation of cerebellar 
ventricular zone precursors at embryonic stages E12 to E14 and specifically drives 
GABAergic over glutamatergic granule cell differentiation in the cerebellum (Hoshino et al., 
2005; Pascual et al., 2007). 
Also differences in the physiological function of GABAergic neurons among fore- and 
hindbrain populations were defined by several enriched candidates. One example was the 
strong presence of factors associated with the SST pathway. SST modulates GABA-signaling 
and a differential expression of its receptors during cerebellar development has been reported 
in rats (Bossy-Wetzel et al., 2004b; Viollet et al., 1997). Furthermore, differential expression 
of the potassium inwardly-rectifying channel KCNJ6 might characterize the specific 
electrophysiological features of these cells. 
 
4.6 Candidates that may serve as surface markers for GABAergic 
neurons 
To overcome the need of mouse strains with genetically labeled GABAergic neurons and 
maybe allow the purification of further subpopulations of these cells, new surface markers 
have to be identified. This would enable direct labeling of intact GABAergic neurons 
followed by magnetic or flow cytometric isolation protocols. 
Many genes had been identified to be highly and specifically expressed in GABAergic 
neurons by gene expression profiling. However, only very few of these candidates were 
localized in the plasma membrane and could serve as cell surface markers for the isolation of 
GABAergic neurons. Only one of these, CD72, was identified for which an antibody specific 
for an extracellular epitope was available. The strong and specific expression of CD72 in 
GABAergic neurons, as identified by microarrays, was validated by in situ hybridization 
using postnatal day 1 as well as adult mice. Subsequently, a monoclonal antibody was used to 
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stain cells dissociated from GAD67-GFP mice to check for protein expression on GABAergic 
neurons. Unfortunately, no staining was observed on any brain cell (data not shown). There 
are several possible reasons for this observation. First, the protein can be sensitive to protease 
digestion. However, even with very low protease concentrations (either 10 min incubation in 
0.5 U/ml Papain or 0.1% Trypsin), no staining was observed. Second, post-translational 
protein modifications, like glycosylations, may differ among distinct tissues. As the antibody 
was generated to recognize the CD72 protein on hematopoietic cells, it may not bind 
differently modified forms in the brain. And third, due to post-transcriptional regulation, the 
protein level may be too low for an antibody staining, although the mRNA level was rather 
high. 
A parallel approach to the molecular identification of novel markers was to use purified 
GABAergic neurons directly as immunogenic material in order to generate antibodies specific 
for so far unknown surface markers of these cells. Unfortunately, ten different immunization 
approaches did not lead to the generation of a single specific antibody. One reason could be 
that GABAergic neurons do not express surface proteins which are exclusively expressed by 
these cells but also on other populations of brain cells. To overcome this problem, 
recombinant GFP protein was used as decoy instead of GFP- cells in several approaches, so 
that only the anti-GFP reactivity but not that for other proteins was directed to the 
contralateral lymph node. However, by using this strategy, again no specific antibody was 
identified. Furthermore, even the use of PHA-L as adjuvant did not result in a larger size of 
the target lymph nodes that were very small compared to the decoy lymph nodes. Therefore, 
the most likely explanation is that GABAergic neurons do not express highly immunogenic 
epitopes on their surface, or at least that these targets are highly sensitive to the obligatory 
protease treatment. The use of CpG as a more potent adjuvant increased the general efficiency 
but not the specificity of the immune response. 
As an alternative to this approach, a newly established protocol for the direct identification of 
cell surface glycoproteins by tandem mass spectrometry was used (Zhang et al., 2003). 
Thereby, novel surface markers can be identified directly on the protein level and therefore 
also overcome the mentioned problem of post-transcriptional regulation. A group of proteins 
was identified in the GFP+ but not the GFP- fraction of cells isolated from GAD67-GFP mice. 
Most of these candidates were indeed known to be localized in the membrane fraction. 
Several identified proteins were also enriched in GABAergic neurons on the transcriptome 
level as found by the gene expression analysis. Other candidates, as expected, did not 
correlate with the transcriptome data. This can be explained by post-transcriptional regulation 
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and protein stability. In conclusion, several proteins were identified that are probably 
expressed on the surface of GABAergic neurons and can serve as targets for a directed 
generation of monoclonal antibodies. Furthermore, an analysis of the specific function for 
these candidates on GABAergic neurons may provide new insights for the understanding of 
this cell population. In addition, the proteins which were found only in the GFP- fraction 
might represent novel surface markers specific for other populations of brain cells. Therefore, 
they may be used either for the purification or the depletion of the respective cells. 
 
4.7 Isolation and molecular analysis of olfactory bulb interneurons 
and their progenitors 
In an additional approach, the differentiation of periglomerular layer interneurons was 
analyzed as it represents an appropriate and accessible model system for the generation of 
GABAergic as well as dopaminergic neurons. Like for the analysis of GABAergic neuron 
subtypes from distinct brain regions, a method for the isolation of the respective cell 
populations was established. In this case, the use of GFP-fluorescence in cells from the 
GAD67-GFP mouse strain as a marker was not possible, because GFP is also expressed in 
progenitor cells and distinct differentiation states can not be distinguished. However, the 
combination of reducing the starting population complexity by microdissection and a two step 
magnetic cell sorting approach based on the surface markers A2B5 and PSA-NCAM, allowed 
for the purification of early Type A neuronal precursors from the SVZ as well as late 
precursors and mature interneurons from the periglomerular layer. The purified populations 
were analyzed by whole genome gene expression profiling. 
Unsupervised hierarchical clustering of correlation coefficients was used again to define a 
general genomic relationship between the respective cell populations. Both cell types isolated 
from the periglomerular layer grouped closely together but displayed major differences 
compared to early Type A neuronal precursors. This indicates that the major changes during 
the development of olfactory bulb GABAergic interneurons occur during the migration of 
Type A precursor cells from the SVZ to the olfactory bulb, whereas only minor changes occur 
during the late step of differentiation in the periglomerular layer. In addition, the genomic 
relationship as well as a multiclass SAM analysis resulted in a molecular validation of the 
proposed model in which PSA+ periglomerular layer precursors represent an intermediate 
state between SVZ Type A precursors and PSA- periglomerular layer interneurons. 
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4.8 Genes important for early differentiation states of olfactory bulb 
interneurons 
Several genes were found to be strongly upregulated in both periglomerular cell types 
compared to their SVZ progenitors and may therefore represent candidates important for early 
steps during the generation GABAergic interneurons. 
Whereas known marker genes of neuronal precursors, like DCX and TUBB3 were 
downregulated, genes that were known before to be expressed in mature GABAergic neurons, 
like CALB1, CALR and NPY were upregulated (Kanatani et al., 2000; Rohner-Jeanrenaud et 
al., 1996). Also the upregulated gene PTN is linked to neuronal differentiation and neurite 
outgrowth (Carvalho, 2003). Furthermore, PTN as well as APOE, APOD, FBLN2, S100A1 
and S100A13 have important functions in neuronal synaptic plasticity, calcium signaling and 
calcium homeostasis (Hartmann et al., 1994; Okazaki et al., 2002). In addition, NRXN1, 
which interacts with the also enriched NLGN2, influences synaptic transmission by regulating 
calcium channels (Comoletti et al., 2003; Missler et al., 2003), whereas VTN can selectively 
regulate the inactivating potassium current (Vasilyev and Barish, 2003). Interestingly, 
NLGN2 was shown to be specific for inhibitory synapses (Varoqueaux et al., 2004), which 
matches with the observation that it is upregulated during differentiation. The enriched gene 
NOTCH1 is also involved in synaptogenesis by decreasing the number of dendrites but 
increasing the number of inhibitory synapses (Salama-Cohen et al., 2006). FABP7, a Notch 
target gene in the central nervous system, was also upregulated (Anthony et al., 2005). In 
summary, many candidates were identified that may play important roles during the 
regulation of synaptic plasticity in olfactory bulb interneurons. 
In addition, an enrichment of further genes connected to neuronal differentiation was 
observed. EphrinA5, Semaphorin4A, Vimentin and CSPG3 act as axon guidance and cell 
motility factors (Lampa et al., 2004; Li et al., 2005; Menet et al., 2003; Moretti et al., 2006). 
Interestingly, it was shown that EphrinA5 expression is modulated by expression of different 
odorant receptors (Cutforth et al., 2003). For SEPT4, a gene of the cytoskeleton, a role in the 
development of neurons was already published (Takahashi et al., 2003). However, it was not 
connected to this system so far, whereas the enriched prion protein was already suggested to 
act during adult neurogenesis (Steele et al., 2006). The glutamate receptors GRIK1 and 
GRINL1A, CALB1, CALR, GLUD, SLC13A3, MT2 and DBI correlated with an increased 
state of differentiation in periglomerular layer cells (Pajor et al., 2001; Stankovic, 2005). Mice 
deficient for TNC show a delayed onset of odor detection, showing that a functional relevance 
for at least several of the identified candidates can be expected (de Chevigny et al., 2006). 
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The upregulation of extracellular matrix components like MATN2, FBLN2, TNC, PTN, VTN 
and CSPG3 by periglomerular layer precursors and interneurons suggests an intrinsic role of 
these cells in building up the neurogenic environment of the olfactory bulb (Mates et al., 
2002). Furthermore, the high expression of APOE may be involved directly in the change 
from tangential chain- to radial individual migration of neuronal precursors upon arrival in the 
olfactory bulb. The apolipoprotein-E receptor 2 as well as its downstream signaling target, the 
adaptor protein disabled-1 is present in the migrating cells and Reelin acts as a detachment 
signal by activating this cascade (Ghashghaei et al., 2007; Hack et al., 2002). It is possible, 
that the high expression of APOE acts as an autocrine signal to enhance this process. 
As shown for GABAergic neurons from other brain areas, also targets of the WNT signaling 
pathway, like APCDD1 (Jukkola et al., 2004) as well as IGF1 were enriched. A number of 
transcription factors like OLIG1, XBP1, NFI/A, ZFP277, ZMYND11, GTF2B and E4F1 were 
strongly upregulated. Several of them, like Nuclear Factor I/A, are already known to be 
involved in neuronal development (Shu et al., 2003; Wang et al., 2004). However, the 
specific role of these genes during adult neurogenesis still has to be investigated. 
 
4.9 Genes important for late differentiation states of olfactory bulb 
interneurons 
Although a high correlation coefficient of 0.97 between periglomerular layer precursors and 
interneurons indicated a high similarity of these cell types, several candidates were identified 
that were significantly regulated and may therefore be important for this final step of 
differentiation. About three times more genes were strongly upregulated than downregulated, 
indicating that this step is mainly controlled by increasing gene expression of differentiation 
correlated genes. 
Like for the results concerning periglomerular layer- against Type A cells, genes with 
functions in mature neurons, like GAD2, SST and NRXN, were identified to be upregulated 
in the PSA- fraction, whereas markers of neuronal progenitor cells, like TUBB3, Nestin and 
DCX, were further downregulated, correlating with an increased degree of differentiation. 
An upregulation of NPY during the migration of Type A neuronal precursors from the SVZ to 
the olfactory bulb was described above. In the downstream transition from PSA+ to PSA- 
periglomerular layer cells, upregulation of GPR103, an NPY receptor connected to the 
metabolic syndrome (Takayasu et al., 2006), was found. This indicates the existence of an 
autocrine NPY signaling pathway in these cells. 
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Several genes that are important for vesicular and neurotransmitter transport, like STX3, 
STX6, SYT4 and SLC1A1 (Ferguson et al., 2004a; Ferguson et al., 2004b), became 
upregulated in mature interneurons. SLC1A1 is known to be expressed on GABAergic 
neurons, where it provides glutamate as a precursor for GABA synthesis (Palmada and 
Centelles, 1998). 
A large group of genes connected to the cytoskeleton, important for neurite outgrowth, 
morphology and positioning, was differently expressed. Regulators of the cytoskeleton like 
KTN1 as well as NTRK3, C130076O07Rik, TBCE, BC050903 (DCAMKL1) and Ablim1 
were upregulated, which are known to be involved in axon outgrowth and guidance (Bommel 
et al., 2002; Deuel et al., 2006; Erkman et al., 2000; Martin et al., 2002). Also the 
neurotrophic tyrosine kinase NTRK3, which plays a role in axon extension (Stenqvist et al., 
2005), was enriched, as was the receptor tyrosine kinase substrate SPRED1, of which a 
function in the brain was suggested (Engelhardt et al., 2004). In contrast, CRMP1, MAPT, 
KIF5A, TUBB3 and EPB4.2 were examples of downregulated genes connected to the 
cytoskeletal control (Bretin et al., 2005; Kanai et al., 2000; Yamashita et al., 2006). Many of 
the upregulated genes in this group are involved in neurite outgrowth, which is important for 
new interneurons finding their neuronal circuit. In contrast, the downregulated genes mainly 
function in the general migration of cells, important during earlier steps. Together, the 
regulation and interaction of these genes may regulate the final positioning, morphological 
changes and axonal innervations during the differentiation of periglomerular layer 
interneurons. 
Furthermore, a number of transcription factors with expression differences among these 
populations were identified. Transcription factors like BHLHB9, PAX6 and PAX8, OBOX2 
and 3, PMS1, SFPI1, GABPB1, MTF1, ZHX3, and ISL2, were enriched in mature 
interneurons. In contrast, transcription factors like PNMA1, SOX30, ZFP219, and NFKBIE 
were downregulated in PSA- interneurons. These genes are therefore likely to be involved in 
the specification of inhibitory interneurons. Interestingly, an oppositional regulation of the 
homeobox transcription factors DLX1 and DLX2 was observed. Whereas DLX2 was enriched 
in PSA- interneurons, DLX1 was enriched in PSA+ precursors. In contrast, DLX5 and 6 were 
already downregulated in both periglomerular layer populations compared to Type A 
precursors. This suggests that DLX genes are important for the early as well as the late 
differentiation of olfactory bulb interneurons. In combination with the results that members of 
the DLX family were enriched in all GABAergic neuron populations of the forebrain, a 
general function of these genes for GABAergic differentiation from embryonic to adult stages 
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can be suggested, which is in concordance to published data (Brill et al., 2008; He et al., 
2001). In addition, an oppositional regulation of the basic helix-loop-helix transcription 
factors ND1 (NeuroD1) and ND2 (NeuroD2) was observed. Whereas NeuroD1 became 
highly upregulated in mature interneurons, NeuroD2 was downregulated. In addition, also 
PAX6, a target gene of NeuroD1 (Marsich et al., 2003) was upregulated upon differentiation. 
NeuroD1 as well as NeuroD2 are already known to be important factors in the development of 
the nervous system, but in contrast to the DLX genes, nothing was known about their function 
during the generation of inhibitory interneurons so far (Cho and Tsai, 2004; Noda et al., 
2006). As the regulation of these two candidates suggests a function during the differentiation 
of olfactory bulb interneurons, they were chosen for a further analysis in order to test their 
functional relevance in vivo. 
 
4.10 Overexpression of NeuroD2 interfered with the migration and 
differentiation of neuronal precursors in vivo 
The NeuroD2 expression was downregulated during differentiation of periglomerular 
interneurons. This suggested the importance of this transcription factor during an early state in 
the development of olfactory bulb interneurons. Also previous published results concerning 
NeuroD2 indicate an early function of this transcription factor during neurogenesis, important 
especially for an initial neurogenic fate decision (Lin et al., 2004). In concordance, after 
overexpression of NeuroD2 in mouse embryonic stem cells, N1E-115 neuroblastoma cells, or 
P19 embryonal carcinoma cells, neuronal differentiation is observed (Farah et al., 2000; 
Kanda et al., 2004; Mie et al., 2003). Furthermore, as a lack of NeuroD2 expression results in 
Congenital hypothyroidism (cretinism) in mice (Lin et al., 2006), the understanding of its 
function during neurogenesis is of broad interest for the development of novel therapies. The 
question was, if NeuroD2 is downregulated only as a downstream result of an increasing 
differentiation state, or if this downregulation is necessary to allow further differentiation. To 
address this question, NeuroD2 overexpression was induced in radial glia, neuronal precursors 
and mature neurons of the olfactory system by in vivo electroporation. 
After overexpression of NeuroD2 for 2 days in vivo, no significant different phenotype 
compared to the control condition was observed. In conclusion, a strong expression of this 
gene neither affects the stem cell properties of radial glia, nor impairs the behavior of Type C 
or early Type A progenitors regarding their cell morphology or division rate. 
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In contrast, 4 days after electroporation, a strongly altered phenotype was observed. Whereas 
in the control most of the electroporated cells were Type A neuronal precursors localized in 
anterior parts of the RMS or even arrived in the olfactory bulb, NeuroD2 overexpressing cells 
showed an overall more caudal localization. The majority of cells were still localized in the 
SVZ but showed normal bipolar morphology. This indicates that an expression of NeuroD2 
above normal wild type levels decelerates or even impairs the migration of Type A neuronal 
precursor cells from the SVZ to the olfactory bulb. However, it has to be shown if the time the 
cells need to change from a non-migratory phenotype inside the SVZ into a migratory 
phenotype and enter the RMS is prolonged, or if the general speed of migration inside the 
RMS is altered. The first hypothesis seems to be more probable from the overall distribution 
of the cells as well as their intact morphology and orientation. However, an overall decreased 
migratory speed should be visible by in vitro migration assays. 
In addition, the molecular mechanisms underlying this phenotype still have to be evaluated. 
The mechanisms allowing high migration speeds of up to 120 µm/h, as observed in wild type 
Type A cells, are poorly understood (Alvarez-Buylla and Garcia-Verdugo, 2002; Wichterle et 
al., 1997). One possibility is that NeuroD2 directly or indirectly interferes with the expression 
of genes important for correct migration. Possible targets would be genes regulating 
microtubule polymerization and depolymerization, like the microtubule associated protein 
Doublecortin (Gleeson et al., 1999). Doublecortin mutations do not affect the direction of 
migration but can reduce its velocity (Kappeler et al., 2006; Koizumi et al., 2006a; Koizumi 
et al., 2006b). Other targets could be related cell surface adhesion- and chemotaxis signaling 
molecules. Besides PSA-NCAM (Cremer et al., 1994), further candidates are α6β1 integrin 
that appears to be necessary for chain migration of Type A cells (Jacques et al., 1998) or the 
Eph tyrosine kinase receptors EPHA4 and EPHB1-3, which are important for neuroblast 
migration (Conover et al., 2000). On the other hand, NeuroD2 overexpression may result in a 
negative regulation of genes important for the onset of migration. This initiation is regulated 
by chemoattractive as well as chemorepulsive signals (Ghashghaei et al., 2007). However, as 
the existence of an olfactory bulb is not essential for correct migration of Type A precursors 
(Kirschenbaum et al., 1999), it seems that chemorepulsion is the main force to direct 
migration. Chemorepulsion mediated by Slit-Robo signaling may be involved in the migration 
of young neurons in the RMS (Hu, 1999; Wu et al., 1999) and an overexpression of NeuroD2 
probably extends the time until this pathway is activated. Additionally, interfering with 
chemoattraction signals mediated by DCC/Netrin signaling (Mason et al., 2001; Murase and 
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Horwitz, 2002) may lead to comparable results. The interaction of NeuroD2 with these 
candidates will be analyzed in further studies. 
A deceleration instead of a complete migratory block is also in agreement with the 
observation that after 15 days the precursors finally arrived in the olfactory bulb. In the 
control condition, most electroporated cells were differentiated into granule- or 
periglomerular layer interneurons after this time period. In contrast, a significantly higher 
amount of cells overexpressing NeuroD2 were still localized in the core of the olfactory bulb 
and showed a bipolar precursor like morphology. The most prominent effect was observed for 
periglomerular layer interneurons. Besides the strongly decreased amount of this cell type, 
their morphology was altered in the way that the number of neurite branches and synaptic 
connections was significantly reduced suggesting an immature state. Similar effects were 
observed during cortical development, where NeuroD2 was shown to regulate synaptic 
maturation of thalamocortical connections (Ince-Dunn et al., 2006). Experiments with 
extended time periods are required to show if these effects originate from decelerated 
migration inducing prolonged differentiation, or if the maintained expression of NeuroD2 
completely inhibits this process. This may be the case if NeuroD2 is a repressor of factors 
essential for final differentiation, like proteins involved in the regulation of the cytoskeleton, 
cell-cell contacts or synaptic maturation. A further goal would be the identification of the 
downstream target genes mediating these effects. 
In conclusion, NeuroD2 represents a novel key regulator involved in the control of olfactory 
bulb interneuron generation and its downregulation is essential for normal differentiation. 
 
4.11 Overexpression of NeuroD1 induced highly specific a 
premature and ectopic dopaminergic differentiation in vivo 
In contrast to NeuroD2, the expression of NeuroD1 was upregulated during the final 
differentiation of periglomerular layer precursors into mature interneurons. This suggested an 
importance of this transcription factor during the late state of olfactory bulb interneuron 
development, which is in agreement with published data from other systems. Mice lacking 
NeuroD1 show a malformation of the dentate gyrus, the cerebellum and develop epilepsy (Liu 
et al., 2000b; Miyata et al., 1999). Interestingly, the granule cells of the dentate gyrus in these 
mice are normally generated but fail to mature (Schwab et al., 2000). The function of 
NeuroD1 for the final step of differentiation in this system is supported by the here presented 
observation of an upregulation in a late state of development. Notably, granule cells of the 
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dentate gyrus and cerebellum are, like periglomerular interneurons, postnatally generated 
microneurons, suggesting a general role for NeuroD1 during postnatal differentiation. In 
addition, NeuroD1 mutant mice show a severe reduction of sensory neurons in the cochlear-
vestibular ganglion important for vestibular and auditory systems (Kim et al., 2001; Liu et al., 
2000a) and also the terminal differentiation of photoreceptors is dependent on its expression 
(Pennesi et al., 2003). The consequential question was again, if the upregulation of NeuroD1 
is only a marker of an increasing differentiation state, or if this upregulation is essential or 
even sufficient to drive final differentiation. Therefore, the effects upon ectopic expression of 
NeuroD1 were analyzed by in vivo electroporation. 
Overexpression of NeuroD1 for two days resulted in an efficient and specific depletion of 
radial glia. This indicates that an expression of NeuroD1 is not consistent with stem cell 
maintenance. A possible explanation is that NeuroD1 either activates genes responsible for 
the transition of radial glia into progenitor cells or represses factors important for a stem cell 
status. Usually, radial glia undergo asymmetrical divisions resulting in one precursor and one 
radial glia cell (Merkle and Alvarez-Buylla, 2006). Perhaps a NeuroD1 mediated impairment 
of initiating the correct asymmetry results in a prematurely conversion of radial glia into 
precursor cells. Further studies will focus on the identification of target genes mediating this 
phenotype. 
A dramatic phenotype appeared upon overexpression of NeuroD1 for 4 days. In the control 
condition, the majority of cells were bipolar Type A neuronal precursors in the RMS at this 
time point. In contrast, cells expressing NeuroD1, especially the cells with high 
electroporation efficiencies, were localized at ectopic positions and showed a multipolar, 
interneuron-like morphology. Comparable morphologies were found in the control first after 
approximately 15 days. This indicates a dose dependent effect of NeuroD1 for the regulation 
of the cellular differentiation state. Besides the induced morphological differentiation, also the 
expression of known differentiation marker genes was altered. Cells expressing NeuroD1 
downregulated the expression of precursor markers like DCX and PSA-NCAM. As PSA-
NCAM is important for the regulation of cell adhesion in the RMS (Chazal et al., 2000; Ono 
et al., 1994), its downregulation may represent an initial reason for the ectopic localization of 
many cells. Probably, after downregulation of PSA-NCAM the cells are displaced by the 
migratory population. A possible changed expression of other cell adhesion- and chemotaxis 
signaling molecules towards a more mature composition could also lead to an active 
innervation of the striatum as it represents the nearest niche for mature neurons. In 
concordance to the downregulation of progenitor marker genes, expression of NeuN, a 
Discussion 
   
120 
frequently used marker of differentiated neurons, was induced. As the morphology of 
ectopically localized cells inside the striatum was still interneuron-like, a significant part of 
the final cellular morphology seems to be regulated intrinsically rather than dependent on 
extracellular cues. Strikingly, an examination of the neurotransmitter phenotype resulted in 
the observation of a highly specific differentiation towards a dopaminergic fate. In the control 
condition, expression from the TH-promotor, a specific marker for dopaminergic cells, is 
activated only in the anterior RMS and mature dopaminergic neurons are exclusively found in 
the granule and periglomerular layers of the olfactory bulb (Saino-Saito et al., 2004; 
Sawamoto et al., 2001). The observation of an ectopic and premature differentiation towards a 
dopaminergic fate inside the striatum, SVZ and RMS suggests that NeuroD1 is a key 
regulator for the specification of this olfactory bulb interneuron subtype. Interestingly, the 
PAX6 gene, which was also found to be enriched in mature interneurons, is activated by 
NeuroD1 (Marsich et al., 2003). It was shown that precursors deficient for PAX6 can not 
differentiate into dopaminergic neurons anymore (Hack et al., 2005; Kohwi et al., 2005). This 
suggests that NeuroD1 is a novel regulator for dopaminergic differentiation which is mediated 
by the activation of PAX6. In addition, as PAX6 was shown to be essential for this step, it is 
likely that also the expression of NeuroD1 is not only sufficient but furthermore essential for 
a dopaminergic fate decision. However, an inhibition of NeuroD1 expression is necessary to 
finally proof this hypothesis. A recent study claims further that a direct interaction between 
DLX2 and PAX6 is important for dopaminergic differentiation (Brill et al., 2008). The 
overexpression of PAX6 and DLX2 by in vivo electroporation may answer the question, if 
there are additional genes involved in this cascade and if their expression is also sufficient to 
induce ectopic and premature dopaminergic differentiation. 
After an extended period of time, the cells that were electroporated with NeuroD1 
disappeared. Whereas after 8 days cells with neuronal morphology inside the striatum and the 
RMS were still visible, none of these cells were found after 15 days, indicating that this 
population was removed, most probably by apoptosis. About 50% of the newly generated 
cells, especially those which do not differentiate properly, are removed by programmed cell 
death also under wild type condition (Kim et al., 2007; Lemasson et al., 2005). It is widely 
accepted that neuronal survival is strictly dependent on extracellular signals, like neurotrophin 
signaling and correct synaptical activity (Lipsky and Marini, 2007). The premature and 
ectopic differentiation of neuronal precursors upon NeuroD1 expression impairs their correct 
positioning as well as circuit establishment. This probably results in the displacement from 
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correct survival factors resulting in extensive anoikis. Further experiments will define the 
exact time window and perhaps the involved signaling cascades of induced cell death. 
The observed effects seem to be specific for this system, as preliminary experiments showed 
no effect of NeuroD1 overexpression in cortical projection neuron precursors (data not 
shown). This may be due to an already fixed developmental fate of these cells. However, it 
was shown that PAX6 is essential for the generation of glutamatergic neurons during cortical 
development (Heins et al., 2002; Kroll and O'Leary, 2005; Nikoletopoulou et al., 2007; 
Stoykova et al., 1996). As NeuroD1 activates PAX6 (Marsich et al., 2003), its role may be 
changed in this system because of altered functions for such downstream effectors. Another 
point could be that the progenitor population is not competent to respond to NeuroD1 
expression in this case, for example due to missing additional cofactors which still have to be 
identified. 
In summary, an early overexpression of NeuroD1 is not compatible with the stem cell status 
of radial glia cells. Furthermore, NeuroD1 can induce the premature and ectopic 
differentiation of neuronal precursors in the striatum, RMS and SVZ towards a dopaminergic 
neurotransmitter phenotype. This effect seems to be dose dependent. 
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5 Conclusion and Outlook 
In the first part of this work, a molecular analysis of regionally defined GABAergic neurons 
was carried out. This analysis was based on the establishment of a protocol for the isolation of 
highly pure GABAergic neuron populations from distinct brain areas. Potential new marker 
genes for GABAergic neurons and factors probably important for their differentiation and 
general functionality were determined. Furthermore, genes characteristic for regionally 
defined populations of GABAergic neurons were identified, reflecting region specific 
functionality and pointing to different developmental pathways generating fore- and hindbrain 
subpopulations. These genes build a molecular basis for a detailed understanding of 
morphological, physiological and developmental differences among these cells and can be 
used, for example, to generate region-specific knockout mice using the Cre/loxP-system. 
Furthermore, putative cell surface markers specific for GABAergic neurons were identified 
by defining the cell surface proteome. These candidates allow for the targeted generation of 
antibodies that would enable new possibilities to purify GABAergic neurons or even 
subpopulations of these cells. 
In summary, this study led to the identification of new candidate genes that will be 
characterized in future analysis to increase our understanding of the genesis and function of 
GABAergic neurons and associated diseases. 
 
In the second part of this work, a specific molecular analysis of interneuron differentiation 
was carried out. The isolation and characterization of mature olfactory bulb interneurons as 
well as their progenitor cells allowed for the identification of genes involved in the regulation 
of this differentiation process. Two of these candidates, NeuroD1 and NeuroD2, were 
analyzed for their functional relevance in vivo. 
The overexpression of NeuroD2 decelerated or even impaired the migration and 
differentiation of neuronal precursor cells. Therefore, NeuroD2 represents a novel key 
regulator involved in the control of olfactory bulb interneuron generation probably via 
maintaining the precursor state. Further experiments have to identify target genes of NeuroD2 
and clarify the basal mechanisms underlying these effects. Migration assays after the 
overexpression or knock down of NeuroD2 in vitro and in vivo, for example by shRNA, 
probably will increase our understanding concerning these points. 
In contrast, the overexpression of NeuroD1 is sufficient to induce the premature and ectopic 
differentiation of neuronal precursors in the striatum, RMS and SVZ towards a dopaminergic 
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neurotransmitter phenotype. Subsequent experiments will show, if NeuroD1 is also essential 
or if there is a redundancy in this system. Therefore, the knockdown of NeuroD1 expression 
by shRNA or the complete knock out by electroporation of a Cre-expression construct in 
conditionally targeted mice will be done in the near future. It would be also interesting to 
investigate a possible interaction between NeuroD1 and NeuroD2, for example a dependent 
cross regulation and to identify novel target genes as well as interacting partners of NeuroD1. 
As the SVZ represents a major source for adult stem cells in the brain, its targeted modulation 
has a huge potential for intrinsic repair approaches upon neurodegeneration. In addition, it 
will be addressed, if the expression of NeuroD1 alone or in combination with additional 
factors can induce dopaminergic differentiation in embryonic stem- or induced pluripotent 
stem cells. Grafting of such cells into the striatum of Parkinson’s disease model mice would 
represent the first step towards a therapeutic application. However, further molecular and 
electrophysiological characterization of these cells need to be done prior to downstream 
applications. 
This study yielded new insights on the regulation of adult neurogenesis. As the SVZ is 
affected by multiple neurodegenerative diseases, like Huntington’s-, Parkinson’s- and 
Alzheimer’s disease, understanding the underlying mechanisms is essential for the 
development of novel cell- or drug based therapeutic approaches. 
 
Appendix 
   
124 
6 Appendix 
6.1 Sequences of NeuroD1 and NeuroD2 
 
Protein Sequence of NeuroD1 (single letter amino acid code): 
        10         20         30         40         50         60  
MTKSYSESGL MGEPQPQGPP SWTDECLSSQ DEEHEADKKE DELEAMNAEE DSLRNGGEEE  
 
        70         80         90        100        110        120  
EEDEDLEEEE EEEEEEEDQK PKRRGPKKKK MTKARLERFK LRRMKANARE RNRMHGLNAA  
 
       130        140        150        160        170        180  
LDNLRKVVPC YSKTQKLSKI ETLRLAKNYI WALSEILRSG KSPDLVSFVQ TLCKGLSQPT  
 
       190        200        210        220        230        240  
TNLVAGCLQL NPRTFLPEQN PDMPPHLPTA SASFPVHPYS YQSPGLPSPP YGTMDSSHVF  
 
       250        260        270        280        290        300  
HVKPPPHAYS AALEPFFESP LTDCTSPSFD GPLSPPLSIN GNFSFKHEPS AEFEKNYAFT  
 
       310        320        330        340        350  
MHYPAATLAG PQSHGSIFSS GAAAPRCEIP IDNIMSFDSH SHHERVMSAQ LNAIFHD 
 
 
Protein Sequence of NeuroD2 (single letter amino acid code): 
        10         20         30         40         50         60  
MLTRLFSEPG LLSDVPKFAS WGDGDDDEPR SDKGDAPPQP PPAPGSGAPG PARAAKPVSL  
 
        70         80         90        100        110        120  
RGGEEIPEPT LAEVKEEGEL GGEEEEEEEE EEGLDEAEGE RPKKRGPKKR KMTKARLERS  
 
       130        140        150        160        170        180  
KLRRQKANAR ERNRMHDLNA ALDNLRKVVP CYSKTQKLSK IETLRLAKNY IWALSEILRS  
 
       190        200        210        220        230        240  
GKRPDLVSYV QTLCKGLSQP TTNLVAGCLQ LNSRNFLTEQ GADGAGRFHG SGGPFAMHPY  
 
       250        260        270        280        290        300  
PYPCSRLAGA QCQAAGGLGG GAAHALRTHG YCAAYETLYA AAGGGGASPD YNSSEYEGPL  
 
       310        320        330        340        350        360  
SPPLCLNGNF SLKQDSSPDH EKSYHYSMHY SALPGSRPTG HGLVFGSSAV RGGVHSENLL  
 
       370        380  
SYDMHLHHDR GPMYEELNAF FHN 
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6.2 Tables of genes strongly regulated during olfactory bulb 
interneuron differentiation 
 
Table 6.1: Genes upregulated during the differentiation of Type A progenitor cells into 
periglomerular layer precursors and interneurons 
          
Symbol Gene Name GeneBank Ratio p-Value 
          
     
Slc1a3 solute carrier family 1, member 3 NM_148938 159,9 0 
X66118 glutamate receptor subunit GluR5-2c X66118 155,3 0 
Fabp7 fatty acid binding protein 7, brain NM_021272 153,2 0 
AK122233 mRNA for mKIAA0275 protein AK122233 150,9 0 
1810029G24Rik RIKEN cDNA 1810029G24 gene NM_025468 150,8 0 
Aqp1 aquaporin 1 NM_007472 134,5 9,49675E-24 
Phlda1 pleckstrin homology-like domain, family A, member 1 NM_009344 127,7 0 
Sep15 selenoprotein 15 NM_053102 118,1 0 
M10466 mouse alpha-globin mRNA M10466 116,8 0 
Nr2f1 nuclear receptor subfamily 2, group F, member 1 NM_010151 115,0 0 
Hba-a1 hemoglobin alpha, adult chain 1 NM_008218 111,3 0 
D12Ertd553e DNA segment, Chr 12, ERATO Doi 553 NM_029758 109,9 0 
2610205H19Rik RIKEN cDNA 2610205H19 gene NM_027430 98,3 0 
Sepp1 selenoprotein P, plasma, 1 NM_009155 92,3 0 
Olfr807 olfactory receptor 807 NM_146929 90,6 9E-05 
mt-Cytb subunit I of cytochrome c oxidase X57780 87,8 0 
Fmo1 flavin containing monooxygenase 1 NM_010231 85,9 1,58318E-15 
Zcchc2 zinc finger, CCHC domain containing 2 BC055760 81,4 0 
Tm4sf2 transmembrane 4 superfamily member 2 NM_019634 79,6 0 
Srcasm similar to adaptor molecule srcasm AK033712 78,8 0 
Vtn vitronectin NM_011707 75,7 3,65607E-36 
Prkar1a protein kinase, cAMP dependent regulatory, type I, alpha NM_021880 74,2 0 
Scrn1 mRNA for mKIAA0193 protein AK129084 73,8 4,47174E-30 
BF142805 601790552F1 NCI_CGAP_Lu30 cDNA clone IMAGE:4021285 5' BF142805 73,1 0 
Grik1 glutamate receptor, ionotropic, kainate 1 NM_146072 72,8 3,05391E-26 
AF378830 cytochrome c oxidase subunit II AF378830 69,9 0 
Npy neuropeptide Y NM_023456 69,8 0 
Tkt transketolase NM_009388 67,5 0 
Eps15 epidermal growth factor receptor pathway substrate 15 BC048783 66,0 0 
2010012C16Rik RIKEN cDNA 2010012C16 gene NM_025564 64,1 1,96883E-43 
BY592157 BY592157 RIKEN full-length enriched BY592157 63,8 3,62395E-18 
TC1323472 Q86ZH4 probable centromere/microtubule binding protein CBF5 TC1323472 62,4 2,48733E-07 
Ctsl cathepsin L NM_009984 62,3 0 
TC1367583 Cytochrome b (Fragment) TC1367583 62,1 0 
BC055791 cDNA clone MGC:67622 IMAGE:6410794 BC055791 61,9 0 
Rpl26 ribosomal protein L26 NM_009080 58,2 0 
Ptn pleiotrophin NM_008973 58,1 0 
Slc16a6 similar to monocarboxylate transporter 7 AK032026 57,0 0 
1700019B16Rik RIKEN cDNA 1700019B16 gene NM_028829 56,4 0 
Rps26 ribosomal protein S26 NM_013765 55,9 0 
Sc4mol sterol-C4-methyl oxidase-like NM_025436 54,6 0 
Atp6ap2 ATPase, H+ transporting, lysosomal accessory protein 2 NM_027439 52,1 0 
Hs3st1 heparan sulfate (glucosamine) 3-O-sulfotransferase 1 NM_010474 51,7 0 
Txn1 thioredoxin 1 NM_011660 51,4 1,89141E-41 
BC020382 Mus musculus, clone IMAGE:3582855 BC020382 50,9 0 
6530401D17Rik RIKEN cDNA 6530401D17 gene NM_029823 50,4 0 
Dbi diazepam binding inhibitor NM_007830 50,0 0 
Lrp4 low density lipoprotein receptor-related protein 4 NM_172668 48,0 1,05803E-36 
8030451F13Rik RIKEN cDNA 8030451F13 gene NM_175418 45,7 0 
Grp58 glucose regulated protein NM_007952 44,8 1,4013E-45 
Mbnl1 muscleblind-like 1 NM_020007 44,6 8,55629E-14 
TC1294250 T-cell immunomodulatory protein precursor TC1294250 44,5 0 
Sec6l1 mRNA for mFLJ00157 protein AK131141 43,2 0,000100646 
AB023957 EIG 180 mRNA for ethanol induced gene product AB023957 43,0 7,471E-42 
D130058I21Rik RIKEN cDNA D130058I21 gene NM_177776 43,0 0 
Aprin mRNA for mKIAA0979 protein AK122414 42,7 0 
Acadl acetyl-Coenzyme A dehydrogenase, long-chain NM_007381 42,2 3,53248E-22 
TC1243572 RL35_RAT (P17078) 60S ribosomal protein L35 TC1243572 42,0 0 
BI646741 BI646741 603279769F1 NCI_CGAP_Mam3 cDNA clone BI646741 41,5 1,34595E-09 
Gas5 growth arrest specific 5 NM_013525 41,4 0 
C1qbp complement component 1, q subcomponent binding protein NM_007573 41,2 0 
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Table 6.1: continued 
          
Symbol Gene Name GeneBank Ratio p-Value 
          
     
Rps24 ribosomal protein S24 NM_207634 40,7 0 
Slc13a3 solute carrier family 13, member 3 NM_054055 40,6 0 
Slco2b1 solute carrier organic anion transporter family, member 2b1 NM_175316 40,6 0 
Atp5h ATP synthase, H transporting, mitochondrial F0 complex, subunit d NM_027862 40,1 0 
Nrxn1 neurexin I NM_020252 39,8 4,07897E-27 
Olig1 oligodendrocyte transcription factor 1 NM_016968 39,0 9,26293E-21 
1700010A06Rik RIKEN cDNA 1700010A06 gene NM_027044 38,3 0 
Rpl35 ribosomal protein L35 NM_025592 38,0 1,74462E-43 
Pgk1 phosphoglycerate kinase 1 NM_008828 37,7 0 
Pea15 phosphoprotein enriched in astrocytes 15 NM_008556 37,5 0 
Tnc tenascin C NM_011607 37,2 2,69162E-29 
Psma5 proteasome subunit, alpha type 5 NM_011967 36,3 0 
Cd81 CD 81 antigen NM_133655 35,9 2,30283E-33 
Mest mesoderm specific transcript NM_008590 35,8 0 
BE985144 UI-M-CG0p-bdi-a-04-0-UI.s1 NIH_BMAP_Ret4_S2 cDNA clone BE985144 35,8 0 
Tmsb10 thymosin, beta 10 NM_025284 35,3 0 
Apod apolipoprotein D NM_007470 35,3 7,08905E-24 
Slc30a4 solute carrier family 30, member 4 NM_011774 34,6 0 
1110019J04Rik UI-M-FZ0-ccu-c-05-0-UI.r1 NIH_BMAP_FZ0 cDNA clone CA326234 34,6 1,77225E-29 
Oat ornithine aminotransferase NM_016978 34,4 0 
Stard13 serologically defined colon cancer antigen 13 NM_146258 34,0 7,20275E-08 
Cct5 chaperonin subunit 5 NM_007637 33,9 0 
D6Wsu176e DNA segment, Chr 6, Wayne State University 176 NM_138587 33,6 4,12227E-20 
Ppp4r1 protein phosphatase 4, regulatory subunit 1 NM_146081 33,5 1,88191E-39 
2700060E02Rik RIKEN cDNA 2700060E02 gene NM_026528 33,0 0 
BC016624 similar to actin, beta, clone IMAGE:4501052 BC016624 33,0 1,26035E-30 
Atp11a potential phospholipid-transporting ATPase IH (EC 3.6.3.13) AK028779 32,9 4,78914E-34 
D130038B21Rik RIKEN cDNA D130038B21 gene NM_178644 32,8 3,74793E-21 
Mtdh LYRIC like (Rattus norvegicus) AK035302 32,6 1,4013E-45 
Rps21 ribosomal protein S21 NM_025587 32,6 1,03183E-17 
BC016267 clone IMAGE:4924122 BC016267 31,3 1,982E-41 
Aatk apoptosis-associated tyrosine kinase NM_007377 31,0 0 
Glud glutamate dehydrogenase NM_008133 30,9 0 
Gpd2 glycerol phosphate dehydrogenase 1, mitochondrial AK079336 30,8 0 
Kctd12 potassium channel tetramerisation domain containing 12 NM_177715 30,8 0 
Maged1 melanoma antigen, family D, 1 NM_019791 30,8 0 
Nab1 Ngfi-A binding protein 1 NM_008667 30,7 2,27299E-31 
Rps21 40S ribosomal protein S21 homolog AK010610 30,6 0 
Il18 interleukin 18 NM_008360 30,5 0 
Rpl9 ribosomal protein L9 NM_011292 30,0 4,89701E-29 
Scd2 stearoyl-Coenzyme A desaturase 2 NM_009128 29,9 9,67975E-27 
Psat1 phosphoserine aminotransferase 1 NM_177420 29,6 0 
Rpl18a Ribosomal protein L18A NM_029751 29,3 0 
Hadhb hydroxyacyl-Coenzyme A dehydrogenase, beta subunit  NM_145558 29,0 2,72763E-42 
Plp1 proteolipid protein (myelin) 1 NM_011123 28,6 3,44929E-40 
Sorcs3 sortilin-related VPS10 domain containing receptor 3 NM_025696 28,6 1,77848E-10 
AU022870 expressed sequence AU022870 NM_177682 28,5 0 
6430556C10Rik RIKEN cDNA 6430556C10 gene NM_178725 27,5 1,87298E-26 
AK042850 similar to serine threonine kinase 32 homolog AK042850 26,9 0,004605 
Igfbp3 insulin-like growth factor binding protein 3 AK077477 26,7 3,29854E-08 
1200015A19Rik RIKEN cDNA 1200015A19 gene NM_026388 26,2 3,69912E-25 
          
     
List of genes that showed the strongest upregulation during the differentiation of Type A progenitor 
cells into periglomerular layer precursors and interneurons. The ratio indicates the mean fold 
upregulation in periglomerular cells compared to Type A progenitor cells. The p-Value indicates the 
significance level (two-tailed t test) of a differential regulation. 
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Table 6.2: Genes downregulated during the differentiation of Type A progenitor cells 
into periglomerular layer precursors and interneurons 
          
Symbol Gene Name GeneBank Ratio p-Value 
          
     
AK122256 mRNA for mKIAA0357 protein AK122256 37,0 0,0042 
D130016K21Rik RIKEN cDNA D130016K21 gene NM_177145 32,0 0,00006 
TC1322692 A33283 ADP-ribosylation factor 1 - human homolog TC1322692 29,9 0 
4932432K03Rik putative HIV-1 infection related protein homolog AK036465 28,9 0,02307 
9430029A11 RIKEN cDNA 9430029A11 gene NM_177881 28,0 1,86789E-16 
A930011O12Rik RIKEN cDNA A930011O12 gene BC030402 27,7 3,44569E-08 
ENSMUST000075701 Q7PI85 (Q7PI85) ENSANGP00000022586 ENSMUST000075701 20,4 6,9735E-28 
Dspg3 dermatan sulphate proteoglycan 3 NM_007884 19,9 2,53065E-40 
E030034C22Rik RIKEN cDNA E030034C22 gene NM_144840 19,6 6,0032E-05 
AV280394 cDNA clone 4933414A22 3' AV280394 19,3 0,032945438
BM934588 UI-M-BH3-aqq-h-06-0-UI.r1 NIH_BMAP_M_S4 cDNA clone BM934588 18,7 3,80591E-18 
Hipk1 homeodomain interacting protein kinase 1 NM_010432 18,0 1,2872E-17 
ORF28 open reading frame 28 NM_138664 17,1 3,94017E-09 
Sema3e sema domain, short basic domain, secreted, 3E AK049580 16,7 0,073725 
AY255623 secretin receptor AY255623 16,3 0,008225 
Plxna4 plexin A4 NM_175750 16,1 1,14243E-11 
BC059864 cDNA clone MGC:69721 IMAGE:6417471 BC059864 15,5 2,83408E-06 
1700122C07Rik serine/threonine kinase 33 AK020360 14,7 0,00277 
Cpz carboxypeptidase Z NM_153107 14,6 1,54633E-13 
AF543214 strain C57BL/6 CD72 variant AF543214 14,6 0 
1700067I02Rik RIKEN cDNA 1700067I02 gene NM_178387 14,1 1,96672E-38 
Kirl2 killer immunoglobulin-like receptor-like 2 NM_177748 14,0 7,8656E-27 
Mc5r melanocortin 5 receptor NM_013596 13,5 1,37067E-15 
D330023I21Rik BB383K5.1 homolog [Homo sapiens] AK077972 13,2 0,04569 
A630050E13Rik RIKEN cDNA A630050E13 gene NM_176982 12,9 0,05395 
Fpr-rs4 formyl peptide receptor, related sequence 4 NM_008041 12,9 5,86865E-42 
Dcdc2 doublecortin domain containing 2 NM_177577 12,9 9,9154E-32 
4930548H24Rik RIKEN cDNA 4930548H24 gene NM_026296 12,5 3,74042E-29 
4931407G18Rik RIKEN cDNA 4931407G18 gene NM_027631 12,1 7,68195E-07 
Nap1l2 nucleosome assembly protein 1-like 2 NM_008671 12,1 0,0001 
6820408C15 RIKEN cDNA 6820408C15 gene NM_177656 12,0 2,74265E-07 
Epb4.9 erythrocyte protein band 4.9 AK048309 11,7 2,9181E-13 
AK019935 serine protease inhibitor 2-1 AK019935 11,6 3,35383E-36 
TC1312776 TGF-beta receptor type I precursor, partial (17%) TC1312776 11,1 1,06042E-08 
AY236491 transmembrane channel-like protein 3 AY236491 11,0 1,00453E-10 
Loxl3 lysyl oxidase-like 3 NM_013586 11,0 6,89564E-21 
Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 NM_009991 11,0 6,43055E-26 
Z83815 axonemal dynein heavy chain (partial, ID mdhc7) Z83815 10,8 6,31685E-07 
AK040722 GA repeat binding protein, beta 1 AK040722 10,7 0,042985 
D32072 mRNA for TGF-b type II receptor isoform D32072 10,6 0,001975 
Scn3a sodium channel 21 L42337 10,5 1,1122E-06 
AW544865 expressed sequence AW544865 NM_178918 10,5 1,10326E-10 
NAP042698-1 cDNA clone E030012C13 3' NAP042698-1 10,4 1,32003E-25 
2310045A20Rik RIKEN cDNA 2310045A20 gene NM_172710 10,3 1,1391E-18 
Ar androgen receptor NM_013476 10,1 1,27715E-20 
Dnase2a deoxyribonuclease II alpha NM_010062 10,0 3,2938E-34 
4930429J24Rik RIKEN cDNA 4930429J24 gene NM_026132 9,9 2,81371E-21 
1110030H18Rik SV2 related protein homolog AK082744 9,8 0 
Grik2 glutamate receptor, ionotropic, kainate 2 (beta 2) NM_010349 9,7 0,00004 
AK047503 DGCRK6 protein homolog [Homo sapiens] AK047503 9,6 0,002185 
Insm1 insulinoma-associated 1 NM_016889 9,6 2,50185E-20 
NAP013333-001 RIKEN cDNA 4930526H21 gene NAP013333-001 9,4 3,00959E-07 
Rab3b RAB3B, member RAS oncogene family NM_023537 9,2 0,001160223
TC1282921 Q9NS72 (Q9NS72) Leucine-zipper-like protein 1 TC1282921 9,2 2E-05 
AK037161 calcium binding protein P22 AK037161 9,2 0,014075 
AW554518 cDNA clone 4921522H04 3' AV255740 9,1 1,33413E-11 
Akr1b7 aldo-keto reductase family 1, member B7 NM_009731 9,1 7,84803E-11 
AK122557 mRNA for mKIAA1809 protein AK122557 9,1 4,95811E-07 
Cacna2d1 calcium channel, voltage-dependent, alpha2/delta subunit 1 NM_009784 9,0 3,73469E-08 
A430083B19 RIKEN cDNA A430083B19 gene NM_177624 9,0 0,001955 
Kcnd1 potassium voltage-gated channel, Shal-related family, member 1 NM_008423 8,9 4,37471E-20 
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Table 6.2: continued 
     
          
Symbol Gene Name GeneBank Ratio p-Value 
          
     
BC055738 cDNA clone MGC:67028 IMAGE:6413697 BC055738 8,8 0 
H2-M10.5 histocompatibility 2, M region locus 10.5 NM_177637 8,8 1,05415E-08 
AI313915 expressed sequence AI313915 NM_144845 8,8 4,00227E-23 
C030030A07Rik RIKEN cDNA C030030A07 gene NM_178776 8,7 0,01702 
Prelp proline arginine-rich end leucine-rich repeat NM_054077 8,7 1,7016E-09 
Nalp9c NACHT, LRR and PYD containing protein 9c NM_194062 8,6 2,79524E-30 
Scnn1a sodium channel, nonvoltage-gated, type I, alpha polypeptide NM_011324 8,6 5,51302E-26 
NAP022882-001 similar to putative protein (80.3 kD) (5T676) (LOC382989) NAP022882-001 8,5 0,013345 
AK083596 ischemia related factor NYW-1 homolog AK083596 8,5 0 
Golga4 golgi autoantigen, golgin subfamily a, 4 NM_018748 8,5 0,00086 
X65157 desmoyokin, partial X65157 8,5 6,7321E-07 
Shprh SNF2 histone linker PHD RING helicase NM_172937 8,5 0,00531 
Xlr5 X-linked lymphocyte-regulated 5 NM_031493 8,4 1,75296E-21 
AK040212 cDNA FLJ10893 fis, clone NT2RP4002791 homolog AK040212 8,4 0,043185 
AK090281 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 AK090281 8,3 4,66087E-29 
5430404L10Rik RIKEN cDNA 5430404L10 gene NM_025769 8,3 0,001575001
ENSMUST000024744 ORF 2. [Source:SPTREMBL;Acc:Q62295] ENSMUST000024744 8,3 6,77082E-09 
NAP018455-001 similar to KIAA1529 protein NAP018455-001 8,2 0,023271167
AY364010 NALP12 AY364010 8,1 9,47896E-19 
1700028O09Rik RIKEN cDNA 1700028O09 gene NM_029381 8,1 3,21073E-10 
Star steroidogenic acute regulatory protein NM_011485 8,1 0,00337 
Frmd3 FERM domain containing 3 NM_172869 8,0 2,96379E-33 
AK076605 BM259 homolog [Rattus norvegicus] AK076605 8,0 0,121375 
Dcx doublecortin NM_010025 8,0 0,00098 
Nos1 nitric oxide synthase 1, neuronal NM_008712 8,0 1,03225E-09 
Il2ra interleukin 2 receptor, alpha chain NM_008367 7,8 0,000860928
1700027M21Rik RIKEN cDNA 1700027M21 gene NM_025499 7,8 5,6981E-26 
Cox5a cytochrome c oxidase, subunit Va AK046580 7,7 2,78609E-12 
Olfr993 olfactory receptor 993 NM_146435 7,7 0,00001 
AY255593 G protein-coupled receptor PGR23 AY255593 7,7 7,7912E-43 
6430571L13Rik RIKEN cDNA 6430571L13 gene NM_175486 7,7 1,79133E-17 
Myh3 Mouse embryonic/foetal skeletal myosin heavy chain M11154 7,6 4,51187E-15 
Slco6c1 solute carrier organic anion transporter family, member 6c1 NM_028942 7,6 8,7273E-24 
Olfr352 olfactory receptor 352 NM_146940 7,5 0,01954 
Kcnq2 potassium voltage-gated channel, subfamily Q, member 2 NM_010611 7,5 0,000415641
Ms4a1 Mouse CD20 cell surface protein M62541 7,4 1,41442E-22 
Msx2 homeo box, msh-like 2 NM_013601 7,4 5,1206E-15 
AK051460 adenosine deaminase 3 AK051460 7,4 0,005465005
Cnnm1 cyclin M1 NM_031396 7,4 5,1701E-34 
Lenep lens epithelial protein NM_020517 7,4 2,66703E-20 
NAP039752-1 Makorin 1 NAP039752-1 7,4 1,68156E-44 
Lpin3 lipin 3 NM_022883 7,4 3,8046E-15 
AK082644 Zinc finger protein 68 AK082644 7,3 0,000245001
Cd3z CD3 antigen, zeta polypeptide NM_031162 7,2 0,004165 
B830013J05Rik RIKEN cDNA B830013J05 gene NM_178722 7,2 6,0264E-17 
5330420D20Rik similar to D-aspartate oxidase (EC 1.4.3.1) (DASOX) AK017475 7,2 0,072755 
3830417A13Rik RIKEN cDNA 3830417A13 gene NM_027512 7,2 1,70399E-16 
Lgr8 similar to G protein coupled receptor affecting testicular descent AK039086 7,2 4,96148E-08 
Glt8d2 RIKEN cDNA 1110021D20 gene NM_029102 7,1 0,00137 
AB081756 brain chitinase like protein 2 AB081756 7,0 0,006055017
Zfa zinc finger protein, autosomal NM_009540 6,9 3,61342E-11 
          
     
List of genes that showed the strongest downregulation during the differentiation of Type A progenitor 
cells into periglomerular layer precursors and interneurons. The ratio indicates the mean fold 
downregulation in periglomerular cells compared to Type A progenitor cells. The p-Value indicates the 
significance level (two-tailed t test) of a differential regulation. 
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Table 6.3: Genes upregulated during the differentiation of periglomerular layer 
precursors into mature interneurons 
          
Symbol Gene Name GeneBank Ratio p-Value 
          
     
Grap2 RIKEN monocytic adaptor AK030809 694,4 2,11E-28 
Olfr1204 olfactory receptor 1204 NM_146463 478,5 2,34E-22 
BF021831 uy58f06.y1 McCarrey Eddy round spermatid cDNA clone BF021831 478,5 2,74E-15 
Nfat5 nuclear factor of activated T-cells 5 AK045123 381,7 4,83E-18 
Mak10 corneal wound healing related protein AK050805 378,8 1,61E-18 
AK041673 proton myo-inositol transporter homolog AK041673 363,6 8,65E-22 
4833418A01Rik RIKEN cDNA 4833418A01 gene NM_198005 359,7 3,53E-21 
Hpse heparanase NM_152803 344,8 6,54E-22 
Trpv3 transient receptor potential cation channel, subfamily V, member 3 NM_145099 321,5 2,62E-18 
AI592258 mt14e07.y1 Soares mouse 3NbMS cDNA clone AI592258 316,5 4,00E-21 
Obox2 oocyte specific homeobox 2 NM_145708 298,5 4,92E-15 
Trim21 tripartite motif protein 21 NM_009277 293,3 1,60E-15 
Prlpe prolactin-like protein E NM_008930 276,2 5,67E-21 
Gpr103 G protein-coupled receptor 103 NM_198192 273,2 2,57E-11 
Vipr2 vasoactive intestinal peptide receptor 2 NM_009511 267,4 2,97E-14 
BC020388 ATP-binding cassette, sub-family D (ALD), member 2 BC020388 257,1 1,83E-15 
TC1253808 L1 element insertion in intron 3 of Mitf gene TC1253808 251,3 1,46E-20 
AK042696 NMDA receptor-regulated gene 1 AK042696 247,5 1,70E-21 
Edn1 endothelin 1 NM_010104 247,5 4,48E-17 
9230117E20Rik RIKEN cDNA 9230117E20 gene NM_030061 238,7 1,45E-13 
Pi4k2b phosphatidylinositol 4-kinase type 2 beta NM_028744 235,3 4,92E-15 
1700012M14Rik RIKEN cDNA 1700012M14 gene NM_023816 234,2 2,27E-12 
AK173321 mKIAA1993 protein AK173321 230,9 9,76E-14 
Nin ninein NM_008697 211,9 3,14E-18 
4931414P19Rik RIKEN cDNA 4931414P19 gene NM_028890 211,4 5,26E-12 
BC058796 cDNA clone MGC:67967 IMAGE:6486091 BC058796 207,5 3,47E-21 
BC056221 cDNA clone IMAGE:5253487 BC056221 204,5 1,29E-13 
AB049605 caveolin-2 isoform AB049605 189,8 1,65E-13 
AK011813 TAT1protein homolog AK011813 184,8 1,20E-12 
AK017788 small nuclear ribonucleoprotein D1 AK017788 183,8 9,54E-18 
BI732528 603355435F1 NIH_MGC_94 cDNA clone IMAGE:5362568 BI732528 183,8 0,00003 
Olfr908 olfactory receptor 908 NM_146872 180,8 6,02E-12 
Ntng1 netrin G1 AK048796 180,2 8,19E-15 
2600011C06Rik RIKEN cDNA 2600011C06 gene BC067400 179,2 6,81E-12 
Pcdhb11 protocadherin beta 11 NM_053136 178,9 0,0049 
BC022150 cDNA clone IMAGE:5102760 BC022150 170,1 5,48E-08 
Pms1 postmeiotic segregation increased 1 NM_153556 167,5 2,34E-11 
Ndrg3 N-myc downstream regulated 3 AK029378 155,5 3,15E-10 
BC021897 mRNA similar to RIKEN cDNA 2900042B11 gene BC021897 154,1 4,92E-11 
2010002A20Rik RIKEN cDNA 2010002A20 gene NM_025655 145,3 3,83E-09 
AK051306 cAMP responsive element binding protein, delta chain homolog AK051306 144,1 1,76E-10 
V1re2 vomeronasal 1 receptor, E2 NM_134191 142,5 1,81E-12 
AK129034 mRNA for mKIAA0013 protein AK129034 141,2 9,06E-12 
Fgg fibrinogen, gamma polypeptide NM_133862 139,9 6,20E-10 
Htr3b 5-hydroxytryptamine (serotonin) receptor 3B NM_020274 139,7 2,49E-08 
Slco5a1 solute carrier organic anion transporter family, member 5A1 NM_172841 134,8 1,85E-09 
Olfr244 olfactory receptor 244 NM_001005520 132,5 2,62E-08 
AK041992 KPL2 homolog AK041992 131,6 1,81E-11 
Dedd2 similar to death effector domain-containing / DNA-binding protein 2 AK043908 130,9 9,38E-14 
AK053176 interleukin 18 receptor accessory protein AK053176 129,0 3,25E-09 
G630039H03Rik RIKEN cDNA G630039H03 gene BC031204 124,7 5,75E-09 
AY263157 Tmc3 protein AY263157 123,3 3,83E-10 
BC056494 cDNA clone IMAGE:5707460 BC056494 117,0 1,41E-08 
Olfr676 olfactory receptor 676 NM_147095 105,0 8,59E-10 
Mmp20 matrix metalloproteinase 20 (enamelysin) NM_013903 104,4 7,78E-11 
AK035678 programmed cell death 1 ligand 1 AK035678 104,1 2,10E-08 
Cts8 cathepsin 8 NM_019541 103,8 1,11E-10 
AK041814 signal transducer and activator of transcription 1 AK041814 102,6 4,67E-11 
Rgmb RGM domain family, member B NM_178615 101,5 2,25E-09 
G431001I09Rik D123 homolog AK047302 101,1 3,54E-07 
NAP020528-001 similar to MrgA6 G protein-coupled receptor NAP020528-001 96,2 0,00012 
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Table 6.3: continued 
          
Symbol Gene Name GeneBank Ratio p-Value 
          
     
AK036217 F-box protein FBL2 homolog AK036217 95,4 9,50E-10 
Olfr107 olfactory receptor 107 NM_146511 89,6 0,00003 
BC048502 cDNA sequence BC048502 NM_177631 89,0 2,04E-06 
Tnfrsf21 death receptor 6 AK036984 88,4 4,47E-07 
Olfr142 olfactory receptor 142 NM_146984 87,1 2,08E-06 
Ube2l3 ubiquitin-conjugating enzyme E2L 3 AK032396 85,0 1,10E-09 
AK087984 Pinch protein (particulary interesting new cys-his protein) homolog AK087984 82,8 1,81E-08 
ENSMUST000009521 interferon-induced protein with tetratricopeptide repeats 1 ENSMUST000009521 82,0 0,00013 
Pftk1 PFTAIRE protein kinase 1 AK087398 81,0 4,71E-08 
AK018271 requiem AK018271 78,2 1,98E-06 
4922502D21Rik RIKEN cDNA 4922502D21 gene NM_199034 77,5 0,00002 
Ube1y1 ubiquitin-activating enzyme E1, Chr Y 1 NM_011667 74,5 0,00001 
Dhfr dihydrofolate reductase NM_010049 73,6 0,00003 
AK042238 nuclear receptor coactivator 6 interacting protein AK042238 71,3 2,94E-07 
Rapgef6 rap guanine nucleotide exchange factor homolog AK038235 69,8 0,00007 
Stxbp4 syntaxin binding protein 4 AK012293 64,7 2,51E-06 
Tshb thyroid stimulating hormone AK036251 61,9 0,00136 
Grb14 growth factor receptor bound protein 14 AK034134 61,3 0,00058 
Astn2 astrotactin 2 AK047058 61,1 1,70E-06 
Bcl2l10 Bcl2-like 10 NM_013479 60,3 0,00007 
Srpk2 serine/arginine-rich protein specific kinase 2 AK014004 60,0 0,00004 
Ndufab1 acyl carrier protein (ACP) AK003696 59,6 2,95E-07 
Areg amphiregulin NM_009704 59,3 0,00064 
Cd209a CD209a antigen NM_133238 55,6 0,00061 
Neurod1 neurogenic differentiation 1 NM_010894 54,5 0,00063 
Lmo6 LIM domain only 6 NM_175097 53,7 2,15E-07 
Rrm2b ribonucleotide reductase M2 B (TP53 inducible) NM_199476 49,4 4,27E-06 
Kng1 kininogen 1 NM_023125 42,2 0,00523 
Edaradd EDAR (ectodysplasin-A receptor)-associated death domain NM_133643 36,3 0,00019 
Ell3 elongation factor RNA polymerase II-like 3 NM_145973 36,1 0,00314 
V1rb1 vomeronasal 1 receptor, B1 NM_053225 21,4 0,00003 
Klrk1 killer cell lectin-like receptor subfamily K, member 1 NM_033078 21,1 0,00363 
AB093209 mRNA for mKIAA0054 protein AB093209 17,2 1,87E-07 
Creb3l4 cAMP responsive element binding protein 3-like 4 NM_030080 15,5 0,00279 
Eraf erythroid associated factor NM_133245 15,3 0 
2310075A12Rik RIKEN cDNA 2310075A12 gene NM_178027 10,1 6,81E-09 
Tes testis derived transcript NM_207176 10,0 0,00801 
AK048143 SRY-box containing gene 6 AK048143 10,0 0,00367 
Hbb-b1 hemoglobin, beta adult major chain NM_008220 9,0 7,97E-13 
Olfr998 olfactory receptor 998 NM_146436 8,5 0,00059 
C230012O17Rik RIKEN cDNA C230012O17 gene NM_176944 8,2 0,00406 
2010321J07Rik RIKEN cDNA 2010321J07 gene NM_028094 7,7 0 
Clra C lectin-related protein A NM_153506 7,7 0,0031 
Sfpi1 SFFV proviral integration 1 NM_011355 7,4 5,18E-06 
Brd7 bromodomain containing 7 NM_012047 7,3 0,00911 
Olfr805 olfactory receptor 805 NM_146555 7,1 9,36E-29 
Slc4a1 solute carrier family 4 (anion exchanger), member 1 NM_011403 7,1 0 
Zwint ZW10 interactor NM_025635 7,1 3,46E-08 
Ktn1 kinectin 1 NM_008477 6,9 8,48E-15 
BC038279 RIKEN cDNA C130052G03 gene BC038279 6,5 0,00553 
TC1334041 Q7PJ14 (Q7PJ14) ENSANGP00000025094 (Fragment) TC1334041 6,1 0 
Srp54 signal recognition particle 54 NM_011899 5,5 0,00016 
M10466 Mouse alpha-globin M10466 5,3 0 
TC1343649 COAT_FMVD (P09519) Probable coat protein TC1343649 5,2 0,00002 
1100001I19Rik RIKEN cDNA 1100001I19 gene NM_172920 5,1 0,00349 
AA674270 mouse major urinary protein IV AA674270 5,0 1,71E-06 
          
     
List of genes that showed >5-fold upregulation during the differentiation of periglomerular layer 
precursors into mature periglomerular interneurons. The ratio indicates the mean fold upregulation in 
periglomerular layer interneurons compared to periglomerular precursors. The p-Value indicates the 
significance level (two-tailed t test) of a differential regulation. 
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Table 6.4: Genes downregulated during the differentiation of periglomerular layer 
precursors into mature interneurons 
          
Symbol Gene Name GeneBank Ratio p-Value 
          
     
AK051785 12 days embryo spinal ganglion cDNA AK051785 143,6 0,00004 
MOR135-11 olfactory receptor MOR135-11 NM_146923 130,2 3,21E-06 
AK042378 3 days neonate thymus cDNA AK042378 130,1 0,00332 
Pnma1 paraneoplastic antigen MA1 NM_027438 118,5 4,79E-08 
Lrba adult male urinary bladder cDNA AK035483 110,3 1,25E-06 
Bmp15 bone morphogenetic protein 15 NM_009757 106,6 1,53E-08 
Smc2l1 fibroblast growth factor inducible gene 16 U42385 81,7 0,00063 
Adarb2 adenosine deaminase, RNA-specific, B2 NM_052977 77,3 0,00003 
V1rb6 vomeronasal 1 receptor, B6 NM_020522 75,9 0,00023 
Cbfa2t2h core-binding factor, runt domain, alpha subunit 2 AK030597 71,3 0,00002 
Sox30 SRY-box containing gene 30 NM_173384 69,8 0,00005 
Nlgn1 neuroligin 1 homolog AK083116 69,2 0,00029 
Hist1h3a histone 1, H3a NM_013550 64,3 0,00069 
Sdfr2 stromal cell derived factor receptor 2 NM_009146 63,8 0,00058 
2610524B01Rik RIKEN cDNA 2610524B01 gene NM_028150 60,2 0,00013 
AK086594 stromal interaction molecule 1 AK086594 59,2 0,00373 
Sh3d1B SH3 domain protein 1B AK050865 57,9 0,00005 
Prpf39 PRP39 pre-mRNA processing factor 39 homolog BC033575 57,0 0,00017 
Ngfb nerve growth factor, beta NM_013609 51,5 0,00022 
Ptpn13 protein-tyrosine phosphatase nonreceptor-type 13 AK084198 47,6 1,93E-07 
Pla2g4c phospholipase A2, group IVC (cytosolic, calcium-independent) NM_001004762 47,1 0,00041 
Ikbkg inhibitor of kappaB kinase gamma NM_178590 46,4 0,00016 
Armc8 armadillo repeat containing 8 BC030311 45,8 0,00066 
AK031304 eukaryotic translation initiation factor 2, subunit 3 AK031304 43,3 0,00297 
Mum1l1 melanoma associated antigen (mutated) 1-like 1 NM_175541 40,9 0,00039 
Sytl2 synaptotagmin-like 2 NM_031394 40,6 0,00124 
Clca1 chloride channel calcium activated 1 NM_009899 37,7 0,0021 
AK042419 asporin AK042419 35,5 0,00495 
AK016178 histone 4 protein AK016178 35,1 0,00155 
AK030290 sex comb on midleg-like 1 AK030290 33,8 0,00038 
Lipl2 lipase-like, ab-hydrolase domain containing 2 NM_172837 33,4 0,00817 
2810034D10Rik zinc finger protein 54 homolog AK012854 33,1 0,00153 
1700083M11Rik RIKEN cDNA 1700083M11 gene NM_029674 31,8 0,00185 
Ndufab1 acyl carrier protein AK008788 31,0 0,00131 
AF222442 Nkx-1.2 gene, 3' untranslated region AF222442 30,5 0,00109 
Vim vimentin AK033175 30,3 0,00686 
AK009272 flavohemoprotein B5/B5RR AK009272 29,7 0,00878 
1500019C06Rik RIKEN cDNA 1500019C06 gene AK005284 29,4 0,00136 
AK044643 myocyte enhancer factor 2C AK044643 28,0 0,00531 
4931409K22 RIKEN cDNA 4931409K22 gene NM_177676 27,9 0,00824 
AK046777 Cdk5 and Abl enzyme substrate AK046777 23,2 0,00317 
TC1349965 Q8BUJ7 TC1349965 19,7 0,00721 
BE981005 UI-M-CG0-bct-c-04-0-UI.s1 NIH_BMAP_Ret4_S1 cDNA clone BE981005 18,2 0,00876 
BC055056 cDNA clone MGC:62829 IMAGE:6492855 BC055056 17,7 0,00113 
BC055295 dedicator of cytokinesis 8 BC055295 17,3 0,00652 
Lyzs lysozyme NM_017372 16,5 0,00132 
AK049000 mitochondrial intermediate peptidase homolog AK049000 15,5 0,00841 
Prkcn PKC MU protein homolog AK050059 15,3 0,00726 
Igfbpl1 insulin-like growth factor binding protein-like 1 NM_018741 14,3 3,49E-12 
BC054851 cDNA clone IMAGE:6528953 BC054851 13,6 0,00205 
Kif5a kinesin family member 5A NM_008447 10,3 2,53E-10 
Neurod2 neurogenic differentiation 2 NM_010895 9,1 5,80E-08 
S100a5 S100 calcium binding protein A5 NM_011312 8,5 2,81E-41 
1200007B05Rik RIKEN cDNA 1200007B05 gene NM_026165 7,0 0,00239 
Nfkb1 NFkB p105 subunit AK036827 7,0 6,61E-07 
BB254136 BB254136 RIKEN full-length enriched BB254136 6,4 0,00238 
0610030H11Rik RIKEN cDNA 0610030H11 gene NM_026712 6,2 3,06E-13 
D130060C09Rik RIKEN cDNA D130060C09 gene NM_177054 6,0 0,00451 
Gng13 guanine nucleotide binding protein 13, gamma NM_022422 5,6 1,42E-17 
BC055811 cDNA sequence BC055811 NM_198610 5,0 0,00007 
Cadps2 cerebellum postnatal development associated protein 2 AK042634 5,0 0,0001 
          
     
List of genes that showed >5-fold downregulation during the differentiation of periglomerular layer 
precursors into mature periglomerular interneurons. The ratio indicates the mean fold downregulation 
in periglomerular layer interneurons compared to periglomerular precursors. The p-Value indicates the 
significance level (two-tailed t test) of a differential regulation. 
References 
   
132 
7 References 
Abts, H., Emmerich, M., Miltenyi, S., Radbruch, A., Tesch, H., 1989. CD20 positive human 
B lymphocytes separated with the magnetic cell sorter (MACS) can be induced to 
proliferation and antibody secretion in vitro. J Immunol Methods 125, 19-28. 
 
Ache, B.W., Young, J.M., 2005. Olfaction: diverse species, conserved principles. Neuron 
48, 417-430. 
 
Akbarian, S., Smith, M.A., Jones, E.G., 1995. Editing for an AMPA receptor subunit RNA 
in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and 
schizophrenia. Brain Res 699, 297-304. 
 
Alexi, T., Hughes, P.E., van Roon-Mom, W.M., Faull, R.L., Williams, C.E., Clark, R.G., 
Gluckman, P.D., 1999. The IGF-I amino-terminal tripeptide glycine-proline-glutamate 
(GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of 
Huntington's disease. Exp Neurol 159, 84-97. 
 
Alonso, M., Viollet, C., Gabellec, M.M., Meas-Yedid, V., Olivo-Marin, J.C., Lledo, P.M., 
2006. Olfactory discrimination learning increases the survival of adult-born neurons in 
the olfactory bulb. J Neurosci 26, 10508-10513. 
 
Alvarez-Buylla, A., Garcia-Verdugo, J.M., 2002. Neurogenesis in adult subventricular 
zone. J Neurosci 22, 629-634. 
 
Anderson, S.A., Eisenstat, D.D., Shi, L., Rubenstein, J.L., 1997. Interneuron migration 
from basal forebrain to neocortex: dependence on Dlx genes. Science 278, 474-476. 
 
Andrews, W., Barber, M., Hernadez-Miranda, L.R., Xian, J., Rakic, S., Sundaresan, V., 
Rabbitts, T.H., Pannell, R., Rabbitts, P., Thompson, H., Erskine, L., Murakami, F., 
Parnavelas, J.G., 2007. The role of Slit-Robo signaling in the generation, migration and 
morphological differentiation of cortical interneurons. Dev Biol. 
 
Anthony, T.E., Mason, H.A., Gridley, T., Fishell, G., Heintz, N., 2005. Brain lipid-binding 
protein is a direct target of Notch signaling in radial glial cells. Genes Dev 19, 1028-1033. 
 
Anton, E.S., Ghashghaei, H.T., Weber, J.L., McCann, C., Fischer, T.M., Cheung, I.D., 
Gassmann, M., Messing, A., Klein, R., Schwab, M.H., Lloyd, K.C., Lai, C., 2004. Receptor 
tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult 
forebrain. Nat Neurosci 7, 1319-1328. 
 
Appay, V., Bosio, A., Lokan, S., Wiencek, Y., Biervert, C., Kusters, D., Devevre, E., Speiser, 
D., Romero, P., Rufer, N., Leyvraz, S., 2007. Sensitive Gene Expression Profiling of 
Human T Cell Subsets Reveals Parallel Post-Thymic Differentiation for CD4+ and 
CD8+ Lineages. J Immunol 179, 7406-7414. 
 
Arevian, A.C., Kapoor, V., Urban, N.N., 2008. Activity-dependent gating of lateral 
inhibition in the mouse olfactory bulb. Nat Neurosci 11, 80-87. 
 
References 
   
133 
Arlotta, P., Molyneaux, B.J., Chen, J., Inoue, J., Kominami, R., Macklis, J.D., 2005. 
Neuronal subtype-specific genes that control corticospinal motor neuron development in 
vivo. Neuron 45, 207-221. 
 
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., 
Cumano, A., Lauvau, G., Geissmann, F., 2007. Monitoring of blood vessels and tissues by a 
population of monocytes with patrolling behavior. Science 317, 666-670. 
 
Awapara, J., Landua, A.J., Fuerst, R., Seale, B., 1950. Free gamma-aminobutyric acid in 
brain. J Biol Chem 187, 35-39. 
 
Beal, M.F., Ferrante, R.J., 2004. Experimental therapeutics in transgenic mouse models of 
Huntington's disease. Nat Rev Neurosci 5, 373-384. 
 
Becker, M., Lavie, V., Solomon, B., 2007. Stimulation of endogenous neurogenesis by 
anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease. Proc Natl 
Acad Sci U S A 104, 1691-1696. 
 
Belluzzi, O., Benedusi, M., Ackman, J., LoTurco, J.J., 2003. Electrophysiological 
differentiation of new neurons in the olfactory bulb. J Neurosci 23, 10411-10418. 
 
Ben-Ari, Y., Cherubini, E., Corradetti, R., Gaiarsa, J.L., 1989. Giant synaptic potentials in 
immature rat CA3 hippocampal neurones. J Physiol 416, 303-325. 
 
Birnboim, H.C., Doly, J., 1979. A rapid alkaline extraction procedure for screening 
recombinant plasmid DNA. Nucleic Acids Res 7, 1513-1523. 
 
Blatow, M., Caputi, A., Monyer, H., 2005. Molecular diversity of neocortical GABAergic 
interneurones. J Physiol 562, 99-105. Epub 2004 Nov 2011. 
 
Bommel, H., Xie, G., Rossoll, W., Wiese, S., Jablonka, S., Boehm, T., Sendtner, M., 2002. 
Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant 
progressive motor neuronopathy, a model of human motoneuron disease. J Cell Biol 159, 
563-569. 
 
Bormann, J., 1988. Electrophysiology of GABAA and GABAB receptor subtypes. Trends 
Neurosci 11, 112-116. 
 
Bormann, J., 2000. The 'ABC' of GABA receptors. Trends Pharmacol Sci 21, 16-19. 
 
Bormann, J., Feigenspan, A., 1995. GABAC receptors. Trends Neurosci 18, 515-519. 
 
Bosch, M., Pineda, J.R., Sunol, C., Petriz, J., Cattaneo, E., Alberch, J., Canals, J.M., 2004. 
Induction of GABAergic phenotype in a neural stem cell line for transplantation in an 
excitotoxic model of Huntington's disease. Exp Neurol 190, 42-58. 
 
Bossy-Wetzel, E., Schwarzenbacher, R., Lipton, S.A., 2004a. Molecular pathways to 
neurodegeneration. Nat Med 10 Suppl, S2-9. 
References 
   
134 
Bossy-Wetzel, E., Talantova, M.V., Lee, W.D., Scholzke, M.N., Harrop, A., Mathews, E., 
Gotz, T., Han, J., Ellisman, M.H., Perkins, G.A., Lipton, S.A., 2004b. Crosstalk between 
nitric oxide and zinc pathways to neuronal cell death involving mitochondrial 
dysfunction and p38-activated K+ channels. Neuron 41, 351-365. 
 
Boutin, C., Diestel, S., Desoeuvre, A., Tiveron, M.C., Cremer, H., 2008. Efficient in vivo 
electroporation of the postnatal rodent forebrain. PLoS ONE 3, e1883. 
 
Bradford, D.S., Foster, R.R., Nossel, H.L., 1970. Coagulation alterations, hypoxemia, and 
fat embolism in fracture patients. J Trauma 10, 307-321. 
 
Bretin, S., Reibel, S., Charrier, E., Maus-Moatti, M., Auvergnon, N., Thevenoux, A., 
Glowinski, J., Rogemond, V., Premont, J., Honnorat, J., Gauchy, C., 2005. Differential 
expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of 
distinct neurons in the mouse brain. J Comp Neurol 486, 1-17. 
 
Brill, M.S., Snapyan, M., Wohlfrom, H., Ninkovic, J., Jawerka, M., Mastick, G.S., Ashery-
Padan, R., Saghatelyan, A., Berninger, B., Gotz, M., 2008. A dlx2- and pax6-dependent 
transcriptional code for periglomerular neuron specification in the adult olfactory bulb. 
J Neurosci 28, 6439-6452. 
 
Brooks, P.C., Lin, J.M., French, D.L., Quigley, J.P., 1993. Subtractive immunization yields 
monoclonal antibodies that specifically inhibit metastasis. J Cell Biol 122, 1351-1359. 
 
Cantor, H., Simpson, E., Sato, V.L., Fathman, C.G., Herzenberg, L.A., 1975. 
Characterization of subpopulations of T lymphocytes. I. Separation and functional 
studies of peripheral T-cells binding different amounts of fluorescent anti-Thy 1.2 
(theta) antibody using a fluorescence-activated cell sorter (FACS). Cell Immunol 15, 180-
196. 
 
Carleton, A., Petreanu, L.T., Lansford, R., Alvarez-Buylla, A., Lledo, P.M., 2003. Becoming 
a new neuron in the adult olfactory bulb. Nat Neurosci 6, 507-518. 
 
Carothers, A.M., Urlaub, G., Mucha, J., Grunberger, D., Chasin, L.A., 1989. Point mutation 
analysis in a mammalian gene: rapid preparation of total RNA, PCR amplification of 
cDNA, and Taq sequencing by a novel method. Biotechniques 7, 494-496, 498-499. 
 
Cartier, L., Laforge, T., Feki, A., Arnaudeau, S., Dubois-Dauphin, M., Krause, K.H., 2006. 
Pax6-induced alteration of cell fate: shape changes, expression of neuronal alpha 
tubulin, postmitotic phenotype, and cell migration. J Neurobiol 66, 421-436. 
 
Carvalho, D.P., 2003. Modulation of uterine iodothyronine deiodinases--a critical event 
for fetal development? Endocrinology 144, 4250-4252. 
 
Chazal, G., Durbec, P., Jankovski, A., Rougon, G., Cremer, H., 2000. Consequences of 
neural cell adhesion molecule deficiency on cell migration in the rostral migratory 
stream of the mouse. J Neurosci 20, 1446-1457. 
 
Chen, G., Trombley, P.Q., van den Pol, A.N., 1996. Excitatory actions of GABA in 
developing rat hypothalamic neurones. J Physiol 494 ( Pt 2), 451-464. 
 
References 
   
135 
Chen, J.H., Wen, L., Dupuis, S., Wu, J.Y., Rao, Y., 2001. The N-terminal leucine-rich 
regions in Slit are sufficient to repel olfactory bulb axons and subventricular zone 
neurons. J Neurosci 21, 1548-1556. 
 
Chen, K., Ochalski, P.G., Tran, T.S., Sahir, N., Schubert, M., Pramatarova, A., Howell, B.W., 
2004. Interaction between Dab1 and CrkII is promoted by Reelin signaling. J Cell Sci 
117, 4527-4536. 
 
Cherubini, E., Conti, F., 2001. Generating diversity at GABAergic synapses. Trends 
Neurosci 24, 155-162. 
 
Cho, J.H., Tsai, M.J., 2004. The role of BETA2/NeuroD1 in the development of the 
nervous system. Mol Neurobiol 30, 35-47. 
 
Cobos, I., Broccoli, V., Rubenstein, J.L., 2005a. The vertebrate ortholog of Aristaless is 
regulated by Dlx genes in the developing forebrain. J Comp Neurol 483, 292-303. 
 
Cobos, I., Calcagnotto, M.E., Vilaythong, A.J., Thwin, M.T., Noebels, J.L., Baraban, S.C., 
Rubenstein, J.L., 2005b. Mice lacking Dlx1 show subtype-specific loss of interneurons, 
reduced inhibition and epilepsy. Nat Neurosci 8, 1059-1068. 
 
Comoletti, D., Flynn, R., Jennings, L.L., Chubykin, A., Matsumura, T., Hasegawa, H., 
Sudhof, T.C., Taylor, P., 2003. Characterization of the interaction of a recombinant 
soluble neuroligin-1 with neurexin-1beta. J Biol Chem 278, 50497-50505. 
 
Conover, J.C., Doetsch, F., Garcia-Verdugo, J.M., Gale, N.W., Yancopoulos, G.D., Alvarez-
Buylla, A., 2000. Disruption of Eph/ephrin signaling affects migration and proliferation 
in the adult subventricular zone. Nat Neurosci 3, 1091-1097. 
 
Coskun, V., Wu, H., Blanchi, B., Tsao, S., Kim, K., Zhao, J., Biancotti, J.C., Hutnick, L., 
Krueger, R.C., Jr., Fan, G., de Vellis, J., Sun, Y.E., 2008. CD133+ neural stem cells in the 
ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci U S A 105, 1026-1031. 
 
Cotton, R.G., Milstein, C., 1973. Letter: Fusion of two immunoglobulin-producing 
myeloma cells. Nature 244, 42-43. 
 
Cremer, H., Lange, R., Christoph, A., Plomann, M., Vopper, G., Roes, J., Brown, R., 
Baldwin, S., Kraemer, P., Scheff, S., et al., 1994. Inactivation of the N-CAM gene in mice 
results in size reduction of the olfactory bulb and deficits in spatial learning. Nature 367, 
455-459. 
 
Curtis, M.A., Faull, R.L., Eriksson, P.S., 2007a. The effect of neurodegenerative diseases 
on the subventricular zone. Nat Rev Neurosci 8, 712-723. 
 
Curtis, M.A., Kam, M., Nannmark, U., Anderson, M.F., Axell, M.Z., Wikkelso, C., Holtas, 
S., van Roon-Mom, W.M., Bjork-Eriksson, T., Nordborg, C., Frisen, J., Dragunow, M., Faull, 
R.L., Eriksson, P.S., 2007b. Human neuroblasts migrate to the olfactory bulb via a lateral 
ventricular extension. Science 315, 1243-1249. 
 
References 
   
136 
Cutforth, T., Moring, L., Mendelsohn, M., Nemes, A., Shah, N.M., Kim, M.M., Frisen, J., 
Axel, R., 2003. Axonal ephrin-As and odorant receptors: coordinate determination of 
the olfactory sensory map. Cell 114, 311-322. 
 
de Chevigny, A., Lemasson, M., Saghatelyan, A., Sibbe, M., Schachner, M., Lledo, P.M., 
2006. Delayed onset of odor detection in neonatal mice lacking tenascin-C. Mol Cell 
Neurosci 32, 174-186. 
 
Deacon, T.W., Pakzaban, P., Isacson, O., 1994. The lateral ganglionic eminence is the 
origin of cells committed to striatal phenotypes: neural transplantation and 
developmental evidence. Brain Res 668, 211-219. 
 
DeFelipe, J., 1997. Types of neurons, synaptic connections and chemical characteristics 
of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the 
neocortex. J Chem Neuroanat 14, 1-19. 
 
DeLong, M.R., 1990. Primate models of movement disorders of basal ganglia origin. 
Trends Neurosci 13, 281-285. 
 
Deuel, T.A., Liu, J.S., Corbo, J.C., Yoo, S.Y., Rorke-Adams, L.B., Walsh, C.A., 2006. 
Genetic interactions between doublecortin and doublecortin-like kinase in neuronal 
migration and axon outgrowth. Neuron 49, 41-53. 
 
Dikkes, P., D, B.J., Guo, W.H., Chao, C., Hemond, P., Yoon, K., Zurakowski, D., Lopez, 
M.F., 2007. IGF2 knockout mice are resistant to kainic acid-induced seizures and 
neurodegeneration. Brain Res 1175, 85-95. 
 
Donovan, M.H., Yazdani, U., Norris, R.D., Games, D., German, D.C., Eisch, A.J., 2006. 
Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's 
disease. J Comp Neurol 495, 70-83. 
 
Durbec, P., Cremer, H., 2001. Revisiting the function of PSA-NCAM in the nervous 
system. Mol Neurobiol 24, 53-64. 
 
Eccles, J.C., Llinas, R., Sasaki, K., 1966. The mossy fibre-granule cell relay of the 
cerebellum and its inhibitory control by Golgi cells. Exp Brain Res 1, 82-101. 
 
Eisen, M.B., Spellman, P.T., Brown, P.O., Botstein, D., 1998. Cluster analysis and display 
of genome-wide expression patterns. Proc Natl Acad Sci U S A 95, 14863-14868. 
 
Elliott, K.A., Hobbiger, F., 1959. gamma Aminobutyric acid; circulatory and respiratory 
effects in different species; re-investigation of the anti-strychnine action in mice. J 
Physiol 146, 70-84. 
 
Emsley, J.G., Hagg, T., 2003. alpha6beta1 integrin directs migration of neuronal 
precursors in adult mouse forebrain. Exp Neurol 183, 273-285. 
 
Engelhardt, C.M., Bundschu, K., Messerschmitt, M., Renne, T., Walter, U., Reinhard, M., 
Schuh, K., 2004. Expression and subcellular localization of Spred proteins in mouse and 
human tissues. Histochem Cell Biol 122, 527-538. 
 
References 
   
137 
Erkman, L., Yates, P.A., McLaughlin, T., McEvilly, R.J., Whisenhunt, T., O'Connell, S.M., 
Krones, A.I., Kirby, M.A., Rapaport, D.H., Bermingham, J.R., O'Leary, D.D., Rosenfeld, 
M.G., 2000. A POU domain transcription factor-dependent program regulates axon 
pathfinding in the vertebrate visual system. Neuron 28, 779-792. 
 
Erlander, M.G., Tillakaratne, N.J., Feldblum, S., Patel, N., Tobin, A.J., 1991. Two genes 
encode distinct glutamate decarboxylases. Neuron 7, 91-100. 
 
Erlander, M.G., Tobin, A.J., 1991. The structural and functional heterogeneity of glutamic 
acid decarboxylase: a review. Neurochem Res 16, 215-226. 
 
Farah, M.H., Olson, J.M., Sucic, H.B., Hume, R.I., Tapscott, S.J., Turner, D.L., 2000. 
Generation of neurons by transient expression of neural bHLH proteins in mammalian 
cells. Development 127, 693-702. 
 
Feldblum, S., Erlander, M.G., Tobin, A.J., 1993. Different distributions of GAD65 and 
GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive 
functional roles. J Neurosci Res 34, 689-706. 
 
Ferguson, G.D., Herschman, H.R., Storm, D.R., 2004a. Reduced anxiety and depression-
like behavior in synaptotagmin IV (-/-) mice. Neuropharmacology 47, 604-611. 
 
Ferguson, G.D., Wang, H., Herschman, H.R., Storm, D.R., 2004b. Altered hippocampal 
short-term plasticity and associative memory in synaptotagmin IV (-/-) mice. 
Hippocampus 14, 964-974. 
 
Fine, E.J., Ionita, C.C., Lohr, L., 2002. The history of the development of the cerebellar 
examination. Semin Neurol 22, 375-384. 
 
Flames, N., Marin, O., 2005. Developmental mechanisms underlying the generation of 
cortical interneuron diversity. Neuron 46, 377-381. 
 
Fon, E.A., Edwards, R.H., 2001. Molecular mechanisms of neurotransmitter release. 
Muscle Nerve 24, 581-601. 
 
Frielingsdorf, H., Schwarz, K., Brundin, P., Mohapel, P., 2004. No evidence for new 
dopaminergic neurons in the adult mammalian substantia nigra. Proc Natl Acad Sci U S 
A 101, 10177-10182. 
 
Frisch, C., Dere, E., Silva, M.A., Godecke, A., Schrader, J., Huston, J.P., 2000. Superior 
water maze performance and increase in fear-related behavior in the endothelial nitric 
oxide synthase-deficient mouse together with monoamine changes in cerebellum and 
ventral striatum. J Neurosci 20, 6694-6700. 
 
Gerfen, C.R., 1992. The neostriatal mosaic: multiple levels of compartmental 
organization in the basal ganglia. Annu Rev Neurosci 15, 285-320. 
 
Ghashghaei, H.T., Lai, C., Anton, E.S., 2007. Neuronal migration in the adult brain: are 
we there yet? Nat Rev Neurosci 8, 141-151. 
 
References 
   
138 
Ghashghaei, H.T., Weber, J., Pevny, L., Schmid, R., Schwab, M.H., Lloyd, K.C., Eisenstat, 
D.D., Lai, C., Anton, E.S., 2006. The role of neuregulin-ErbB4 interactions on the 
proliferation and organization of cells in the subventricular zone. Proc Natl Acad Sci U S 
A 103, 1930-1935. 
 
Gheusi, G., Cremer, H., McLean, H., Chazal, G., Vincent, J.D., Lledo, P.M., 2000. 
Importance of newly generated neurons in the adult olfactory bulb for odor 
discrimination. Proc Natl Acad Sci U S A 97, 1823-1828. 
 
Gleeson, J.G., Minnerath, S.R., Fox, J.W., Allen, K.M., Luo, R.F., Hong, S.E., Berg, M.J., 
Kuzniecky, R., Reitnauer, P.J., Borgatti, R., Mira, A.P., Guerrini, R., Holmes, G.L., Rooney, 
C.M., Berkovic, S., Scheffer, I., Cooper, E.C., Ricci, S., Cusmai, R., Crawford, T.O., Leroy, 
R., Andermann, E., Wheless, J.W., Dobyns, W.B., Walsh, C.A., et al., 1999. 
Characterization of mutations in the gene doublecortin in patients with double cortex 
syndrome. Ann Neurol 45, 146-153. 
 
Gomperts, B.N., Gong-Cooper, X., Hackett, B.P., 2004. Foxj1 regulates basal body 
anchoring to the cytoskeleton of ciliated pulmonary epithelial cells. J Cell Sci 117, 1329-
1337. 
 
Gotz, M., Barde, Y.A., 2005. Radial glial cells defined and major intermediates between 
embryonic stem cells and CNS neurons. Neuron 46, 369-372. 
 
Gotz, M., Huttner, W.B., 2005. The cell biology of neurogenesis. Nat Rev Mol Cell Biol 6, 
777-788. 
 
Graybiel, A.M., 2000. The basal ganglia. Curr Biol 10, R509-511. 
 
Guan, J., Williams, C.E., Skinner, S.J., Mallard, E.C., Gluckman, P.D., 1996. The effects of 
insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-
ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. 
Endocrinology 137, 893-898. 
 
Hack, I., Bancila, M., Loulier, K., Carroll, P., Cremer, H., 2002. Reelin is a detachment 
signal in tangential chain-migration during postnatal neurogenesis. Nat Neurosci 5, 939-
945. 
 
Hack, M.A., Saghatelyan, A., de Chevigny, A., Pfeifer, A., Ashery-Padan, R., Lledo, P.M., 
Gotz, M., 2005. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat 
Neurosci 8, 865-872. 
 
Hansel, D.E., Eipper, B.A., Ronnett, G.V., 2001. Neuropeptide Y functions as a 
neuroproliferative factor. Nature 410, 940-944. 
 
Hartmann, H., Eckert, A., Muller, W.E., 1994. Apolipoprotein E and cholesterol affect 
neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. 
Biochem Biophys Res Commun 200, 1185-1192. 
 
Hashimoto, T., Volk, D.W., Eggan, S.M., Mirnics, K., Pierri, J.N., Sun, Z., Sampson, A.R., 
Lewis, D.A., 2003. Gene expression deficits in a subclass of GABA neurons in the 
prefrontal cortex of subjects with schizophrenia. J Neurosci 23, 6315-6326. 
References 
   
139 
Haughey, N.J., Liu, D., Nath, A., Borchard, A.C., Mattson, M.P., 2002a. Disruption of 
neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal 
precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of 
Alzheimer's disease. Neuromolecular Med 1, 125-135. 
 
Haughey, N.J., Nath, A., Chan, S.L., Borchard, A.C., Rao, M.S., Mattson, M.P., 2002b. 
Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor 
cell homeostasis, in models of Alzheimer's disease. J Neurochem 83, 1509-1524. 
 
He, W., Ingraham, C., Rising, L., Goderie, S., Temple, S., 2001. Multipotent stem cells from 
the mouse basal forebrain contribute GABAergic neurons and oligodendrocytes to the 
cerebral cortex during embryogenesis. J Neurosci 21, 8854-8862. 
 
Heins, N., Malatesta, P., Cecconi, F., Nakafuku, M., Tucker, K.L., Hack, M.A., Chapouton, 
P., Barde, Y.A., Gotz, M., 2002. Glial cells generate neurons: the role of the transcription 
factor Pax6. Nat Neurosci 5, 308-315. 
 
Higginbotham, H., Tanaka, T., Brinkman, B.C., Gleeson, J.G., 2006. GSK3beta and 
PKCzeta function in centrosome localization and process stabilization during Slit-
mediated neuronal repolarization. Mol Cell Neurosci 32, 118-132. 
 
Hirsch, J.A., Gilbert, C.D., 1991. Synaptic physiology of horizontal connections in the 
cat's visual cortex. J Neurosci 11, 1800-1809. 
 
Hoekman, M.F., Jacobs, F.M., Smidt, M.P., Burbach, J.P., 2006. Spatial and temporal 
expression of FoxO transcription factors in the developing and adult murine brain. Gene 
Expr Patterns 6, 134-140. 
 
Hoglinger, G.U., Rizk, P., Muriel, M.P., Duyckaerts, C., Oertel, W.H., Caille, I., Hirsch, E.C., 
2004. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat 
Neurosci 7, 726-735. 
 
Horsch, D., Kahn, C.R., 1999. Region-specific mRNA expression of phosphatidylinositol 
3-kinase regulatory isoforms in the central nervous system of C57BL/6J mice. J Comp 
Neurol 415, 105-120. 
 
Hoshino, M., Nakamura, S., Mori, K., Kawauchi, T., Terao, M., Nishimura, Y.V., Fukuda, A., 
Fuse, T., Matsuo, N., Sone, M., Watanabe, M., Bito, H., Terashima, T., Wright, C.V., 
Kawaguchi, Y., Nakao, K., Nabeshima, Y., 2005. Ptf1a, a bHLH transcriptional gene, 
defines GABAergic neuronal fates in cerebellum. Neuron 47, 201-213. 
 
Hu, H., 1999. Chemorepulsion of neuronal migration by Slit2 in the developing 
mammalian forebrain. Neuron 23, 703-711. 
 
Huang, Z.J., Di Cristo, G., Ango, F., 2007. Development of GABA innervation in the 
cerebral and cerebellar cortices. Nat Rev Neurosci 8, 673-686. 
 
Ince-Dunn, G., Hall, B.J., Hu, S.C., Ripley, B., Huganir, R.L., Olson, J.M., Tapscott, S.J., 
Ghosh, A., 2006. Regulation of thalamocortical patterning and synaptic maturation by 
NeuroD2. Neuron 49, 683-695. 
 
References 
   
140 
Jacques, T.S., Relvas, J.B., Nishimura, S., Pytela, R., Edwards, G.M., Streuli, C.H., ffrench-
Constant, C., 1998. Neural precursor cell chain migration and division are regulated 
through different beta1 integrins. Development 125, 3167-3177. 
 
Jukkola, T., Sinjushina, N., Partanen, J., 2004. Drapc1 expression during mouse embryonic 
development. Gene Expr Patterns 4, 755-762. 
 
Juliano, R.L., 2002. Signal transduction by cell adhesion receptors and the cytoskeleton: 
functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. 
Annu Rev Pharmacol Toxicol 42, 283-323. 
 
Kanai, Y., Okada, Y., Tanaka, Y., Harada, A., Terada, S., Hirokawa, N., 2000. KIF5C, a 
novel neuronal kinesin enriched in motor neurons. J Neurosci 20, 6374-6384. 
 
Kanatani, A., Mashiko, S., Murai, N., Sugimoto, N., Ito, J., Fukuroda, T., Fukami, T., Morin, 
N., MacNeil, D.J., Van der Ploeg, L.H., Saga, Y., Nishimura, S., Ihara, M., 2000. Role of the 
Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-
type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141, 1011-
1016. 
 
Kanda, S., Tamada, Y., Yoshidome, A., Hayashi, I., Nishiyama, T., 2004. Over-expression 
of bHLH genes facilitate neural formation of mouse embryonic stem (ES) cells in vitro. 
Int J Dev Neurosci 22, 149-156. 
 
Kappeler, C., Saillour, Y., Baudoin, J.P., Tuy, F.P., Alvarez, C., Houbron, C., Gaspar, P., 
Hamard, G., Chelly, J., Metin, C., Francis, F., 2006. Branching and nucleokinesis defects in 
migrating interneurons derived from doublecortin knockout mice. Hum Mol Genet 15, 
1387-1400. 
 
Kempermann, G., Wiskott, L., Gage, F.H., 2004. Functional significance of adult 
neurogenesis. Curr Opin Neurobiol 14, 186-191. 
 
Kim, W.R., Kim, Y., Eun, B., Park, O.H., Kim, H., Kim, K., Park, C.H., Vinsant, S., 
Oppenheim, R.W., Sun, W., 2007. Impaired migration in the rostral migratory stream but 
spared olfactory function after the elimination of programmed cell death in Bax knock-
out mice. J Neurosci 27, 14392-14403. 
 
Kim, W.Y., Fritzsch, B., Serls, A., Bakel, L.A., Huang, E.J., Reichardt, L.F., Barth, D.S., Lee, 
J.E., 2001. NeuroD-null mice are deaf due to a severe loss of the inner ear sensory 
neurons during development. Development 128, 417-426. 
 
Kirschenbaum, B., Doetsch, F., Lois, C., Alvarez-Buylla, A., 1999. Adult subventricular 
zone neuronal precursors continue to proliferate and migrate in the absence of the 
olfactory bulb. J Neurosci 19, 2171-2180. 
 
Kohler, G., Milstein, C., 1975. Continuous cultures of fused cells secreting antibody of 
predefined specificity. Nature 256, 495-497. 
 
Kohwi, M., Osumi, N., Rubenstein, J.L., Alvarez-Buylla, A., 2005. Pax6 is required for 
making specific subpopulations of granule and periglomerular neurons in the olfactory 
bulb. J Neurosci 25, 6997-7003. 
References 
   
141 
Koizumi, H., Higginbotham, H., Poon, T., Tanaka, T., Brinkman, B.C., Gleeson, J.G., 2006a. 
Doublecortin maintains bipolar shape and nuclear translocation during migration in the 
adult forebrain. Nat Neurosci 9, 779-786. 
 
Koizumi, H., Tanaka, T., Gleeson, J.G., 2006b. Doublecortin-like kinase functions with 
doublecortin to mediate fiber tract decussation and neuronal migration. Neuron 49, 55-
66. 
 
Kosaka, K., Kosaka, T., 2005. synaptic organization of the glomerulus in the main 
olfactory bulb: compartments of the glomerulus and heterogeneity of the periglomerular 
cells. Anat Sci Int 80, 80-90. 
 
Kroll, T.T., O'Leary, D.D., 2005. Ventralized dorsal telencephalic progenitors in Pax6 
mutant mice generate GABA interneurons of a lateral ganglionic eminence fate. Proc 
Natl Acad Sci U S A 102, 7374-7379. 
 
Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227, 680-685. 
 
Lampa, S.J., Potluri, S., Norton, A.S., Fusco, W., Laskowski, M.B., 2004. Ephrin-A5 
overexpression degrades topographic specificity in the mouse gluteus maximus muscle. 
Brain Res Dev Brain Res 153, 271-274. 
 
Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A.F., 
Boguski, M.S., Brockway, K.S., Byrnes, E.J., Chen, L., Chen, L., Chen, T.M., Chin, M.C., 
Chong, J., Crook, B.E., Czaplinska, A., Dang, C.N., Datta, S., Dee, N.R., Desaki, A.L., Desta, 
T., Diep, E., Dolbeare, T.A., Donelan, M.J., Dong, H.W., Dougherty, J.G., Duncan, B.J., 
Ebbert, A.J., Eichele, G., Estin, L.K., Faber, C., Facer, B.A., Fields, R., Fischer, S.R., Fliss, 
T.P., Frensley, C., Gates, S.N., Glattfelder, K.J., Halverson, K.R., Hart, M.R., Hohmann, J.G., 
Howell, M.P., Jeung, D.P., Johnson, R.A., Karr, P.T., Kawal, R., Kidney, J.M., Knapik, R.H., 
Kuan, C.L., Lake, J.H., Laramee, A.R., Larsen, K.D., Lau, C., Lemon, T.A., Liang, A.J., Liu, 
Y., Luong, L.T., Michaels, J., Morgan, J.J., Morgan, R.J., Mortrud, M.T., Mosqueda, N.F., 
Ng, L.L., Ng, R., Orta, G.J., Overly, C.C., Pak, T.H., Parry, S.E., Pathak, S.D., Pearson, O.C., 
Puchalski, R.B., Riley, Z.L., Rockett, H.R., Rowland, S.A., Royall, J.J., Ruiz, M.J., Sarno, 
N.R., Schaffnit, K., Shapovalova, N.V., Sivisay, T., Slaughterbeck, C.R., Smith, S.C., Smith, 
K.A., Smith, B.I., Sodt, A.J., Stewart, N.N., Stumpf, K.R., Sunkin, S.M., Sutram, M., Tam, 
A., Teemer, C.D., Thaller, C., Thompson, C.L., Varnam, L.R., Visel, A., Whitlock, R.M., 
Wohnoutka, P.E., Wolkey, C.K., Wong, V.Y., Wood, M., Yaylaoglu, M.B., Young, R.C., 
Youngstrom, B.L., Yuan, X.F., Zhang, B., Zwingman, T.A., Jones, A.R., 2007. Genome-
wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176. 
 
Lemasson, M., Saghatelyan, A., Olivo-Marin, J.C., Lledo, P.M., 2005. Neonatal and adult 
neurogenesis provide two distinct populations of newborn neurons to the mouse 
olfactory bulb. J Neurosci 25, 6816-6825. 
 
Leto, K., Carletti, B., Williams, I.M., Magrassi, L., Rossi, F., 2006. Different types of 
cerebellar GABAergic interneurons originate from a common pool of multipotent 
progenitor cells. J Neurosci 26, 11682-11694. 
 
References 
   
142 
Li, D.P., Pan, H.L., 2005. Angiotensin II attenuates synaptic GABA release and excites 
paraventricular-rostral ventrolateral medulla output neurons. J Pharmacol Exp Ther 313, 
1035-1045. 
 
Li, H.P., Oohira, A., Ogawa, M., Kawamura, K., Kawano, H., 2005. Aberrant trajectory of 
thalamocortical axons associated with abnormal localization of neurocan 
immunoreactivity in the cerebral neocortex of reeler mutant mice. Eur J Neurosci 22, 
2689-2696. 
 
Lin, C.H., Stoeck, J., Ravanpay, A.C., Guillemot, F., Tapscott, S.J., Olson, J.M., 2004. 
Regulation of neuroD2 expression in mouse brain. Dev Biol 265, 234-245. 
 
Lin, C.H., Tapscott, S.J., Olson, J.M., 2006. Congenital hypothyroidism (cretinism) in 
neuroD2-deficient mice. Mol Cell Biol 26, 4311-4315. 
 
Lipsky, R.H., Marini, A.M., 2007. Brain-derived neurotrophic factor in neuronal survival 
and behavior-related plasticity. Ann N Y Acad Sci 1122, 130-143. 
 
Liu, M., Pereira, F.A., Price, S.D., Chu, M.J., Shope, C., Himes, D., Eatock, R.A., Brownell, 
W.E., Lysakowski, A., Tsai, M.J., 2000a. Essential role of BETA2/NeuroD1 in 
development of the vestibular and auditory systems. Genes Dev 14, 2839-2854. 
 
Liu, M., Pleasure, S.J., Collins, A.E., Noebels, J.L., Naya, F.J., Tsai, M.J., Lowenstein, D.H., 
2000b. Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. 
Proc Natl Acad Sci U S A 97, 865-870. 
 
Liu, X., Wang, Q., Haydar, T.F., Bordey, A., 2005. Nonsynaptic GABA signaling in 
postnatal subventricular zone controls proliferation of GFAP-expressing progenitors. 
Nat Neurosci 8, 1179-1187. 
 
Lledo, P.M., Alonso, M., Grubb, M.S., 2006. Adult neurogenesis and functional plasticity 
in neuronal circuits. Nat Rev Neurosci 7, 179-193. 
 
Lledo, P.M., Gheusi, G., Vincent, J.D., 2005. Information processing in the mammalian 
olfactory system. Physiol Rev 85, 281-317. 
 
Lledo, P.M., Saghatelyan, A., 2005. Integrating new neurons into the adult olfactory bulb: 
joining the network, life-death decisions, and the effects of sensory experience. Trends 
Neurosci 28, 248-254. 
 
Lledo, P.M., Saghatelyan, A., Lemasson, M., 2004. Inhibitory interneurons in the olfactory 
bulb: from development to function. Neuroscientist 10, 292-303. 
 
Lobo, M.K., Karsten, S.L., Gray, M., Geschwind, D.H., Yang, X.W., 2006. FACS-array 
profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat 
Neurosci 9, 443-452. 
 
Loeb, J.E., Chauveau, J., 1969. [Preparation of DNA by filtration on agarose gel]. Biochim 
Biophys Acta 182, 225-234. 
 
References 
   
143 
Lois, C., Alvarez-Buylla, A., 1994. Long-distance neuronal migration in the adult 
mammalian brain. Science 264, 1145-1148. 
 
Lois, C., Garcia-Verdugo, J.M., Alvarez-Buylla, A., 1996. Chain migration of neuronal 
precursors. Science 271, 978-981. 
 
Madsen, K.K., Larsson, O.M., Schousboe, A., 2008. Regulation of excitation by GABA 
neurotransmission: focus on metabolism and transport. Results Probl Cell Differ 44, 201-
221. 
 
Marin, O., Anderson, S.A., Rubenstein, J.L., 2000. Origin and molecular specification of 
striatal interneurons. J Neurosci 20, 6063-6076. 
 
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., Wu, C., 2004. 
Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5, 793-807. 
 
Marshall, C.A., Novitch, B.G., Goldman, J.E., 2005. Olig2 directs astrocyte and 
oligodendrocyte formation in postnatal subventricular zone cells. J Neurosci 25, 7289-
7298. 
 
Marsich, E., Vetere, A., Di Piazza, M., Tell, G., Paoletti, S., 2003. The PAX6 gene is 
activated by the basic helix-loop-helix transcription factor NeuroD/BETA2. Biochem J 
376, 707-715. 
 
Martin, N., Jaubert, J., Gounon, P., Salido, E., Haase, G., Szatanik, M., Guenet, J.L., 2002. A 
missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat Genet 
32, 443-447. 
 
Mason, H.A., Ito, S., Corfas, G., 2001. Extracellular signals that regulate the tangential 
migration of olfactory bulb neuronal precursors: inducers, inhibitors, and repellents. J 
Neurosci 21, 7654-7663. 
 
Mates, L., Korpos, E., Deak, F., Liu, Z., Beier, D.R., Aszodi, A., Kiss, I., 2002. Comparative 
analysis of the mouse and human genes (Matn2 and MATN2) for matrilin-2, a filament-
forming protein widely distributed in extracellular matrices. Matrix Biol 21, 163-174. 
 
Matter, M.L., Laurie, G.W., 1994. A novel laminin E8 cell adhesion site required for lung 
alveolar formation in vitro. J Cell Biol 124, 1083-1090. 
 
Mattson, M.P., 2000. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1, 
120-129. 
 
McEvilly, R.J., de Diaz, M.O., Schonemann, M.D., Hooshmand, F., Rosenfeld, M.G., 2002. 
Transcriptional regulation of cortical neuron migration by POU domain factors. Science 
295, 1528-1532. 
 
Melcher, T., Maas, S., Herb, A., Sprengel, R., Higuchi, M., Seeburg, P.H., 1996. RED2, a 
brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem 
271, 31795-31798. 
References 
   
144 
Menet, V., Prieto, M., Privat, A., Gimenez y Ribotta, M., 2003. Axonal plasticity and 
functional recovery after spinal cord injury in mice deficient in both glial fibrillary 
acidic protein and vimentin genes. Proc Natl Acad Sci U S A 100, 8999-9004. 
 
Merkle, F.T., Alvarez-Buylla, A., 2006. Neural stem cells in mammalian development. 
Curr Opin Cell Biol 18, 704-709. 
 
Merkle, F.T., Mirzadeh, Z., Alvarez-Buylla, A., 2007. Mosaic organization of neural stem 
cells in the adult brain. Science 317, 381-384. 
 
Merkle, F.T., Tramontin, A.D., Garcia-Verdugo, J.M., Alvarez-Buylla, A., 2004. Radial glia 
give rise to adult neural stem cells in the subventricular zone. Proc Natl Acad Sci U S A 
101, 17528-17532. 
 
Merson, T.D., Dixon, M.P., Collin, C., Rietze, R.L., Bartlett, P.F., Thomas, T., Voss, A.K., 
2006. The transcriptional coactivator Querkopf controls adult neurogenesis. J Neurosci 
26, 11359-11370. 
 
Mie, M., Endoh, T., Yanagida, Y., Kobatake, E., Aizawa, M., 2003. Induction of neural 
differentiation by electrically stimulated gene expression of NeuroD2. J Biotechnol 100, 
231-238. 
 
Miltenyi, S., Muller, W., Weichel, W., Radbruch, A., 1990. High gradient magnetic cell 
separation with MACS. Cytometry 11, 231-238. 
 
Ming, G.L., Song, H., 2005. Adult neurogenesis in the mammalian central nervous 
system. Annu Rev Neurosci 28, 223-250. 
 
Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R.E., Gottmann, K., 
Sudhof, T.C., 2003. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. 
Nature 423, 939-948. 
 
Mittaz, L., Antonarakis, S.E., Higuchi, M., Scott, H.S., 1997. Localization of a novel human 
RNA-editing deaminase (hRED2 or ADARB2) to chromosome 10p15. Hum Genet 100, 
398-400. 
 
Miyata, T., Maeda, T., Lee, J.E., 1999. NeuroD is required for differentiation of the 
granule cells in the cerebellum and hippocampus. Genes Dev 13, 1647-1652. 
 
Mizrahi, A., 2007. Dendritic development and plasticity of adult-born neurons in the 
mouse olfactory bulb. Nat Neurosci 10, 444-452. 
 
Monyer, H., Markram, H., 2004. Interneuron Diversity series: Molecular and genetic tools 
to study GABAergic interneuron diversity and function. Trends Neurosci 27, 90-97. 
 
Moretti, P., Levenson, J.M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, 
D., Arancio, O., Sweatt, J.D., Zoghbi, H.Y., 2006. Learning and memory and synaptic 
plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 26, 319-327. 
 
References 
   
145 
Morin, X., Jaouen, F., Durbec, P., 2007. Control of planar divisions by the G-protein 
regulator LGN maintains progenitors in the chick neuroepithelium. Nat Neurosci 10, 
1440-1448. 
 
Morse, D.E., Duncan, H., Hooker, N., Baloun, A., Young, G., 1980. GABA induces 
behavioral and developmental metamorphosis in planktonic molluscan larvae. Fed Proc 
39, 3237-3241. 
 
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., Erlich, H., 1986. Specific enzymatic 
amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp 
Quant Biol 51 Pt 1, 263-273. 
 
Murase, S., Horwitz, A.F., 2002. Deleted in colorectal carcinoma and differentially 
expressed integrins mediate the directional migration of neural precursors in the rostral 
migratory stream. J Neurosci 22, 3568-3579. 
 
Murray, V., 1989. Improved double-stranded DNA sequencing using the linear 
polymerase chain reaction. Nucleic Acids Res 17, 8889. 
 
Naeve, G.S., Vana, A.M., Eggold, J.R., Verge, G., Ling, N., Foster, A.C., 2000. Expression 
of rat insulin-like growth factor binding protein-6 in the brain, spinal cord, and sensory 
ganglia. Brain Res Mol Brain Res 75, 185-197. 
 
Nguyen-Ba-Charvet, K.T., Picard-Riera, N., Tessier-Lavigne, M., Baron-Van Evercooren, A., 
Sotelo, C., Chedotal, A., 2004. Multiple roles for slits in the control of cell migration in 
the rostral migratory stream. J Neurosci 24, 1497-1506. 
 
Nikoletopoulou, V., Plachta, N., Allen, N.D., Pinto, L., Gotz, M., Barde, Y.A., 2007. 
Neurotrophin Receptor-Mediated Death of Misspecified Neurons Generated from 
Embryonic Stem Cells Lacking Pax6. Cell Stem Cell 1, 529-540. 
 
Noctor, S.C., Martinez-Cerdeno, V., Ivic, L., Kriegstein, A.R., 2004. Cortical neurons arise 
in symmetric and asymmetric division zones and migrate through specific phases. Nat 
Neurosci 7, 136-144. 
 
Noda, T., Kawamura, R., Funabashi, H., Mie, M., Kobatake, E., 2006. Transduction of 
NeuroD2 protein induced neural cell differentiation. J Biotechnol 126, 230-236. 
 
Okazaki, Y., Furuno, M., Kasukawa, T., Adachi, J., Bono, H., Kondo, S., Nikaido, I., Osato, 
N., Saito, R., Suzuki, H., Yamanaka, I., Kiyosawa, H., Yagi, K., Tomaru, Y., Hasegawa, Y., 
Nogami, A., Schonbach, C., Gojobori, T., Baldarelli, R., Hill, D.P., Bult, C., Hume, D.A., 
Quackenbush, J., Schriml, L.M., Kanapin, A., Matsuda, H., Batalov, S., Beisel, K.W., Blake, 
J.A., Bradt, D., Brusic, V., Chothia, C., Corbani, L.E., Cousins, S., Dalla, E., Dragani, T.A., 
Fletcher, C.F., Forrest, A., Frazer, K.S., Gaasterland, T., Gariboldi, M., Gissi, C., Godzik, A., 
Gough, J., Grimmond, S., Gustincich, S., Hirokawa, N., Jackson, I.J., Jarvis, E.D., Kanai, A., 
Kawaji, H., Kawasawa, Y., Kedzierski, R.M., King, B.L., Konagaya, A., Kurochkin, I.V., 
Lee, Y., Lenhard, B., Lyons, P.A., Maglott, D.R., Maltais, L., Marchionni, L., McKenzie, L., 
Miki, H., Nagashima, T., Numata, K., Okido, T., Pavan, W.J., Pertea, G., Pesole, G., 
Petrovsky, N., Pillai, R., Pontius, J.U., Qi, D., Ramachandran, S., Ravasi, T., Reed, J.C., 
Reed, D.J., Reid, J., Ring, B.Z., Ringwald, M., Sandelin, A., Schneider, C., Semple, C.A., 
Setou, M., Shimada, K., Sultana, R., Takenaka, Y., Taylor, M.S., Teasdale, R.D., Tomita, M., 
References 
   
146 
Verardo, R., Wagner, L., Wahlestedt, C., Wang, Y., Watanabe, Y., Wells, C., Wilming, L.G., 
Wynshaw-Boris, A., Yanagisawa, M., Yang, I., Yang, L., Yuan, Z., Zavolan, M., Zhu, Y., 
Zimmer, A., Carninci, P., Hayatsu, N., Hirozane-Kishikawa, T., Konno, H., Nakamura, M., 
Sakazume, N., Sato, K., Shiraki, T., Waki, K., Kawai, J., Aizawa, K., Arakawa, T., Fukuda, 
S., Hara, A., Hashizume, W., Imotani, K., Ishii, Y., Itoh, M., Kagawa, I., Miyazaki, A., Sakai, 
K., Sasaki, D., Shibata, K., Shinagawa, A., Yasunishi, A., Yoshino, M., Waterston, R., 
Lander, E.S., Rogers, J., Birney, E., Hayashizaki, Y., 2002. Analysis of the mouse 
transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420, 
563-573. 
 
Ono, K., Tomasiewicz, H., Magnuson, T., Rutishauser, U., 1994. N-CAM mutation inhibits 
tangential neuronal migration and is phenocopied by enzymatic removal of polysialic 
acid. Neuron 13, 595-609. 
 
Owens, D.F., Kriegstein, A.R., 2002a. Developmental neurotransmitters? Neuron 36, 989-
991. 
 
Owens, D.F., Kriegstein, A.R., 2002b. Is there more to GABA than synaptic inhibition? 
Nat Rev Neurosci 3, 715-727. 
 
Paik, J.H., Skoura, A., Chae, S.S., Cowan, A.E., Han, D.K., Proia, R.L., Hla, T., 2004. 
Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular 
stabilization. Genes Dev 18, 2392-2403. 
 
Pajor, A.M., Gangula, R., Yao, X., 2001. Cloning and functional characterization of a 
high-affinity Na(+)/dicarboxylate cotransporter from mouse brain. Am J Physiol Cell 
Physiol 280, C1215-1223. 
 
Pak, W., Hindges, R., Lim, Y.S., Pfaff, S.L., O'Leary, D.D., 2004. Magnitude of binocular 
vision controlled by islet-2 repression of a genetic program that specifies laterality of 
retinal axon pathfinding. Cell 119, 567-578. 
 
Palmada, M., Centelles, J.J., 1998. Excitatory amino acid neurotransmission. Pathways 
for metabolism, storage and reuptake of glutamate in brain. Front Biosci 3, d701-718. 
 
Pan, J., You, Y., Huang, T., Brody, S.L., 2007. RhoA-mediated apical actin enrichment is 
required for ciliogenesis and promoted by Foxj1. J Cell Sci 120, 1868-1876. 
 
Panzanelli, P., Fritschy, J.M., Yanagawa, Y., Obata, K., Sassoe-Pognetto, M., 2007. 
GABAergic phenotype of periglomerular cells in the rodent olfactory bulb. J Comp 
Neurol 502, 990-1002. 
 
Parnavelas, J.G., Alifragis, P., Nadarajah, B., 2002. The origin and migration of cortical 
neurons. Prog Brain Res 136, 73-80. 
 
Parnavelas, J.G., Anderson, S.A., Lavdas, A.A., Grigoriou, M., Pachnis, V., Rubenstein, J.L., 
2000. The contribution of the ganglionic eminence to the neuronal cell types of the 
cerebral cortex. Novartis Found Symp 228, 129-139; discussion 139-147. 
 
Parrish-Aungst, S., Shipley, M.T., Erdelyi, F., Szabo, G., Puche, A.C., 2007. Quantitative 
analysis of neuronal diversity in the mouse olfactory bulb. J Comp Neurol 501, 825-836. 
References 
   
147 
Pascual, M., Abasolo, I., Mingorance-Le Meur, A., Martinez, A., Del Rio, J.A., Wright, C.V., 
Real, F.X., Soriano, E., 2007. Cerebellar GABAergic progenitors adopt an external 
granule cell-like phenotype in the absence of Ptf1a transcription factor expression. Proc 
Natl Acad Sci U S A 104, 5193-5198. 
 
Pennartz, S., Belvindrah, R., Tomiuk, S., Zimmer, C., Hofmann, K., Conradt, M., Bosio, A., 
Cremer, H., 2004. Purification of neuronal precursors from the adult mouse brain: 
comprehensive gene expression analysis provides new insights into the control of cell 
migration, differentiation, and homeostasis. Mol Cell Neurosci 25, 692-706. 
 
Pennesi, M.E., Cho, J.H., Yang, Z., Wu, S.H., Zhang, J., Wu, S.M., Tsai, M.J., 2003. 
BETA2/NeuroD1 null mice: a new model for transcription factor-dependent 
photoreceptor degeneration. J Neurosci 23, 453-461. 
 
Peters, A., Kara, D.A., Harriman, K.M., 1985. The neuronal composition of area 17 of rat 
visual cortex. III. Numerical considerations. J Comp Neurol 238, 263-274. 
 
Phillips, W., Morton, A.J., Barker, R.A., 2005. Abnormalities of neurogenesis in the R6/2 
mouse model of Huntington's disease are attributable to the in vivo microenvironment. J 
Neurosci 25, 11564-11576. 
 
Radbruch, A., Mechtold, B., Thiel, A., Miltenyi, S., Pfluger, E., 1994. High-gradient 
magnetic cell sorting. Methods Cell Biol 42 Pt B, 387-403. 
 
Ramon, Y.C.S., 1952. Structure and connections of neurons. Bull Los Angel Neuro Soc 17, 
5-46. 
 
Reif, A., Schmitt, A., Fritzen, S., Chourbaji, S., Bartsch, C., Urani, A., Wycislo, M., Mossner, 
R., Sommer, C., Gass, P., Lesch, K.P., 2004. Differential effect of endothelial nitric oxide 
synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J 
Neurosci 20, 885-895. 
 
Roberts, E., Frankel, S., 1950. gamma-Aminobutyric acid in brain: its formation from 
glutamic acid. J Biol Chem 187, 55-63. 
 
Rohner-Jeanrenaud, F., Cusin, I., Sainsbury, A., Zakrzewska, K.E., Jeanrenaud, B., 1996. The 
loop system between neuropeptide Y and leptin in normal and obese rodents. Horm 
Metab Res 28, 642-648. 
 
Rutishauser, U., 1996. Polysialic acid and the regulation of cell interactions. Curr Opin 
Cell Biol 8, 679-684. 
 
Saeed, A.I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., 
Currier, T., Thiagarajan, M., Sturn, A., Snuffin, M., Rezantsev, A., Popov, D., Ryltsov, A., 
Kostukovich, E., Borisovsky, I., Liu, Z., Vinsavich, A., Trush, V., Quackenbush, J., 2003. 
TM4: a free, open-source system for microarray data management and analysis. 
Biotechniques 34, 374-378. 
 
Saghatelyan, A., de Chevigny, A., Schachner, M., Lledo, P.M., 2004. Tenascin-R mediates 
activity-dependent recruitment of neuroblasts in the adult mouse forebrain. Nat 
Neurosci 7, 347-356. 
References 
   
148 
Saghatelyan, A., Roux, P., Migliore, M., Rochefort, C., Desmaisons, D., Charneau, P., 
Shepherd, G.M., Lledo, P.M., 2005. Activity-dependent adjustments of the inhibitory 
network in the olfactory bulb following early postnatal deprivation. Neuron 46, 103-116. 
 
Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B., 
Erlich, H.A., 1988. Primer-directed enzymatic amplification of DNA with a thermostable 
DNA polymerase. Science 239, 487-491. 
 
Saino-Saito, S., Sasaki, H., Volpe, B.T., Kobayashi, K., Berlin, R., Baker, H., 2004. 
Differentiation of the dopaminergic phenotype in the olfactory system of neonatal and 
adult mice. J Comp Neurol 479, 389-398. 
 
Saito, T., Nakatsuji, N., 2001. Efficient gene transfer into the embryonic mouse brain 
using in vivo electroporation. Dev Biol 240, 237-246. 
 
Salama-Cohen, P., Arevalo, M.A., Grantyn, R., Rodriguez-Tebar, A., 2006. Notch and 
NGF/p75NTR control dendrite morphology and the balance of excitatory/inhibitory 
synaptic input to hippocampal neurones through Neurogenin 3. J Neurochem 97, 1269-
1278. 
 
Sambrook, J., Russell, D.W., 2001. Molecular cloning: a laboratory manual. Cold Spring 
Harbor Laboratory Press, Cold Spring Harbor, New York. 
 
Sanai, N., Tramontin, A.D., Quinones-Hinojosa, A., Barbaro, N.M., Gupta, N., Kunwar, S., 
Lawton, M.T., McDermott, M.W., Parsa, A.T., Manuel-Garcia Verdugo, J., Berger, M.S., 
Alvarez-Buylla, A., 2004. Unique astrocyte ribbon in adult human brain contains neural 
stem cells but lacks chain migration. Nature 427, 740-744. 
 
Sanger, F., Nicklen, S., Coulson, A.R., 1977. DNA sequencing with chain-terminating 
inhibitors. Proc Natl Acad Sci U S A 74, 5463-5467. 
 
Sawamoto, K., Nakao, N., Kobayashi, K., Matsushita, N., Takahashi, H., Kakishita, K., 
Yamamoto, A., Yoshizaki, T., Terashima, T., Murakami, F., Itakura, T., Okano, H., 2001. 
Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. 
Proc Natl Acad Sci U S A 98, 6423-6428. Epub 2001 May 6415. 
 
Schmid, R.S., Jo, R., Shelton, S., Kreidberg, J.A., Anton, E.S., 2005. Reelin, integrin and 
DAB1 interactions during embryonic cerebral cortical development. Cereb Cortex 15, 
1632-1636. 
 
Schoppa, N.E., Urban, N.N., 2003. Dendritic processing within olfactory bulb circuits. 
Trends Neurosci 26, 501-506. 
 
Schulman, J.A., Bloom, F.E., 1981. Golgi cells of the cerebellum are inhibited by inferior 
olive activity. Brain Res 210, 350-355. 
 
Schwab, M.H., Bartholomae, A., Heimrich, B., Feldmeyer, D., Druffel-Augustin, S., 
Goebbels, S., Naya, F.J., Zhao, S., Frotscher, M., Tsai, M.J., Nave, K.A., 2000. Neuronal 
basic helix-loop-helix proteins (NEX and BETA2/Neuro D) regulate terminal granule 
cell differentiation in the hippocampus. J Neurosci 20, 3714-3724. 
 
References 
   
149 
Shah, R., Medina-Martinez, O., Chu, L.F., Samaco, R.C., Jamrich, M., 2006. Expression of 
FoxP2 during zebrafish development and in the adult brain. Int J Dev Biol 50, 435-438. 
 
Shimogori, T., Ogawa, M., 2008. Gene application with in utero electroporation in mouse 
embryonic brain. Dev Growth Differ. 
 
Shu, T., Butz, K.G., Plachez, C., Gronostajski, R.M., Richards, L.J., 2003. Abnormal 
development of forebrain midline glia and commissural projections in Nfia knock-out 
mice. J Neurosci 23, 203-212. 
 
Silberberg, G., Wu, C., Markram, H., 2004. Synaptic dynamics control the timing of 
neuronal excitation in the activated neocortical microcircuit. J Physiol 556, 19-27. 
 
Snyder, J.S., Kee, N., Wojtowicz, J.M., 2001. Effects of adult neurogenesis on synaptic 
plasticity in the rat dentate gyrus. J Neurophysiol 85, 2423-2431. 
 
Sotelo, C., 1990. Cerebellar synaptogenesis: what we can learn from mutant mice. J Exp 
Biol 153, 225-249. 
 
Stankovic, R.K., 2005. Atrophy of large myelinated axons in metallothionein-I, II 
knockout mice. Cell Mol Neurobiol 25, 943-953. 
 
Steele, A.D., Emsley, J.G., Ozdinler, P.H., Lindquist, S., Macklis, J.D., 2006. Prion protein 
(PrPc) positively regulates neural precursor proliferation during developmental and 
adult mammalian neurogenesis. Proc Natl Acad Sci U S A 103, 3416-3421. 
 
Stenqvist, A., Agerman, K., Marmigere, F., Minichiello, L., Ernfors, P., 2005. Genetic 
evidence for selective neurotrophin 3 signalling through TrkC but not TrkB in vivo. 
EMBO Rep 6, 973-978. 
 
Stoykova, A., Fritsch, R., Walther, C., Gruss, P., 1996. Forebrain patterning defects in 
Small eye mutant mice. Development 122, 3453-3465. 
 
Stuhmer, T., Anderson, S.A., Ekker, M., Rubenstein, J.L., 2002a. Ectopic expression of the 
Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 129, 
245-252. 
 
Stuhmer, T., Puelles, L., Ekker, M., Rubenstein, J.L., 2002b. Expression from a Dlx gene 
enhancer marks adult mouse cortical GABAergic neurons. Cereb Cortex 12, 75-85. 
 
Taglialatela, P., Soria, J.M., Caironi, V., Moiana, A., Bertuzzi, S., 2004. Compromised 
generation of GABAergic interneurons in the brains of Vax1-/- mice. Development 131, 
4239-4249. 
 
Takahashi, M., Ogino, T., Baba, K., 1969. Estimation of relative molecular length of DNA 
by electrophoresis in agarose gel. Biochim Biophys Acta 174, 183-187. 
 
Takahashi, S., Inatome, R., Yamamura, H., Yanagi, S., 2003. Isolation and expression of a 
novel mitochondrial septin that interacts with CRMP/CRAM in the developing 
neurones. Genes Cells 8, 81-93. 
 
References 
   
150 
Takash, W., Canizares, J., Bonneaud, N., Poulat, F., Mattei, M.G., Jay, P., Berta, P., 2001. 
SOX7 transcription factor: sequence, chromosomal localisation, expression, 
transactivation and interference with Wnt signalling. Nucleic Acids Res 29, 4274-4283. 
 
Takayasu, S., Sakurai, T., Iwasaki, S., Teranishi, H., Yamanaka, A., Williams, S.C., Iguchi, 
H., Kawasawa, Y.I., Ikeda, Y., Sakakibara, I., Ohno, K., Ioka, R.X., Murakami, S., Dohmae, 
N., Xie, J., Suda, T., Motoike, T., Ohuchi, T., Yanagisawa, M., Sakai, J., 2006. A 
neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, 
behavioral arousal, and blood pressure in mice. Proc Natl Acad Sci U S A 103, 7438-7443. 
 
Tamamaki, N., Yanagawa, Y., Tomioka, R., Miyazaki, J., Obata, K., Kaneko, T., 2003. 
Green fluorescent protein expression and colocalization with calretinin, parvalbumin, 
and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467, 60-79. 
 
Tao, W.A., Wollscheid, B., O'Brien, R., Eng, J.K., Li, X.J., Bodenmiller, B., Watts, J.D., 
Hood, L., Aebersold, R., 2005. Quantitative phosphoproteome analysis using a dendrimer 
conjugation chemistry and tandem mass spectrometry. Nat Methods 2, 591-598. 
 
Thomas, T., Voss, A.K., 2004. Querkopf, a histone acetyltransferase, is essential for 
embryonic neurogenesis. Front Biosci 9, 24-31. 
 
Thomas, T., Voss, A.K., Chowdhury, K., Gruss, P., 2000. Querkopf, a MYST family 
histone acetyltransferase, is required for normal cerebral cortex development. 
Development 127, 2537-2548. 
 
Titomanlio, L., Pierri, N.B., Romano, A., Imperati, F., Borrelli, M., Barletta, V., Diano, A.A., 
Castaldo, I., Santoro, L., Del Giudice, E., 2005. Cerebellar vermis aplasia: patient report 
and exclusion of the candidate genes EN2 and ZIC1. Am J Med Genet A 136, 198-200. 
 
Tomasiewicz, H., Ono, K., Yee, D., Thompson, C., Goridis, C., Rutishauser, U., Magnuson, 
T., 1993. Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) 
produces distinct defects in the central nervous system. Neuron 11, 1163-1174. 
 
Treloar, H.B., Feinstein, P., Mombaerts, P., Greer, C.A., 2002. Specificity of glomerular 
targeting by olfactory sensory axons. J Neurosci 22, 2469-2477. 
 
Tusher, V.G., Tibshirani, R., Chu, G., 2001. Significance analysis of microarrays applied 
to the ionizing radiation response. Proc Natl Acad Sci U S A 98, 5116-5121. 
 
Urban, N.N., 2002. Lateral inhibition in the olfactory bulb and in olfaction. Physiol Behav 
77, 607-612. 
 
Varoqueaux, F., Jamain, S., Brose, N., 2004. Neuroligin 2 is exclusively localized to 
inhibitory synapses. Eur J Cell Biol 83, 449-456. 
 
Vasilyev, D.V., Barish, M.E., 2003. Regulation of an inactivating potassium current (IA) 
by the extracellular matrix protein vitronectin in embryonic mouse hippocampal 
neurones. J Physiol 547, 859-871. 
References 
   
151 
Veyrac, A., Giannetti, N., Charrier, E., Reymond-Marron, I., Aguera, M., Rogemond, V., 
Honnorat, J., Jourdan, F., 2005. Expression of collapsin response mediator proteins 1, 2 
and 5 is differentially regulated in newly generated and mature neurons of the adult 
olfactory system. Eur J Neurosci 21, 2635-2648. 
 
Viollet, C., Bodenant, C., Prunotto, C., Roosterman, D., Schaefer, J., Meyerhof, W., 
Epelbaum, J., Vaudry, H., Leroux, P., 1997. Differential expression of multiple 
somatostatin receptors in the rat cerebellum during development. J Neurochem 68, 2263-
2272. 
 
Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., Richardson, E.P., Jr., 
1985. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 
44, 559-577. 
 
Waclaw, R.R., Allen, Z.J., 2nd, Bell, S.M., Erdelyi, F., Szabo, G., Potter, S.S., Campbell, K., 
2006. The zinc finger transcription factor Sp8 regulates the generation and diversity of 
olfactory bulb interneurons. Neuron 49, 503-516. 
 
Wang, W., Stock, R.E., Gronostajski, R.M., Wong, Y.W., Schachner, M., Kilpatrick, D.L., 
2004. A role for nuclear factor I in the intrinsic control of cerebellar granule neuron 
gene expression. J Biol Chem 279, 53491-53497. 
 
Wichterle, H., Garcia-Verdugo, J.M., Alvarez-Buylla, A., 1997. Direct evidence for 
homotypic, glia-independent neuronal migration. Neuron 18, 779-791. 
 
Wijchers, P.J., Hoekman, M.F., Burbach, J.P., Smidt, M.P., 2006. Identification of forkhead 
transcription factors in cortical and dopaminergic areas of the adult murine brain. Brain 
Res 1068, 23-33. 
 
Wonders, C., Anderson, S.A., 2005. Cortical interneurons and their origins. Neuroscientist 
11, 199-205. 
 
Wonders, C.P., Anderson, S.A., 2006. The origin and specification of cortical 
interneurons. Nat Rev Neurosci 7, 687-696. 
 
Wright, C.V., Cho, K.W., Oliver, G., De Robertis, E.M., 1989. Vertebrate homeodomain 
proteins: families of region-specific transcription factors. Trends Biochem Sci 14, 52-56. 
 
Wu, W., Wong, K., Chen, J., Jiang, Z., Dupuis, S., Wu, J.Y., Rao, Y., 1999. Directional 
guidance of neuronal migration in the olfactory system by the protein Slit. Nature 400, 
331-336. 
 
Wurst, W., Auerbach, A.B., Joyner, A.L., 1994. Multiple developmental defects in 
Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in 
forelimbs and sternum. Development 120, 2065-2075. 
 
Xu, Q., Cobos, I., De La Cruz, E., Rubenstein, J.L., Anderson, S.A., 2004. Origins of 
cortical interneuron subtypes. J Neurosci 24, 2612-2622. 
References 
   
152 
Yamashita, N., Uchida, Y., Ohshima, T., Hirai, S., Nakamura, F., Taniguchi, M., Mikoshiba, 
K., Honnorat, J., Kolattukudy, P., Thomasset, N., Takei, K., Takahashi, T., Goshima, Y., 
2006. Collapsin response mediator protein 1 mediates reelin signaling in cortical 
neuronal migration. J Neurosci 26, 13357-13362. 
 
Yang, F.C., Chen, S., Robling, A.G., Yu, X., Nebesio, T.D., Yan, J., Morgan, T., Li, X., 
Yuan, J., Hock, J., Ingram, D.A., Clapp, D.W., 2006. Hyperactivation of p21ras and PI3K 
cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient 
osteoclast functions. J Clin Invest 116, 2880-2891. 
 
Yin, A.H., Miraglia, S., Zanjani, E.D., Almeida-Porada, G., Ogawa, M., Leary, A.G., Olweus, 
J., Kearney, J., Buck, D.W., 1997. AC133, a novel marker for human hematopoietic stem 
and progenitor cells. Blood 90, 5002-5012. 
 
Yoshihara, S., Omichi, K., Yanazawa, M., Kitamura, K., Yoshihara, Y., 2005. Arx 
homeobox gene is essential for development of mouse olfactory system. Development 132, 
751-762. 
 
Young, K.M., Fogarty, M., Kessaris, N., Richardson, W.D., 2007. Subventricular zone stem 
cells are heterogeneous with respect to their embryonic origins and neurogenic fates in 
the adult olfactory bulb. J Neurosci 27, 8286-8296. 
 
Zhang, H., Li, X.J., Martin, D.B., Aebersold, R., 2003. Identification and quantification of 
N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass 
spectrometry. Nat Biotechnol 21, 660-666. 
 
Zhao, M., Momma, S., Delfani, K., Carlen, M., Cassidy, R.M., Johansson, C.B., Brismar, H., 
Shupliakov, O., Frisen, J., Janson, A.M., 2003. Evidence for neurogenesis in the adult 
mammalian substantia nigra. Proc Natl Acad Sci U S A 100, 7925-7930. 
 
Zhao, Y., Kwan, K.M., Mailloux, C.M., Lee, W.K., Grinberg, A., Wurst, W., Behringer, R.R., 
Westphal, H., 2007. LIM-homeodomain proteins Lhx1 and Lhx5, and their cofactor 
Ldb1, control Purkinje cell differentiation in the developing cerebellum. Proc Natl Acad 
Sci U S A 104, 13182-13186. 
 
Zheng, W., Nowakowski, R.S., Vaccarino, F.M., 2004. Fibroblast growth factor 2 is 
required for maintaining the neural stem cell pool in the mouse brain subventricular 
zone. Dev Neurosci 26, 181-196. 
 
 
Acknowledgement 
   
153 
Acknowledgement 
I am very grateful to Prof. Dr. Knebel-Mörsdorf, who supported this work by her supervision 
and her kind and helpful advice and Prof. Dr. Korsching for taking over the second review. 
I am sincerely grateful to my supervisors at Miltenyi Biotec and the Developmental Biology 
Institute of Marseille (IBDML), Dr. Andreas Bosio and Dr. Harold Cremer, for initiation of 
this project, scientific and personal support, critical comments and useful advice throughout 
the whole time. 
I would like to thank Stefan Miltenyi for providing me with the opportunity to perform this 
PhD-thesis at Miltenyi Biotec GmbH, Cologne. I thank the whole Miltenyi Biotec team for 
the great atmosphere and all the support. Many thanks to Dr. Hartmut Scheel, Dr. Stefan 
Tomiuk, Dr. Corinna Scholz and Dr. Kay Hofmann for bioinformatical support and nice 
hiking trips. I would like to thank Dr. Frank Single, Dr. Alena Bencsik and all further 
members of the “Transgenic” team for discussions and support concerning mouse techniques 
and breeding. I would like to thank Daniel Küsters and Dr. Sandra Pennartz for their support 
concerning the in situ hybridizations, tissue dissociation and further questions. Special thanks 
belong to Gerd Großhauser, Dirk Dietrich, Dr. Sebastian Knöbel and Dr. Bernhard 
Gerstmayer for enjoyable time-outs at lunch, jokes, discussions and advice. I am very grateful 
to Dr. Melanie Jungblut for helpful advice and critically reading of this manuscript. 
I would like to thank Camille Boutin, Angelique Desoeuvre and Dr. Marie-Catherine Tiveron 
for the nice and familiar atmosphere and all the support during my time in Marseille. In 
particular, I thank Camille Boutin for teaching me the in vivo electroporation technique and 
lots of other techniques as well as for her great teamwork concerning our ongoing 
collaboration. 
Thanks to Christoph Göttlinger and Birgit Mechthold from the Institute for Genetics of the 
University of Cologne for their assistance concerning the FACS experiments. 
I thank Dr. Bernd Wollscheid and Damaris Bausch for all their support concerning the 
proteome analysis during our ongoing collaboration. 
Of course, I would also like to thank my wife, my whole family and my friends for their 
support during all the time. 
 
Erklärung 
   
154 
Erklärung 
Ich versichere, dass ich die von mir vorgelegte Dissertation selbständig angefertigt, die 
benutzten Quellen und Hilfsmittel vollständig angegeben und die Stellen der Arbeit 
− einschließlich Tabellen, Karten und Abbildungen −, die anderen Werken im Wortlaut oder 
dem Sinn nach entnommen sind, in jedem Einzelfall als Entlehnung kenntlich gemacht habe; 
dass diese Dissertation noch keiner anderen Fakultät oder Universität zur Prüfung vorgelegen 
hat; dass sie − abgesehen von unten angegebenen Teilpublikationen − noch nicht 
veröffentlicht worden ist sowie, dass ich eine solche Veröffentlichung vor Abschluss des 
Promotionsverfahrens nicht vornehmen werde. Die Bestimmungen der Promotionsordnung 
sind mir bekannt. Die von mir vorgelegte Dissertation ist von Frau Prof. Dr. Knebel-Mörsdorf 
betreut worden. 
 
Köln, 06. August 2008 
 
 
 
 
Olaf Thorsten Hardt 
 
 
 
 
 
 
 
 
Teilpublikationen: 
 
Hardt, O; Scholz, C; Küsters, D; Yanagawa, Y; Pennartz, S; Cremer, H; Bosio, A; Gene 
expression analysis defines differences between region specific GABAergic neurons; 
Mol. Cell. Neurosci.; 2008; accepted 
 
 
Lebenslauf 
   
155 
Lebenslauf 
Persönliche Daten 
 
Name:    Olaf Thorsten Hardt 
Geburtsdaten:   17. April 1980 in Köln 
Familienstand:   verheiratet 
Staatsangehörigkeit:  deutsch 
 
Schulbildung 
 
08/86-06/90    Carl-Orff Grundschule, Hürth 
08/90-06/96   Elsa-Brändström Schule, Köln 
08/96-06/99   Gymnasium Hürth, Hürth 
06/99     Abitur, Hürth 
 
Grundwehrdienst 
 
07/99-04/00  Grundwehrdienst als Sanitätssoldat auf dem 
Luftwaffenstützpunkt in Roth und dem Bundessprachenamt 
in Hürth 
 
Hochschulausbildung 
 
10/00-03/05 Studium der Biologie mit den Schwerpunkten Genetik, 
Entwicklungsbiologie und Organische Chemie, Universität zu 
Köln 
09/02     Vordiplom in Biologie 
05/04-03/05 Diplomarbeit im Labor für genetische Biochemie am Institut für 
Genetik der Universität zu Köln, Betreuer: Prof. Dr. Langer 
03/05     Abschluss als Diplom-Biologe 
seit 05/05 Promotionsarbeit im Fach Genetik bei der 
Miltenyi Biotec GmbH in Köln in Kollaboration mit dem 
Developmental Biology Institute of Marseille (IBDML), 
Frankreich, Betreuerin an der Universität zu Köln: 
Prof. Dr. Knebel-Mörsdorf 
10/08  Voraussichtlicher Abschluss der Promotion an der Universität 
zu Köln 
 
Praktika 
 
05/03-08/03 und  Praktika im Labor für genetische Biochemie am Institut für 
03/05-04/05  Genetik der Universität zu Köln 
02/03-04/03 Praktikum an der University of British Columbia in Vancouver, 
Kanada 
05/00-07/00, 02/01-04/01 Werkstudent in der biologischen Forschung für 
und 08/01-09/01  Pflanzenschutz bei der Bayer AG in Monheim 
 
 
Köln, 06.August 2008 
